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V I 
This Reply Brief is submitted on behalf of Petitioners 
Johnson-Bowles Co., Inc., and Marlen V. Johnson. For 
convenience, Respondents are together referred to herein as the 
"Division." Along with their principal brief, Petitioners filed 
an Addendum comprising Exs. A through KK. For continuity, all 
exhibits attached hereto continue as Exs. LL through UU.1 
RESPONDENTS AND THEIR COUNSEL HAVE RECKLESSLY AND 
REPEATEDLY MISSTATED THE RECORD AND FACTS IN THEIR OPPOSING 
BRIEF. 
The Division's opposing brief is riddled with 
misstatements of the evidence and record. For instance, while it 
is undisputed that Petitioners did not directly violate the 
Division's March 1989, Orders prohibiting offers or sales and, 
while Petitioners were never even charged with such, the Division 
repeatedly deceives the Court by stating that they did.2 
Not content with these deceptions, the Division further 
asserts that not only did Petitioners "knowingly violate" its 
orders, they "helped others to violate" such orders. Division 
1
 Certain exhibits attached hereto relate to matters which have occurred since the date 
Petitioners' brief was filed in January, 1991. As per this Court's Order of January 22, 1991 on file herein, the 
Court may take judicial notice of these additional exhibits. 
See e j . , p. 5, Division's Opposing Brief, entitled "Nature of the Case"; p. 13, "Course of 
Proceedings and Disposition Below," deliberately ignoring that the Division amended its petitions in July 1989, 
to delete the very claim that Petitioners directly violated the Division's March 1, 1989, Summary Order; p. 14, 
"Summary of Argument", stating that, "by purchasing U.S.A. Medical stock from six Utah sellers," Petitioners 
"willfully violated the Division's order . . . ."; p. 45, The Johnsons' behavior constituted as direct and willful a 
violation of a Division order as can be imagined." Cf. p. 75, Petitioners' brief. 
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brief, p. 5. On the contrary, the Securities Advisory Board 
expressly found that Petitioners did not "sjlicit" their sellers. 
Ex. EE, 112, p. 6.3 Thus, the record is clear that Petitioners 
"helped" no one do anything. At the same time, the Division has 
filed no cross-appeal, complaining about the very findings and 
conclusions it and its counsel drafted behind Petitioners' 
backs.4 
Most disturbing and pernicious is the Division's 
repeated reference on page after page of its brief to 
Petitioners' unsolicited "purchasing" to complete outstanding 
NASD contracts as "trading". See e.g., pp. 35-36, Division 
brief. The Division thus seeks to deceive the reader into 
believing that Petitioners truly did violate the Division's March 
1989, Orders directly. On the contrary, Petitioners were never 
even charged with "trading". See Ex. L and p. 75, Petitioners1 
brief. Furthermore, Don Sorensen, Johnson-Bowles' CPA, testified 
that Johnson-Bowies' last trade in U.S.A. Medical occurred on 
February 2, 1989, nearly one month before the Division issued its 
Summary Order. R. 1042; p. 183, lines 4-6, Hearing Transcript. 
Petitioners admittedly purchased nearly 400,000 shares of 
^ In other words, Petitioners did not violate the registration provisions of §5, Securities Act of 
1933, or Utah's counterpart, Utah Code Ann. §61-1-7, because they neither offered, sold, nor made an offer to 
buy any securities. Section 5, Securities Act of 1933, Vol. 1, Fed. Sec. L. Rep. (CCH) 1567 at p. 1576, Rel. 
#1422 (11 /21 /90) . 
4
 See pp. 79-81, Petitioners' brief. 
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U.S.A. Medical stock (out of 26 million shares issued and 
outstanding) from 7 individuals "during March 1989." However, 
private, unsolicited purchases between informed, consenting 
adults is not "trading" because such transactions are 
"off-market". If the Division is correct and an "off-market," 
unsolicited, private purchase is tantamount to "trading", then 
anyone who has ever bought or sold stock privately should 
register as a securities broker-dealer.5 
In its Statement of Facts, the Division further deceives 
the Court as to the very definition and purpose of "short 
selling", all as if such were relevant to Petitioners' liability. 
Division's brief, p. 6, n. 6. On the contrary, Judge Aldon 
J. Anderson recently addressed this issue in Carlson v. Bagley 
Securities, Inc., et al., U.S. District Court Case 
No. 89-C-1062A, Memorandum Opinion (DC Utah April 8, 1991), a 
true and correct copy of which is attached hereto as Ex. MM. 
Therein, Judge Anderson states: 
The authority of a broker-dealer to sell 
short is well established in the securities 
industry. See 1 T. Hazen, The Law of 
Securities Regulation §10.3 at 531 (2d ed. 
1990). Despite plaintiffs' assertion that the 
practice is "selling nothing", the ability of 
^ See definition of "dealer" which excludes a person buying or selling for his or her own account, 
Section 3(a)(5) , Securities Exchange Act of 1934, Vol. 2, Fed. Sec. L. Rep. (CCH) 1120,136 at p. 15,052. In 
addition, a person such as Petitioner Johnson who is associated with an NASD member such as 
Johnson-Bowles is permitted under the NASD Rules of Fair Practice to engage in private securities transactions. 
See §40, Private Securities Transactions, NASD Manual (CCH) 112200, pp. 2186-87, Rel. #289 (July 1988), a 
true and correct copy of which is attached hereto as Exhibit LL. 
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a broker-dealer to sell short from a trading 
account performs an important function in 
balancing supply and demand in the over-the-
counter market. [Emphasis added.] 
The Division's relentless deceit upon this Court is 
further exemplified in ill, p. 10, Division brief. Therein, the 
Division states that there was "no gap in coverage" between the 
Temporary Stop Trading Order and the Permanent Stop Trading 
Order. This brazen statement is so contrary to the facts and law 
that Rule 3 3 sanctions should be imposed on Respondents and their 
counsel. By statutory interpretation, the Summary Order of March 
1, 1989 — a relative of the Temporary Restraining Order — could 
only be effective 10-days. Utah Code Ann. §61-1-14(3), Ex. C.6 
In fact, the Division's permanent default order was not issued 
until March 29, 1989, nearly 3 weeks after the March 1, Summary 
Order had expired by operation of law. H's 7 and 9, p. 4-5, 
Findings of Fact; R. 1132-1133, Ex. EE. Yet, throughout the 
Division's opposing brief, it erroneously states that there was 
no hiatus in the orders.7 
Not content with the foregoing misstatements of the 
evidence and record, the Division proceeds with: 
There is nothing in the record that clearly 
establishes whether Otra Clearing House [sic] 
made its buy-in before the Division issued its 
Utah Code Ann, §61-1-14(3) unambiguously states: "The executive director may not extend 
any summary order for more than ten business days." In this case, the Summary Order was never extended. 
' See also pp. 40-44, Division's brief, in which it reiterates this false assertion. 
Stop Trading Order (or before Otra became 
aware of the Order). 
Division brief, p. 11, 112. Despite this statement, Marlen 
Johnson testified to the contrary at the hearing. P. 88, lines 
3-25, Hearing Transcript; R. 947.8 
Finally, the Division repeatedly engages in the crudest 
form of logical fallacy known to man: it misstates each of 
Petitioners1 arguments, thereby enabling it to refute arguments 
Petitioners never made.9 
COUNTERPOINT I 
PART OF THE FINDINGS OF FACT ARE "CLEARLY 
ERRONEOUS." NONETHELESS, THE CONCLUSIONS OF LAW 
ARE NEITHER "CORRECT," "REASONABLE" NOR "RATIONAL." 
A. Paragraph 14 of the findings of fact is "clearly 
erroneous". 
Petitioners have no dispute with the findings of fact in 
the August 13, 1990, Order other than paragraph 14 thereof. This 
is because the parties stipulated to the remainder of the 
findings on July 8, 1990. Ex. CC, Petitioners1 Addendum. 
Paragraph 14 of the findings, R. 1135, Ex. EE, states: 
14. On March 20, 1990, Respondent Marlen 
° Furthermore, since the hearing, Otra's president, John M. Whitesides, has testified at an NASD 
arbitration hearing between Petitioners and Otra that Otra knew about the Division's Summary Order. See Ex. 
NN hereto, lines 1-13, page 169 of the transcript of such arbitration hearing of which this Court may take 
judicial notice. 
Petitioners also object to being recklessly lumped together by the Division as "the 
Johnsons." Johnson-Bowles is not Marlen V. Johnson's alter ego and either one's liability herein is not 
contingent upon the alleged conduct of the other. 
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V, Johnson purchased 54,000 shares of 
U.S.A. Medical Corporation securities from 
Mr. Sax. During the instant proceeding, 
Respondent testified that he purchased those 
securities for an entity known as January 
Corporation as the means to possibly satisfy a 
pending NASD arbitration proceeding between 
Rer ondent Johnson-Bowles Company, Inc. and 
Otra Clearing, Inc. regarding the March 1, 
1989, buy-in of U.S.A. Medical Corporation 
securities by Otra Clearing, Inc. On March 
29, 1990, Respondent Marlen Vernon 
Johnson — through January Corporation — sold 
the 54,000 shares to a firm known as Sorensen, 
Chiodo & May. 
To demonstrate that findings of fact are "clearly 
erroneous," an appellant must "marshall the evidence" in support 
of such findings.10 
Petitioners have not "marshalled the evidence" in 
support of the entire findings because they have no dispute with 
the findings other than 114. Petitioners thus "marshall the 
evidence" in support of 114 of the August 13, 1990, Findings as 
follows: 
(1) In March 1990, a year after 
Petitioner Johnson's March 1989 purchases, 
Petitioner Johnson testified he purchased, for 
January Corporation, 54,000 shares of 
U.S.A. Medical from Richard Sax for the 
purpose, if necessary, of satisfying an 
outstanding NASD contract with OTRA Clearing, 
1
 ° Scharf v. BMG Corp., 700 P.2d 1068, 1070 (Utah 1985); State v. Moore, 147 Utah Adv 
Rep. 28, 32, 802 P.2d 732 (Ct. of App. 1990); State ex rel., M.S. v. Slata, 155 Utah Adv. Rep. 23, 24, _ P.2d 
_ (Ct. of App. 1991). In Saunders v. Sharp, 154 Utah Adv. Rep. 5, 6, _ P.2d _ (Utah 1991), the Utah 
Supreme Court held that if the appellant fails to marshall the evidence, the appellate court assumes the that the 
record supports the findings of the trial court and proceeds to review the accuracy of the lower court's 
conclusions of law and the application of that law in the case. Grayson Roper Ltd v. Finlinson, 782 P.2d 467, 
470 (Utah 1989). 
- 6 -
Inc., a dispute subject of NASD arbitration 
(R. 1012-1013, 1017, 959-960; p. 153, lines 
18-25, p. 154, lines 1-19, p. 158, lines 
23-24, p. 100, lines 13-25, p. 101, lines 
1-24, Hearing Transcript); 
(2) On March 29, 1990, Petitioner 
Johnson, through January Corporation, gave 
Johnson-Bowies' CPA's, Sorensen, Chiodo & May, 
a security interest in such 54,000 shares as 
collateral security for a pre-existing 
accounting bill of $15,000 (R. 1017; p. 158, 
lines 3-19, Hearing Transcript); 
(3) While January Corporation's cost 
basis in the stock was $4,290, the so-called 
"pledge" to Sorensen, Chiodo & May was 
accounted for by way of a stock confirmation 
showing a charge of $30 (R. 1018; p. 159, 
lines 5-19, Hearing Transcript); 
(4) Petitioners stipulated to the 
authenticity of all documents pertaining to 
this innocuous transaction (R. 1147-1153); 
and, 
(5) Petitioner Johnson testified at the 
hearing that the transaction was not intended 
as a "sale" of anything (R. 1013, 1017, 1018, 
and 1026; p. 154, lines 16-19, 158, lines 
10-14, p. 159, lines 10-13, p. 167, lines 
15-23, Hearing Transcript). 
The Division put on no evidence that January Corporation's March 
1990 "pledge" of 54,000 shares was anything other than what 
Mr. Johnson testified it to be, namely, collateral security (and 
good faith) for a pre-existing and outstanding accounting fee.11 
^ 1 Furthermore, if the "pledge" was indeed a "sale," why did the parties have no arrangement as 
to the extent it reduced the $15,000 debt? The fact is, the transaction had no effect on reducing the debt. Thus, 
it could not be a "sale" as it was not a disposition for Value." See former Utah Code Ann. §61- l -13(15) (a ) , 
as in effect, 1989, now amended as§13(16)(a). More importantly, the "public" was certainly not harmed by 
this transaction, nor are Sorensen, Chiodo & May complaining. 
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In fact, the Division had an opportunity to cross-examine Don 
Sorensen in this regard and it failed to do so, leaving 
Mr. Johnson's prior testimony intact and unrebutted. 
R. 1045-1049; pp. 186-190, Hearing Transcript. 
The findings in 114 were neither contemplated in nor 
embraced by the Division's July 19, 1989 Amended Petitions. 
R. I6I-I08; Ex. L. To be sure, January Corporation is not a 
party to these proceedings. Moreover, the Division made no 
motion under Rule 15(b), Utah Rules of Civil Procedure, to amend 
its Amended Petitions to conform to such "evidence". 
The foregoing constitutes the sum of all "marshalled" 
evidence by which the Securities Advisory Board, in secret and 
clandestine conjunction with the Division's counsel, Mark 
J. Griffin, "found" 114 of the August 13, 1990, Findings of Fact. 
As a result, there is no evidence to support a finding that 
January Corporation's use of 54,000 shares of U.S.A. Medical as 
collateral security on an outstanding accounting fee was a "sale" 
of securities by Johnson or Johnson-Bowles.12 
1 z
 Significantly, Rule 144 of the General Rules and Regulations of the Commission, Reg. 
§230.144, Vol. 1, Fed Sec. L. Rep. (CCH) 12705A, a true and correct copy of which is attached hereto as Ex. 
OO, provides a "safe harbor" under which certain transactions in securities are not deemed to be unlawful 
distributions of securities. Rule 144(d)(3) (iv) sets forth conditions under which a pledgee may "tack" the 
holding period of the pledgor for purposes of subsequently selling pledged stock to satisfy a debt or other 
obligation. CCH at p. 2783-84. Under the Rule, a pledge of securities is not a sale. In addition, the 
transaction in issue is not an ordinary pledge sitL ition. A typical pledge involves putting up stock as collateral 
— at the outset — in exchange for the borrowing of money. Such did not occur here as Sorensen, Chioclo & 
May had already advanced money in the form of services rendered and the 54,000 shares were put up after the 
fact to make the accountants, as prior creditors, r ,el secure. 
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Based on the foregoing, 114 is not supported by 
"substantial evidence." Grace Drilling v. Board of Review, 110 
Utah Adv. Rep. 34, 776 P.2d 63, 68 (Ut. Ct. of App. 1990). 
B. The conclusions of law are erroneous under the 
"correctness of error" and/or the "reasonableness/rationality" 
standards. 
If "findings" are "clearly erroneous," it follows, a 
fortiori, that conclusions of law based thereon must be 
erroneous. 
Nonetheless, even if findings of fact are not "clearly 
erroneous" and not against the clear weight of evidence, the 
"conclusions" may be erroneous under the "correctness of error 
standard." Bevans v. Industrial Commission, 131 Utah Adv. Rep. 
99, 790 P. 2d 573, 576 (Ut. Ct. of App. 1990). Because this case 
further requires review of mixed questions of law and fact, 
review boils down to whether the conclusions of law are 
"reasonable and rational." Pro-Benefit Staffing, Inc. v. Board 
of Review, 106 Utah Adv. Rep. 34, 775 P.2d 439, 442 (Ut. Ct. of 
App. 1989). Based on Petitioners' brief, they are not.13 
COUNTERPOINT II 
THE DIVISION MISCONSTRUES PETITIONERS1 
CONSTITUTIONAL ARGUMENTS 
J
 The conclusions of law also fail under the correction-of-error standard applicable to 
undisputed facts. Vali Convalescent v. Division of Health Care Financing, 140 Utah Adv. Rep. 21, 27, 797 P.2d 
438 (Ut. Ct. of App. 1990). 
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Contrary to the Division's baldfaced assertions, the 
"heart" of this appeal is not an argument that the Division's 
March 1989 Orders conflict with the NASD Rules of Fair Practice. 
Division brief, p. 21-26.14 Petitioners have never contended 
they were required to violate a Division order to fulfill their 
NASD obligations. Such was not put forth by Petitioners because 
it isn't true. On the contrary, the Summary Order merely sought 
to prevent innocent Utah residents from acquiring "tainted" 
U.S.A. Medical stock, an objective clearly within the police 
power of the Division. This is undisputed and it is irrelevant 
to this appeal. 
Not content with one mischaracterization on this score, 
the Division compounds its sophistry: Petitioners have never 
argued that NASD Rules "preempt" the Division's March 1, 1989 
Summary Order. Division brief, p. 21. What ij* "preempted" is an 
NASD member's obligation to comply with the NASD Rules of Fair 
Practice vis-&-vis the Division's irrational interpretation of 
its regulatory authority and purpose. For instance, the Division 
claims that dishonoring NASD executory contracts is "honest and 
ethical": the NASD takes an opposite view. See p. 13, 117, and 
pp. 25-26, Petitioners' brief. Accordingly, all of Point II of 
the Division's brief, being based on false premises, is illogical 
and fallacious. 
1 4
 Furthermore, contrary to the Division's assertions, the record is clear that this argument also 
was not, by any means, the basis of Petitioners' motion for summary judgment. Id. 
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A. Petitioners were subject to discipline by the NASD 
had they failed to honor their NASD contracts. 
The Division further deceives this Court by contending 
that Petitioners cite no authority for the proposition that had 
they failed to honor their NASD contracts, they could have been 
expelled by the NASD and fined. Division brief, p. 22. On the 
contrary, In re: Shaskan & Company, Inc., and Friedman & Company, 
authority cited in Petitioners* brief, stand for this very 
proposition. See pp. 25-26, Petitioners' Brief. Further, at 
page 9 3 of the hearing transcript, R. 952, Mr. Johnson testified 
that Ken Schaeffer, Assistant Director of the NASD in Denver told 
him that, "we had to honor the contracts under any circumstances, 
or the NASD would take charge and we would be fined." Division 
brief, p. 22, note 20. While the Division had a year and a half 
to contact Mr. Schaeffer and obtain an affidavit or other 
evidence from the NASD to the contrary, no evidence was adduced 
at the hearing to rebut the foregoing law and evidence. 
B. Petitioners were also subject to discipline by the 
NASD for failing to honor a prospective "buy-in." 
On page 23, Division brief, the Division articulates its 
grand solution to this entire case: Johnson-Bowles should have 
allowed $500,000 worth of "buy-ins" and then Petitioners would 
not have been subjected to NASD sanctions. Ironically, this 
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brilliant solution would have created more problems than ever.15 
For instance, the Petitioners, not having over $500,000 with 
which to honor s zh "buy-i. " could have been subjected to 
disciplinary actun by the NASD for the failure to I Dnor a 
"buy-in." In the Matter of the Application of Nassau Securities 
Service, November 19, 1964, SEC Ex. Act. Release No. 7464, 42 
S.E.C. 445, [f64-'66 Transfer Binder] Fed. Sec. L. .;ep. (CCH) 
177,158, Ex. PP hereto, is directly on point. In Nassau, the 
SEC, on appeal from the NASD, held that the failure of an NASD 
member who made a short sale to pay a $325 balance arising out of 
a "buy-in" executed by the purchaser was a violation of the NASD 
rules requiring members to observe "high standards of commercial 
honor and just and equitable principles of trade."16 
Consequently, the censure, fine and assessed costs imposed by the 
NASD was upheld. The claim by the applicant that its refusal was 
based on suspected fraud was not justified since the applicant 
along with some other 16 dealers, participated in making a market 
in the stock, was aware of the factors which it claims suggested 
a manipulation, and when notified of the "buy-in," it attempted 
to get another extension for delivery. 
Regardless of Nassau, an NASD disciplinary action was in 
fact initiated against Johnson-Bowles in the NASD Denver office 
" It would also have furthered the fraud because the U.S.A. Medical criminals were happily 
sitting with sell orders on the other side of every prospective "buy-in." 
1 6 In other words, Article III, §1, NASD Rules of Fair Practice, Ex. H, Petitioners' Addendum. 
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in September, 1989, NASD Complaint No. DEN-914. This complaint 
was the result of Johnson-Bowies' failure to honor the March 1, 
1989 "buy-in" undertaken by Otra. Such action was brought to the 
attention of the ALJ as set forth on pp. 822 through 825, Vol. 
Ill, of the record, Ex. QQ hereto. Unfortunately for 
Petitioners, it was ignored. 
C. Expecting Johnson-Bowles to defend several NASD 
disciplinary actions and otherwise arbitrate $500,000 worth of 
potential "buy-ins" is an irrational and ludicrous alternative. 
The Division claims that if "buy-ins" were made at 
prices Johnson-Bowles felt was too high, it could have sought 
NASD arbitration. Division brief, p. 24. Ironically, this 
occurred with respect to the Otra Clearing, Inc., "buy-in" and 
yet Petitioners have not prevailed. For example, at January end, 
1991, a panel of three NASD arbitrators made an arbitration award 
against Petitioners in an amount now totaling $108,000.00, an 
amount Otra Clearing is now seeking to convert into a judgment. 
A true and correct copy of the arbitration award, of which this 
Court may take judicial notice, is attached hereto and 
incorporated by reference as Ex. RR. Thus, the alternative that 
Petitioners should have gone out-of-business and defended several 
NASD arbitrations and several NASD disciplinary actions, as 
opposed to doing what they did, is clearly irrational, 
unreasonable, illogical, and naive. As evidenced by the record, 
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Petitioners' fears of facing $500,000 worth "buy-ins" were 
legitimate and not a pipe dream. 
COUNTERPOINT III 
THE ALJ'S DENIAL OF PETITIONERS' 
SEVERAL MOTIONS WAS ERROR. 
A. Converting the administrative adjudicative 
proceedings from informal to formal was error. 
The Division devotes several pages to the argument that 
the ALJ's order converting the proceedings from informal to 
formal was correct. Division brief, pp. 26-28. The Division 
adds nothing to the arguments presented in Petitioners' principal 
brief at pages 23-24. Conversion was not "in the public 
interest" simply because Johnson-Bowles' conduct had no impact or 
effect on "the public." Further, in order to usurp the express 
right to a trial de novo in the district court, the movant must 
show that the defending party will not be prejudiced. The 
Division failed to carry its burden on both accounts.17 
B. The ALJ's denial of Petitioners' Rule 12(b)(1) 
motion was fundamental error. 
The fundamental error of the ALJ's August 29, 1989, 
Order denying Petitioners' Rule 12(b)(1) motion is succinctly set 
forth on page 4 thereof, top. (See R. 152, top; Ex. N, 
1 1
 There is no reason to believe the Securities Advisory Board hearing this case had any greater 
expertise than a Third Judicial District Court judge. Cf. Division brief, p. 16-17, note 15. This is evident from 
the results. Further, the panel was not composed of a lawyer, but two industry and two lay persons, the latter of 
whom may have known nothing about securities law. 
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Petitioners' Addendum.) Therein, the ALJ premises his decision 
on the following: 
Respondents' assertion that the NASD rules of 
conduct [sic] should be accorded the force and 
effect of federal law . . . is not well-
founded. 
This conclusion defies Western Capital & Securities, 
Inc. v. Knudsvig, (Ut. Ct. of App. Case No. 88-0198-CA, February 
7, 1989), 101 Utah Adv. Rep. 65, 768 P.2d 989, ['89 Transfer 
Binder] Fed. Sec. L. Rep. (CCH) 194,3 37. More recent authority 
confirms this error. Lowenschuss v. The Options Clearing Corp., 
et. al., (Del. Ch. Ct., Dec. 21, 1989), [Current Transfer Binder] 
Fed. Sec. L. Rep. (CCH) 195,675 at p. 98,156-157 (a state has no 
subject matter jurisdiction over violations of the Securities 
Exchange Act of 19 34, including violations of any rules and 
regulations promulgated thereunder). [Emphasis added.] If a 
state has no power or authority to enforce or interpret NASD 
Rules of Fair Practice, it certainly has no authority or power to 
regulate NASD members regarding federal, NASD business in a 
manner diametrically inconsistent therewith. 
Had the ALJ properly concluded that the NASD Rules of 
Fair Practice have force and effect of federal law, Petitioners' 
Rule 12(b)(1) motion would have been granted. 
C. Petitioners' Rule 12(b)(6) Motion should have been 
granted as to Count I, the Division's "dishonest or unethical 
business practices" claim. 
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With regard to the ALJfs Rule 12(b)(6) ruling, the 
Division wholly ignores arguments 4A, B, D, H-N in Petitioners' 
brief. See Division brief, pp. 30-36.18 While; the Division dis-
cusses Petitioners' arguments 4F and G, rebuttal is not 
merited.19 Instead of addressing Petitioners' other points, the 
Division dwells on Petitioners' privileges and immunities 
argument. On this score, the Division claims that Johnson-Bowles 
is not a citizen of these United States and therefore the 
privileges and immunities clause offers it no protection. If so, 
what country is Johnson-Bowles supposed to be a citizen of? And 
what about Petitioner Johnson?20 Further, Petitioners do not 
belabor this argument because according to their research, the 
privileges and immunities clause is intimately related to the 
equal protection clause of the 14th Amendment and involves a 
similar analysis.21 Because Petitioners are indeed citizens of 
1 b
 Cf. Petitioners' brief, pp. 43-63. 
1
 ^ This is also the case with the Division's irrelevant reference to criminal aiding and abetting. 
Division brief, pp. 18-19, note 17. The Division has never charged Petitioners' sellers with criminal conduct 
and aiding and abetting cannot lie without a principal violation. Further, the finding that Petitioners didn't 
"solicit" their sellers renders the Division's argument frivolous. See pp. 55-59 and 70-75, Petitioners' brief. 
2
 ^ To be sure, authority holds that federal licensees have property rights under the Constitution. 
Gonzalez v. Freeman, 334 F.2d 570 (D.C. Cir. 1964) (due process is involved in suspending a federal licensee's 
right to enter contracts). 
2 1
 Nowalk, Rotunda & Young, Constitutional Law, Hornbook Series, West Publishing 
Company, St. Paul, Minn. (1978), pp. 276 (discussing Toomer v. Witsell, 334 U.S. 385 (1948), and 
explaining that the test to determine a violation of the Article IV privileges and immunities clause is whether 
there are valid reasons for a state to make distinctions based on one's state citizenship and whether the degree of 
discrimination bears "a close relation" to these reasons). 
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these United States and the State of Utah, Petitioners' 
privileges and immunities argument has not been rebutted.22 
On page 33, the Division again mischaracterizes 
Petitioners' argument. Petitioners have not argued that "the 
order suspending their licenses was an illegal ex post facto law 
under Article I, Section 10 of the Constitution." What they have 
argued is that they had no notice that purchasing securities in 
private transactions at a time when the Division's March Orders 
may not have been in effect was sanctionable conduct impairing 
their livelihoods. Simply put, the attempt to discipline 
Petitioners, after the fact, has the effect of an ex post facto 
law. While the Division further argues that the prohibition 
against ex post facto laws only applies to criminal penalties, 
the Division ignores the fact that administrative adjudicative 
proceedings may be considered quasi-criminal. 
On page 34, Division brief, the Division once again 
misstates Petitioners' argument. Petitioners have never argued 
that they had a constitutional right to sell U.S.A. Medical stock 
during the effectiveness of the Division's March Orders. What 
was argued is that Petitioners have a constitutional right not to 
have federal executory contracts arbitrarily interfered with by a 
state entity. The issue is not whether Petitioners had any right 
to "offer or sell" any U.S.A. Medical stock during the pendency 
z z
 This case is also one of reverse-discrimination by a state because Petitioners have been 
targeted only because they are Utah citizens. 
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of a "stop order," because they never did.23 To be sure, 
Johnson-Bowies' last "trading" transaction in U.S.A. Medical 
stock was on February 2, 1989. The ministerial "delivery" of 
securities under Article 8, U.C.C., is not the same as entering 
into new contracts for the "offer or sale" thereof. 
The Division fails to distinguish Brewster v. Maryland 
Securities Commissioner, 548 A.2d 157 (Md. App. 1988), a 
"dishonest and unethical practices" case. Petitioners have cited 
this case for principle that in order to be disciplined for such 
alleged misconduct requires notice (i.e., reference to "business 
practice, custom and usage"), id. at p. 159-160. For example, 
registration of an unsolicited, "off-market" purchase is not — 
and never has been — required. Thus, by suspending all 
exemptions from registration, such a transaction is unaffected.24 
In short, nothing in the "business practice, custom or usage" of 
the securities industry would give a person notice that the 
Division deemed the mere purchase of securities on an unsolicited 
basis as requiring registration. 
2
 3 The Division also argues that Petitioners violated the SECs 10-day suspension order issued 
on March 6, 1989. Division brief, p. 42, note 36. This argument begs the same question and is not supported 
by evidence that Petitioners purchased stock sometime "during March 1989." Further, this argument is frivolous 
because buying stock from six Utah residents is not interstate conduct triggering application of the SECs order. 
Moreover, Petitioners were never charged with violating the SECs 10-day suspension order. To be sure, the 
Securities Advisory Board never found that Mr. Johnson's purchase from New York resident Sheldon Flateman 
was a violation of the SECs 10-day suspension order. 
^^ This is confirmed by the plain language of §5 (the registration provisions) of the Securities 
Act of 1933 which only requires registration for an "offer to buy" securities (i.e., a solicitation). The same is 
even more evident in the Utah Uniform Securities Act which only requires registration for "offers or sales". See 
Utah Code Ann. §61-1-7. Thus, if unsolicited purchases need not be registered under state and federal 
securities law, it is certainly preposterous to require an exemption for them. 
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D. The Failure to either Grant or Consider Other 
Motions of Petitioners was Error, 
Respecting Petitioners1 motion for summary judgment, the 
Division contends that the motion was not granted because 
"'dishonest or unethical conduct1 was certainly not disputed." 
Division brief, p. 38. This is not what occurred. The Division 
itself made a cross-motion for summary judgment. Yet, the ALJ 
denied both motions for summary judgment, determining that the 
issue of "solicitation" was a material issue of fact necessary to 
impose liability under Division Rule R177-6-lg. R. 597-608; Ex. 
AA. Ironically, subsequent to the ALJ's decision denying both 
motions for summary judgment, the Securities Advisory Board 
"found" that: 
. . . there is no sufficient evidence to find 
that respondents or any of their agents 
solicited any of the above named seven (7) 
individuals to sell their U.S.A. Medical 
Corporation securities. 
Paragraph 12, page 6, last sentence, Findings of Fact and 
Conclusions of Law, R. 1134, Ex. EE. 
In light of the Board's findings of no "solicitation," 
and assuming the ALJ's summary judgment decision, Ex. AA, is 
otherwise correct, the proceedings should be reversed and 
vacated. 
The Division next argues that other procedural 
objections posed by the Petitioners' brief are moot. Division 
brief, pp. 38-40. This is not true. The Division further 
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contends that two motions made by the Petitioners on August 20, 
1990 and supported by an affidavit are also moot. This is 
because Petitioners allegedly "waived" their objections by 
failing to raise such in their August 23, 1990, Request for 
Agency Review before the Department of Commerce. Division brief, 
p. 39. As with other reckless assertions in the Division brief, 
this too is an outrageous falsehood. As set forth on pages 6, 
bott., 7, top, of Petitioners' August 23, 1990, Request for 
Agency Review, R. 857 bott., 858, top, Ex. SS hereto, Petitioners 
specifically sought a ruling from Director Buhler on such 
motions. See also Argument 8, pp. 78-81, Petitioners' brief. 
Lastly, since Petitioners filed their principal brief, 
the Division has approved a registration of the securities of 
U.S.A. Medical (now known as Life Concepts, Inc.). A Division 
Certified Copy of the Prospectus and Certificate of Registration 
announcing the effectiveness of the registration statement are 
together attached hereto as Ex. TT. An examination of the 
Prospectus reveals that the Division has not required anything to 
be disclosed to the public about U.S.A. Medical that would have 
affected Petitioners' decision to purchase U.S.A. Medical 
securities during March 1989. Thus, the absence of an effective 
registration statement on U.S.A. Medical's securities in March 
1989 had no bearing on Petitioners' conduct as mere purchasers. 
See Petitioners' argument 4M on pp. 60-62 of their brief, citing 
SEC v. Ralston Purina Company, 346 U.S. 119 (1953). 
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COUNTERPOINT IV 
THE DIVISION FAILED TO PROVE THAT 
PETITIONERS PURCHASED STOCK DURING 
A TIME PERIOD IN WHICH EITHER 
MARCH ORDER WAS IN EFFECT. 
The Division argues that its March 1989 Orders were in 
effect throughout March 1989, namely, at all times when 
Petitioners admittedly purchased U.S.A. Medical stock. Division 
brief, pp. 40-44. This argument is neither the law nor is it 
supported by the record. The law is clear that the Division's 
Summary Order of March 1, 1989, was only valid for ten (10) days. 
Further, it was not extended for an additional ten day or lesser 
period as permitted under Utah Code Ann. §61-1-14(3), Ex. C. The 
Division deliberately misleads the Court by quoting the portion 
of the statute whereby the order can be made permanent. Reading 
the statute from the Division's perspective, it would be 
ludicrous for a statute to provide that a "permanent order'1 may 
be extended for any period of up to but not exceeding ten (10) 
days. 
While Petitioners did receive notice of the March 1, 
Summary Order, Ex. J, they were not a respondent therein and they 
were not aware that they could have, even if they wanted to, made 
a written request that the matter be set down for a hearing. In 
fact, the Petitioners never received any notice that the matter 
was set for hearing or scheduled to be made permanent on or about 
March 29, 1989. The Order was thus made permanent three weeks 
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after its expiration and without notice or opportunity to be 
heard. As a result, it is undisputed that there were nearly 
three weeks during March 1989 _i which no Division order 
suspending exemptions was in place. At the same time, the 
Stipulation entered into between the Petitioners and the Division 
sets forth that Petitioners purchased stock subject of the 
Amended Petitions "during March." R. 1156; p. 3, 112, Ex. CC, 
Petitioners' Addendum. The Division put on no evidence as to 
exactly when such purchases occurred and contrary to the 
Division's disingenuous contentions, the burden is not on the 
Petitioners to prove a negative; nor is it their burden to prove 
that they acted "honestly or ethically." Steadman v. Securities 
& Exchange Commission, (U.S. Sup. Ct., Feb. 15, 1981) 450 U.S. 
91, 67 L.Ed. 2d 69, 101 S.Ct. 999, [f81 Transfer Binder] Fed. 
Sec. L. Rep. (CCH) 197,878 (discussing the prosecutor's burden of 
proof in SEC administrative proceedings). The conclusions of law 
are thus "incorrect" because the Division failed to carry its 
burden (i.e., it failed to show that Petitioners' conduct in any 
way undermined its orders). 
In nearly two pages of discussion, the Division 
mistakenly analogizes its power and authority to permanently 
suspend exemptions with the SEC's authority to suspend 
registration statements. The SEC's authority to suspend 
registration statements is analogous to Utah Code Ann. §61-1-12, 
not §61-1-14. Yet the Division cites SEC Rule 261 for the 
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proposition that the SEC may suspend all exemptions on a 
permanent basis. On the contrary, Rule 261, a true and correct 
copy of which is attached hereto as Ex. UU, solely involves the 
SEC's ability to permanently suspend a registered exemption such 
as the Regulation A exemption.25 Rule 261, promulgated under 
Regulation A, only applies to an exemption conferred by the 
filing of a registered exempt offering statement. This false 
argument is typical of the reckless deception repeatedly used by 
the Division to stack the deck and otherwise mislead this Court. 
COUNTERPOINT V 
THE DIVISION'S ORDER SUSPENDING 
PETITIONERS' LICENSES FOR ONE YEAR 
AND PLACING THEM ON PROBATION FOR 
TWO YEARS IS IRRATIONAL AND UNREASONABLE 
IN LIGHT OF THE FACT THAT NO VIOLATION 
OCCURRED AND NO ONE SUSTAINED OR COULD 
HAVE SUSTAINED DAMAGE FOR PETITIONERS' CONDUCT. 
The Division's final argument is that the sanction 
imposed was reasonable in light of "severity and willful nature" 
of Petitioners' conduct. This statement alone begs the question 
of this entire appeal. To be sure, who has been harmed? 
The Division argues that Petitioners profited "to the 
tune of more than $500,000," and this false assumption allegedly 
justifies its pound of flesh. The fallacy here is that avoiding 
being defrauded out of $500,000 is not the same as making a 
Z!3
 See ej . , Tabby's International, Inc. v. SEC, (5th Cir. 1973), 479 F.2d 1080, 1083, [1973 
Transfer Binder] Fed. Sec. L. Rep. (CCH) 194,014; In the Matter of Capital Leasing Corp., (1964) Securities 
Act Release No. 33-4714, 42 S.E.C. 232, [1964-1966 Transfer Binder] Fed. Sec. L. Rep. (CCH) 177,128. 
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"profit" of $500,000. In fact, the Division seriously takes the 
position that it would have preferred seeing $500,000 go into the 
pockets of the U.S.A. Medical criminals, namely, those on the 
other side of every prospective "buy-in." This is precisely what 
would have occurred had "buy-ins" been effectuated through the 
market. Ironically, such would have undermined the objectives 
underlying the Division's Orders more than anything Petitioners 
did or ever could have done. 
CONCLUSION 
The Division fails to recognize Petitioners' upstanding 
and noble responsibility in having exposed the entire 
U.S.A. Medical stock fraud and doing everything possible to see 
that it attained a price it was worth, namely zero. The Division 
ignores that U.S.A. Medical's price was artificial and that no 
one should be forced by state government to further a fraud, let 
alone to the extent of $500,000. The Division also ignores that 
protecting oneself from a ^raud is not the same as "profiting", a 
conclusion of law so bizarre as to be incomprehensible. 
Mitigating one's damages — damages caused by 
others — is not a "dishonest or unethical business practice." 
Acting in good faith to protect other innocent parties, 
specifically one's fellow NASD members, from sustaining hundreds 
of thousands of dollars in damage is also not "dishonest or 
unethical." In addition, single-handedly uncovering and exposing 
an egregious fraud and otherwise handing government a fraud case 
-24-
against others on a silver platter can hardly be "dishonest or 
unethical." The irony of this case is that Petitioners' noble 
conduct — far from furthering any fraud — frustrated the fraud. 
At the same time, the Division contends by default that, 
extorting Petitioners with a $50,000 fine when government has no 
power or authority to impose a fine of even 500 is apparently 
"honest or ethical" and certainly not tantamount to government 
misconduct, let alone a crime. Thus, the real question is: who 
is the most "dishonest or unethical", the Petitioners, who miti-
gated theirs and others' damages in good faith, thereby 
preventing the criminals in the scheme from reaping $500,000 or 
more in illegal profits or, the Division, who committed the crime 
of extortion and blackmail upon Petitioners? In Viacom 
International, Inc. v. Icahn, (S.D. NY, 1990) 747 F.Supp. 205, 
[1990 Transfer Binder] Fed. Sec. L. Rep. (CCH) 195,473, the 
U.S. district court for the Southern District of New York defined 
extortion as "the use of wrongful means to achieve a wrongful 
objective." The Court held that "both elements occur whenever 
one exploits fear to obtain property to which one has no lawful 
claim." Viacom at CCH p. 97,482. While criminal extortion is 
hardly "honest or ethical", seeking $50,000 for fear of impairing 
Petitioners* livelihoods is precisely what the Division and its 
counsel have done in this case with impunity. See e.g., Utah 
Code Ann. §76-6-406. Cf. Utah Code Ann. §76-8-509. See also p. 
17, 529, Petitioners' brief. Petitioners submit that an 
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investigation of the Division and Attorney General's office 
should be ordered and felony extortion charges brought against 
all culpable parties. 
Based on the foregoing, the August 13, 1990, Findings of 
Fact, Conclusions of Law and Order should be reversed and 
vacated. 
Respectfully submitted thi 
attorney for Petitioners 
PROOF OF SERVICE 
The undersigned hereby certifies that on the 30th day of 
May, 1991, (s)he hand-delivered two (2) true and correct copies 
of the foregoing REPLY BRIEF OF PETITIONERS with attendant 
exhibits to: 
Earl S. Maeser, Director 
Utah Division of Securities 
Utah Department of Commerce 
160 East 300 South, Second Floor 
P.O. Box 45802 
Salt Lake City, Utah 84145-0802 
and two (2) of the same to: 
R. Paul Van Dam 
Attorney General 
David N. Sonnenreich 
Assistant Attorney General 
Fair Business Enforcement Unit 
115 State Capitol Building 
Salt Lake City, Utah .84114 
1000.01A:REPLY.1-8 (FOOT.5-6) 
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EXHIBIT "LL" 
2186 NASD Manual—Rules of Fair Practice 289 7-88 
# # • Selected NASD Notices to Members 
85-89 Adoption of New Rule of Fair Practice Relating to Permission for 
Members to Alter Their Methods of Operation Under SEC Rule 
15c3-3 ("Customer Protection Rule") 
(December 31, 1985) 
H 2199 Approval of Change in Exempt Status Under SEC Rule 
15c3-3 
Sec. 39. (a) Application—For the purposes of this section, the term "member" 
shall be limited to any member of the Association who is not designated to another self-
regulatory organization by the Securities and Exchange Commission for financial 
responsibility pursuant to Section 17 of the Securities Exchange Act of 193< and Rule 
17d-l promulgated thereunder. 
(b) A member operating pursuant to any exemptive provision as contained in 
subparagraph (k) of SEC Rule 15c3-3 under the Securities Exchange Act of 1934 
("Rule 15c3-3"), shall not change its method of doing business in a manner which will 
change its exemptive status from that governed by subparagraph (k)(l) or (k)(2)(b) to 
that governed by subparagraph (k)(2)(a), or from subparagraph (k)(l), (k)(2)(a) or 
(k)(2)(b) to a fully computing firm that is subject to all provisions of Rule 15c3-3, or 
commence operations that will disqualify it for continued exemption under Rule 15c3-3 
without first having obtained the prior written approval of the Association. 
(c) In making the determination as to whether to approve, deny in whole or in 
part an application made pursuant to subsection (b), the Association staff shall 
consider among other things the type of business in which the member is engaged, the 
training, experience and qualifications of persons associated with the member, the 
member's procedures for safeguarding customer funds and securities, the member's 
overall financial and operational condition and any other information deemed relevant 
in the particular circumstances and the time these measures would remain in effect. 
[Adopted effective November 7, 1985.] 
U 2200 Private Securities Transactions 
Sec. 40. (a) Applicability—No person associated with a member shall participate 
in any manner in a private securities transaction except in accordance with the 
requirements of this section. 
(b) Written Notice—Prior to participating in any private securities transaction, 
an associated person shall provide written notice to the member with which he is 
associated describing in detail the proposed transaction and the person's proposed role 
therein and stating whether he has received or may receive selling compensation in 
connection with the transaction; provided however that, in the case of a series of 
related transactions in which no selling compensation has been or will be received, an 
associated person may provide a single written notice. 
(c) Transactions for Compensation— 
(1) In the case of a transaction in which an associated person has received or 
may receive selling compensation, a member which has received notice pursuant 
to Subsection (b) shall advise the associated person in writing stating whether the 
member: 
(A) approves the person's participation in the proposed transaction, or 
(B) disapproves the person's participation in the proposed transaction. 
(2) If the member approves a person's participation in a transaction pursuant 
to Subsection (c)(1), the transaction shall be recorded on the books and records of 
1f 2199 Art. Ill, Sec. 39 ©1988, Commerce Clearing House, Inc. 
289 7SS NASD Manual—Rules of Fair Practice 2187 
the member and the member shall supervise the person's participation in the 
transaction as if the transaction were executed on behalf of the member 
(3) If the member disapproves a person's participation pursuant to Subsec 
tion (c)(1), the person shall not participate in the transaction in any manner 
directly or indirectly 
(d) Transactions Not For Compensation—In the case of a transaction or a series ot 
related transactions in which an associated person has not and will not receive any 
selling compensation, a member winch has received notice pursuant to Subsection (b) 
shall provide the associated person prompt written acknowledgement of said notice and 
may, at its discretion, require the person to adhere to specified conditions in connection 
with his participation in the transaction 
(e) Definitions—For purposes of this section, the following terms shall have the 
stated meanings 
(1) "Private securities transaction" shall mean any securities ansaction 
outside the regular course or scope of an associated person's emplov ^nt with a 
member, including, though not limited to, new offerings of securities wmch are not 
registered with the Commission, provided however that transactions subject to the 
notification requirements of Article III, Section 28 of the Rules of Fair Practice 
transactions among immediate family members (as defined in the Interpretation 
of the Board of Governors on Free-Riding and Withholding) for which no associ 
ated person receives any selling compensation, and personal transactions in 
investment company and variable annuity securities, shall be excluded 
(2) "Selling compensation" shall mean any compensation paid directlv or 
indirectly from whatever source in connection with or as a result of the purchase 
or sale of a security, including, though not limited to, commissions, finder s fees 
securities or rights to acquire securities, rights of participation in profits, tax 
benefits, or dissolution proceeds, as a general partner or otherwise, or expense 
reimbursements 
[Adopted effective November 12, 1985 ] 
• • • Cross Reference 
Article III, Sec 1 —Business Conduct of Members § 2151 
Article III, Sec 28 —Transactions for Personnel of Another Member 
§2178 
• • • Selected NASD Notice to Members 
85-21 Solicitation of Comments on Proposed Rule on Private Securities 
Transactions 
(March 29, 1985) 
85-54 Propose New Rule of Fair Practice Relating to Private Securities 
Transactions 
(August 13, 1985) 
85-84 New Rule of Fair Practice Relating to Private Securities Transac-
tions 
(December 18, 1985) 
[The next page is 2189 ] 
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IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH 
CENTRAL DIVISION 
JOHN E. CARLSON and LINDA 
CARLSON, 
Plaintiffs, 
vs. 
D. 
BAGLEY SECURITIES, INC., EDWARD 
DALLIN BAGLEY, EDWARD BRYAN 
BAGLEY, LISA BAGLEY, 
CAROLYN CREAMER BAGLEY, 
JOHN DOES V through 
INDIVIDUALS, 
Defendants. 
and 
and 
X, 
Case No: 89-C-1062A 
MEMORANDUM OPINION 
(In lieu of findings of fact 
and conclusions of law pursuant 
to Fed. R. Civ. P. 52(a)) 
Judge Aldon J. Anderson 
On January 17-18, 1991, a bench trial was held in the above 
matter. Plaintiffs John E. Carlson and Linda D. Carlson were 
represented by Ronald E. Nehring, Thomas M. Melton and Stephanie A. 
Beam. Defendants Bagley Securities, Inc., Edward Dallin Bagley, 
Edward Bryan Bagley, Lisa Bagley and Carolyn Creamer Bagley were 
represented by Richard J. Leedy. The parties presented documentary 
and sworn testimony. The trial was continued until February 12, 
1991 at which time the court heard closing arguments and took the 
matter under advisement. Having thoroughly reviewed the evidence 
and the extensive briefing of the parties, the court is prepared to 
issue its ruling. 
I. Facts 
Plaintiffs John E. Carlson and Linda D. Carlson ("the 
Carlsons") are residents of Minnesota. In early 1989, Mr. Carlson 
became aware of a company called Dial-A-Gift through conversations 
with Robert Lorsbach, a Salt Lake City stockbroker associated with 
Aesir Securities. The Carlsons had previously invested in stocks 
through Lorsbach while he was associated with another brokerage 
house. Lorsbach recommended Dial-A-Gift stock to the Carlsons as 
a potential investment but could not personally execute the sale 
because Aesir Securities was not yet registered to transact 
business in Minnesota. Lorsbach suggested that they could cortact 
Todd Knowles who was working at Bagley Securities and was 
registered in Minnesota to make the trade. (Tr. Vol I, pp. 4-8).^ 
In early April 1989, Carlson telephoned Knowles to inquire if 
Knowles would purchase for him approximately $80,000 in Dial-A-Gift 
shares at the quoted price of $4 per share. At Lorsbach!s 
suggestion, Carlson told Knowles he wanted the stock certificates 
to be delivered to him. Knowles agreed and told Carlson that he 
1A11 citations to the transcript are to the reporter's partial 
transcript of trial. For ease of reference, each partial 
transcript will be designated as follows: 
January 17, 1991, a.m. — Volume I 
January 17, 1991, p.m. — Volume II 
January 18, 1991, a.m. — Volume III 
January 18, 1991, p.m. — Volume IV 
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could expect to receive the stock certificates within ten days to 
two weeks after the trade. (Tr. Vol. I, pp. 8-10, Vol. IV p. 49). 
Lorsbach was also in communication with Knowles. Lorsbach gave 
Knowles a price quote on Dial-A-Gift shares at Aesir Securities and 
told Knowles that he could purchase the stock from Aesir. (Tr. 
Vol. IV p.44). 
Todd Knowles attempted to fill Carlson's order but because of 
tight market conditions was able to purchase only a portion of the 
requested shares. (Tr. Vol. I, p. 13, Vol. IV p. 49). Lorsbach 
was in contact with Knowles on a daily basis and continued to press 
Knowles to fill the order. 
Because of the difficulty in filling the order by purchasing 
the shares on the market, Bagley Securities decided to become a 
market maker in Dial-A-Gift and to short the remaining shares to 
Carlson. Carlson and Lorsbach claim that Knowles did not disclose 
that Bagley Securities intended to short the shares. (Tr. Vol. I 
p. 34, Vol. II p. 28). Knowles claims that Lorsbach agreed to the 
short sale and further agreed that Bagley Securities could deliver 
the certificates as the short was covered. (Tr. Vol. IV pp. 56-
58). Bagley Securities sold Carlson a total of 17,500 Dial-A-
Gift shares of which 4,700 were purchased by Bagley Securities from 
other market makers (agency trades), and 12,800 were shorted to 
Carlson from the trading account of Bagley Securities (principal 
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trades). Carlson paid Bagley Securities a total of $79,159 for the 
shares. (Tr. Vol. IV pp. 68-74, Exb.47). 
By early May, 1989, Carlson became concerned that he had not 
yet received the certificates. Over the next two weeks, Carlson 
repeatedly asked Knowles and Bagley Securities to explain the 
delay. After each request, Carlson was told that the certificates 
were on their way. (Tr. Vol. I pp. 22-25). 
By letter dated May 23, 1989, Bagley Securities informed 
Carlson that Bagley Securities had purchased 17,500 shares of Dial-
A-Gift stock from Midwest Clearing Corporation and that Carlson 
would receive the securities as soon as Bagley received them from 
Midwest. (Ex. 30)' Carlson called Lorsbach after receiving the May 
23rd letter. Lorsbach told Carlson that he couldnft believe that 
they had purchased the shares. (Tr. Vol. I, p. 3 0) Based upon the 
reassurances in the letter, Carlson was willing to give Bagley more 
time to produce the certificates. 
Carlson's patience eventually wore thin and by letter dated 
June 20, 1989 demanded delivery of the certificates within five 
days. (Doc. 31). Bagley Securities responded with a letter from 
counsel dated July 5, 1989 which alleged that a fraudulent 
distribution of Dial-A-Gift shares had occurred and informed 
Carlson that Bagley Securities would not deliver the certificates 
until the allegations were disproved. Bagley Securities did not 
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offer to return Carlson's money. (Exb. 28). 
On November 29, 1989, plaintiffs filed suit against Bagley 
Securities.2 In December, 1989, Carlson learned that Bagley 
Securities had attempted to make partial delivery of the stock by 
transferring 17,200 shares of Dial-A-Gift stock into his account at 
National Securities. Carlson refused delivery because the price 
quotes for the shares had significantly fallen. (Tr. Vol. I, 
p.40). 
II. Analysis 
In their first amended complaint, plaintiffs allege fourteen 
separate causes of action including violations of federal and state 
securities laws, conversion, breach of contract, negligence and 
breach of fiduciary duty. Plaintiffs seek compensatory and 
punitive damages under various statutory and common law provisions. 
A. Plaintiffs1 Claims Under Federal Securities Laws 
Section 10(b) of the Securities Exchange Act of 1934 makes it 
unlawful for "any person [t]o use or employ, in connection with the 
purchase or sale of any security, . . . any manipulative or 
2The complaint was later amended to include claims against 
Edward Dallin Bagley ("Dal Bagley"), Edward Bryan Bagley, Lisa 
Bagley and Carolyn Creamer Bagley as officers and directors of 
Bagley Securities. 
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deceptive device" that violates SEC rules. IT J.S.C. §78j(b). 
Rule 10b-5 gives meaning to this prohibition. I makes it illegal 
"for any person . . . to make any untrue stateir. nt of a material 
fact or to omit to state a material fact necessary in order to make 
the statement made . . . not misleading . . . in connection with 
the purchase or sale of any security." 17 C.F.R. §240.10b-5 
(1990). 
Plaintiffs allege that Bagley Securities and Dal Bagley 
violated Rule 10b-5 by failing to disclose that Bagley Securities 
intended to short the Dial-A-Gift shares to Carlson and by failing 
to deliver the certificates as requested by Carlson. Plaintiffs 
claim that at the time Bagley Securities issued the confirmation 
slips evidencing each trade, Bagley Securities knew or should have 
known that it could not provide the certificates requested by the 
Carlsons. In support of their claim, plaintiffs identify a series 
of alleged misrepresentations and omissions which plaintiffs claim 
are actionable under Rule 10b-5. 
First, plaintiffs claim that Bagley Securities had a duty to 
disclose that Bagley Securities was shorting the Dial-A-Gift shares 
to the Carlsons• While acting on behalf of the Carlsons, Bagley 
Securities made both principal and agency trades. An agency t~ade 
is one in which a broker goes out in the market and purchases 
shares from third parties on behalf of the customer. A principal 
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trade is one in which the broker sells the shares to the customer 
from the firm's trading account. Bagley Securities sold Carlson 
4,700 shares on an agency basis and 12,800 shares from its trading 
account. (Tr. Vol. Ill pp. 85-90, Vol. IV pp. 83-86). Because 
Bagley Securities did not hold an inventory of Dial-A-Gift shares 
in its trading account, the account was short 12,800 shares. 
Although Knowles claims that Lorsbach was aware of Bagley 
Securities1 plan to short the sale, Lorsbach claims that he was 
unaware of such a plan. However, Lorsbach testified that Bagley 
Securities1 "decision to sell long or short is their choice." Tr. 
Vol II p. 28). 
The authority of a broker-dealer to sell short is well 
established in the securities industry. See 1 T. Hazen, The Law of 
Securities Regulation § 10.3 at 531 (2d ed. 1990). Despite 
plaintiffs1 assertion that the practice is "selling nothing," the 
ability of a broker-dealer to sell short from a trading account 
performs an important function in balancing supply and demand in 
the over-the-counter market. However, because the practice can be 
abused by unscrupulous broker-dealers, short selling is highly 
regulated. Id. at 532; 17 C.F.R. § 240.15c3-l, 15c3-3 (1990). 
Carlson did not independently investigate Dial-A-Gift as an 
investment but relied on Lorsbach!s advice. (Tr. Vol. I, p. 46). 
Lorsbach claimed, and Carlson acknowledged that Lorsbach dealt with 
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Knowles as Carlson's agent. The evidence showed that Lorsbach 
worked as a registered representative for Aesir Securities which 
controlled a large block of Dial-A-Gift shares and would have been 
aware of tight market conditions. The court believes that Lorsbach 
was aware, either by conversation with Knowles or by logical 
inference from the surrounding conditions, that Bagley Securities 
intended to short the shares. As Carlson's agent, Lorsbachfs 
knowledge is imputed to Carlson. 
Plaintiffs also claim that Bagley Securities violated Rule 
10b-5 by failing to deliver the certificates as promised. Although 
short sales are highly regulated by the SEC and the National 
Association of Securities Dealers ("NASD11), the court is unaware of 
any rule which requires a market maker to cover a short position 
and deliver certificates to a customer within a specific time 
frame. Instead, NASD Rule 15c3-3 states that 
[njothing stated in this rule shall be construed as 
affecting the absolute right of a customer of a broker or 
dealer to receive in the course of normal business 
operations following demand made on the broker or dealer, 
the physical delivery of certificates for: (1) Fully-paid 
securities to which he is entitled . . . . 
NASD Rule 15c3-3(l), NASD Manual (CCH 1989). 
Plaintiffs rely on a series of cases before the Securities and 
Exchange Commission in support of their argument that such conduct 
violates Rule 10b-5. These administrative proceedings resulted in 
disciplinary action against broker-dealers who sold short to their 
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customers and failed to cover the shorts within a reasonable time. 
However, in each case cited by plaintiffs, the dealer shorted the 
stock without any intention to cover the transaction and 
appropriated the customer's funds for the brokerfs own use. See In 
re Sebastian, 38 S.E.C. 865 (1959) ("Registrant's sale of the 
securities without informing the customer that the securities were 
pledged and would not promptly be released from such lien 
constituted a misrepresentation of a material fact and the sale 
operated as a fraud and deceit upon the purchaser."); In re 
Bliedung, 38 S.E.C. 518 (1958) (broker-dealer "had no intention of 
filling their orders promptly and [] he intended using their funds 
in his other business activities") ; In re Shaver & Co. 36 S.E.C. 92 
(1954) (broker-dealer appropriated customers1 funds with no 
intention of filling orders); In re Ankenv, 29 S.E.C. 514 (1949) 
("The record thus makes it plain that Ankeny had no real intention 
of filling his customers1 orders promptly"). The present case may 
be distinguished in at least two ways. First, the evidence 
suggested that at the time of the transaction, Bagley Securities 
fully intended to cover the short and deliver the shares. Second, 
there is no evidence that Bagley Securities appropriated the 
Carlson's funds for its own use at the time of the short sale. 
Bagley Securities was required to maintain sufficient funds in a 
reserve account at Midwest Clearing, to cover the short in its 
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trading account. Because Bagley Securi' .es would not receive the 
benefit of these funds until the short was covered, Bagley 
Securities would have little to gain by promising delivery without 
intending to deliver. 
While the.failure of a broker-dealer to disclose that he is a 
market maker states a claim under Rule 10b-5 Bischoff v. G.K. Scott 
& Co., Inc. 687 F. Supp. 746, 751 (E.D.N.Y. 1986), the court has 
found no authority which states that a market maker is required to 
disclose whether it is short or long in its trading account. After 
each trade was executed by Bagley Securities for the Carlson 
account, Bagley Securities sent Carlson a confirmation slip. Each 
slip identified Bagley Securities as a market maker in Dial-A-Gift 
stock.3 
Plaintiffs claim that after the confirmation slips were issued 
and after the Carlsons had made payment in full for the securities, 
Bagley Securities made certain misrepresentations concerning its 
intention to deliver the certificates. For a misrepresentation or 
omission to be actionable under § 10(b) and Rule 10b-5, the 
challenged statement must have been made "in connection with the 
3Each confirmation slip showed the date of the trade, the 
quantity and price of shares purchased. Confirmation slips 
documenting agency or long trades showed that a commission was 
charged on the transaction. Those confirmation slips evidencing 
principal or short trades showed that no commission was charged or 
billed to the Carlsons. Each slip carried the notation, "WE ARE A 
MARKET MAKER IN THIS SECURITY." (Exbs. 4-11). 
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purchase or sale of . . . [a] security." 15 U.S.C. §78j (b) ; 17 
C.F.R. § 240.10b-5. In order to satisfy the "in connection with" 
requirement, there must be an actual purchase or sale of a security 
that is connected with a challenged statement. Blue Chip Stamps v. 
Manor Drug Store, 421 U.S. 723, 737-38 (1975). Statements which 
occur after the actual purchase of a security cannot form the basis 
for liability under Rule 10b-5. Ballan v. Wilfred American 
Educational Corp.. 720 F. Supp. 241, 250 (E.D.N.Y. 1989); 
Konstantinakos v. F.D.I.C., 719 F. Supp. 35, 38 (D. Mass. 1989); 
Perez-Rubio v. Wyckoff. 718 F. Supp. 217, 236 (S.D.N.Y. 1989); 
Seattle-First National Bank v. Carlstedt, 678 F. Supp. 1543, 1547 
(W.D. Okl. 1987). 
Shortly after the sales were made, Carlson began to inquire as 
to when he might expect delivery of the certificates. Bagley 
Securities avoided a direct reply to Carlson1s requests until May 
23, 1989 when Dal Bagley wrote Carlson that Bagley Securities had 
purchased 17,500 shares of Dial-A-Gift stock through Midwest 
Clearing Corporation. In fact, when the letter was written, Bagley 
Securities had not yet covered the short in the trading account. 
However, these subsequent misrepresentations are not actionable 
under Rule 10b-5. 
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B. Plaintiffs1 Claims Under the Utah Uniform Securities Act 
Plaintiffs' claims under state securities laws are based on 
the same conduct alleged as violations of Rule 10b-5. Section 61-
1-22(1;(b) of the Utah Uniform Securities Act provides that any 
person who: 
offers, sells, or purchases a security by means of any 
untrue statement of a material fact or any omission to 
state a material fact necessary in order to make the 
statements made, in the light of the circumstances under 
which they are made, not misleading, the buyer not 
knowing of the untruth or omission, and who does not 
sustain the burden of proof that he did not know, and in 
the exercise of reasonable care could not have known, of 
the untruth of omission, is liable to the person selling 
the security to or buying the security from him . . . . 
Utah Code Ann. § '61-1-22(1) (b) (Supp. 1989). 
As discussed above, the misrepresentation by Bagley Securities 
of its intent to deliver the certificates occurred after the sale 
had been made. Plaintiffs have failed to identify any other untrue 
statement or omission of a material fact by which means Bagley 
Securities offered or sold Dial-A-Gift shares. Therefore, 
plaintiffs1 claims under state securities laws must be denied. 
C. Plaintiffs' Common Law Causes of Action 
1. Fraud 
Plaintiffs claim that the confirmation slips and subsequent 
representations by Bagley Securities, including the May 23, 1989 
letter to Carlson, were intentional or reckless misrepresentations 
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which induced the Carlsons to advance funds or to forego further 
inquiry into the whereabouts of their stock certificates. 
Plaintiffs' claim for fraud against defendants must fail because 
plaintiffs have failed to show by clear and convincing evidence 
that defendants falsely represented a material fact to induce the 
plaintiffs to purchase Dial-A-Gift stock- See Schwartz v. Tanner, 
576 P. 2d 873, 875 (Utah 1978) ("The elements of actionable fraud to 
be proved are a false representation of an existing material fact, 
made knowingly or recklessly for the purpose of inducing reliance 
thereon, upon which plaintiff reasonably relies to his 
detriment.") . 
2. Conversion 
Plaintiffs claim that Bagley Securities converted their 
property, namely the money paid and certain Dial-A-Gift shares, to 
its own use. Plaintiffs' claim for conversion is not a proper 
remedy because plaintiffs were never in actual possession of the 
Dial-A-Gift certificates which were to be purchased for them. See 
Benton v. State, 709 P.2d 362, 365 (Utah 1985) ("A conversion is an 
act of wilful interference with a chattel, done without lawful 
justification by which the person entitled thereto is deprived of 
its use and possession.11). 
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3, Breach of Contract 
However, plaintiffs1 ninth cause of action, for breach of 
contract against Bagley Securities, is a proper remedy. When 
Carlson instructed Knowles to purchase the shares, Bagley 
Securities was aware that Carlson wanted to receive the actual 
stock certificates. Dal Bagley understood that when Bagley 
Securities sold the Carlsons the shares, Bagley had an enforceable 
contract with Carlson to deliver the shares. The terms of that 
contract were established by the oral communications between Bagley 
Securities and Carlson, either directly or through Lorsbach his 
agent. 
Each confirmation slip sent to Carlson established the exact 
quantity and price of shares he was to receive from Bagley 
Securities. Although a specific date was not set for the delivery 
of the shares, it was clear that Carlson was to receive the actual 
certificates. Utah law provides as follows: 
Unless otherwise agreed, the transferor of a certificated 
security or the transferor, pledgor, or pledgee of an 
uncertificated security on due demand must supply his 
purchaser with any proof of his authority to transfer, 
pledge, or release or with any other requisite necessary 
to obtain registration of the transfer, pledge, or 
release of the security . . . . Failure within a 
reasonable time to comply with a demand made gives the 
purchaser the right to reject or rescind the transfer, 
pledge, or release. 
Utah Code Ann. § 70A-8-316 (Supp. 1990). Carlson repeatedly 
demanded delivery of the Dial-A-Gift certificates and was entitled 
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to receive them within a reasonable time. 
The determination of a reasonable date for delivery must be 
made in light of all the facts and circumstances. Carlson entered 
his order for the Dial-A-Gift shares on the advice of Lorsbach. 
Lorsbach represented to Knowles that the stock was available from 
Aesir Securities. However, the early trading experience of Bagley 
Securities showed that large blocks of Dial-A-Gift shares were 
difficult to obtain at the price which was then being quoted. When 
Bagley Securities was unable to fill Carlson's order, Lorsbach 
pressured Knowles to complete the transaction or cancel the order. 
The logical inference is that Carlson expected the shares to rise 
in value in the near future. When Bagley Securities decided to 
short the shares, Bagley Securities gambled that it would be able 
to obtain the shares to cover the short and to make a profit on the 
transaction. 
Bagley Securities claims that it was impossible to deliver the 
certificates as requested by Carlson. A contractual obligation to 
perform may be discharged "if an unforeseen event occurs after 
formation of the contract and without fault of the obligated party, 
which event makes performance of the obligation impossible or 
highly impracticable." Western Properties v. Southern Utah 
Aviation, Inc., 776 P.2d 656, 658 (Utah Ct. App. 1989) (footnotes 
omitted). The burden of demonstrating impossibility of performance 
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is on the defendant. Holmgren v. Utah-Idaho Sugar Co., 582 P. 2d 
856, 861 (Utah 1978). In the present case, the short supply and 
rising price of Dial-A-Gift shares was not an unforeseen but a 
specifically contemplated possibility. 
When asked about his efforts to cover the short created by the 
sale to Carlson, Dal Bagley testified that he became a market maker 
and quoted the highest bid for the stock. He also testified that 
he unsuccessfully attempted to purchase or borrow shares from Olsen 
& Company. However, Dal Bagley admitted that he would have been 
able to acquire the necessary shares to cover the short if he had 
been willing to pay enough money. (Tr. Vol. II pp. 102-103). 
Bagley Securities identified itself as a market maker by 
listing its name in the Pink Sheets published by the National 
Quotation Bureau. However, Bagley Securities did not list a bid or 
asked price for Dial-A-Gift shares. Although there was some 
testimony that all market makers should be called before a stock is 
purchased or sold, the only way that a prospective seller of Dial-
A-Gift shares would know of Bagley Securities1 bid price would be 
by telephoning Bagley Securities. Dal Bagley himself testified 
that a broker is required to call only three market makers for a 
price. (Tr. Vol. Ill p. 12) . 
Dal Bagley testified that he did not cover the short because 
he and other market makers would be injured. He also testified 
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that the decision to cover the short would be made by someone who 
sold him the stock. (Tr. Vol. Ill pp. 9-12). Dal Bagley's 
testimony suggests that he was simply unwilling and not unable to 
purchase the stock on the open market to meet his the obligation to 
deliver the certificates to Carlson. It was not until November, 
1989, after the price of Dial-A-Gift shares drastically fell, that 
any attempt was made to deliver the certificates. Bagley 
Securities has failed to carry its burden of demonstrating 
impossibility of performance. 
The testimony at trial concerning a reasonable period of time 
for the delivery of stock certificates was uncertain. While some 
witnesses suggested that certificates might be delivered in a few 
weeks, other witnesses testified that extenuating circumstances 
might delay the delivery for several months. The evidence showed, 
however, that the delay in this case was unreasonable and resulted 
in a material breach of the contract between the plaintiffs and 
Bagley Securities. 
In connection with their breach of contract claim, plaintiffs 
have requested rescission of the contract. This remedy is 
specifically authorized by Utah Code Ann. § 70A-8-316 and seeks to 
place each party in the position it was in before the contract was 
made. 
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III. Conclusion 
The evidence at trial showed that at the time the Dial-A-Gift 
shares were shorted to the Carlsons, Bagley Securities fully 
intended to deliver the requested certificates. While Bagley 
Securities did make subsequent misrepresentations concerning the 
certificates, these misrepresentations are not actionable under 
federal or state securities laws. 
However, Bagley Securities did fail to perform its contractual 
obligation to deliver the certificates within a reasonable time. 
Plaintiffs have requested and are entitled to reject or rescind the 
transaction. The evidence showed that plaintiffs paid Bagley 
Securities a total of $79,159.00 for Dial-A-Gift shares and that no 
certificates were delivered. Judgment will be entered against 
Bagley Securities in that amount. All other claims are dismissed. 
IT IS SO ORDERED. 
DATED this ft day of April, 1991. 
BY THE COURT: 
/ 
sM^*^?/* 
Aldon J. Anderspn 
United States Senior Judge 
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[H 2705A] Persons Deemed Not to Be Engaged in a 
Distribution and Therefore Not Underwriters 
Preliminary Note to Rule 144 
Rule 144 is designed to implement the fundamental purposes of the Act, as 
expressed in its preamble, "To provide full and fair disclosure of the character of the 
securities sold in interstate commerce and through the mails, and to prevent fraud in 
the sale thereof " The rule is designed to prohibit the creation of public markets in 
securities of issuers concerning which adequate current information is not available to 
the public. At the same time, where adequate current information concerning the issuer 
is available to the public, the rule permits the public sale in ordinary trading 
transactions of limited amounts of securities owned by persons controlling, controlled 
by or under common control with the issuer and by persons who have acquired 
restricted securities of the issuer. 
Certain basic principles are essential to an understanding of the requirement of 
registration in the Act. 
1. If any person utilizes the jurisdictional means to sell any non-exempt security to 
any other person, the security must be registered unless a statutory exemption can be 
found for the transaction. 
2. In addition to the exemptions found in Section 3, four exemptions applicable to 
transactions in securities are contained in Section 4 Three of these Section 4 exemp-
tions are clearly not available to anyone acting as an "underwriter" of securities (The 
fourth, found in Section 4(4), is available only to those who act as brokers under certain 
limited circumstances.) An understanding of the term "underwriter" is therefore 
important to anyone who wishes to determine whether or not an exemption from 
registration is available for his sale of securities. 
The term underwriter is broadly defined in Section 2(11) of the Act to mean any 
person who has purchased from an issuer with a view to, or offers or sells for an issuer 
in connection with, the distribution of any security, or participates or has a direct or 
indirect participation in any such undertaking, or participates or has a participation in 
the direct or indirect underwriting of any such undertaking. The interpretation of this 
definition has traditionally focused on the words "with a view to" in the phrase 
"purchased from an issuer with a view to . . distribution " Thus, an investment 
banking firm which arranges with an issuer for the public sale of its securities is clearly 
an "underwriter" under that Section. Individual investors who are not professionals in 
the securities business may also be "underwriters" within the meaning of that term as 
used in the Act if they act as links in a chain of transactions through which securities 
move from an issuer to the public. Since it is difficult to ascertain the mental state of 
the purchaser at the time of his acquisition, subsequent acts and circumstances have 
been considered to determine whether such person took with a view to distribution at 
the time of his acquisition. Emphasis has been placed on factors such as the length of 
time the person has held the securities and whether there has been an unforeseeable 
change in circumstances of the holder. Experience has shown, however, that reliance 
upon such factors as the above has not assured adequate protection of investors 
through the maintenance of informed trading markets and has led to uncertainty in the 
application of the registration provisions of the Act. 
It should be noted that the statutory language of Section 2(11) is in the disjunc-
tive. Thus, it is insufficient to conclude that a person is not an underwriter solely 
because he did not purchase securities from an issuer with a view to their distribution. 
It must also be established that the person is not offering or selling for an issuer in 
connection with the distribution of the securities, does not participate or have a direct 
or indirect participation in any such undertaking, and does not participate or have a 
participation in the direct or indirect underwriting of such an undertaking. 
H2705A Reg. §230.144 ©1990, Commerce Clearing House, Inc. 
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In determining when a person is deemed not to be engaged in a distribution 
several factors must be considered. 
First, the purpose and underlying policy of the Act to protect investors requires 
that there be adequate current information concerning the issuer, whether the resales 
of securities by persons result in a distribution or are effected in trading transactions 
Accordingly, the availability of the rule is conditioned on the existence of adequate 
current public information. 
Secondly, a holding period prior to resale is essential, among other reasons, to 
assure that those persons who buy under a claim of a Section 4(2) exemption have 
assumed the economic risks of investment, and therefore are not acting as conduits for 
sale to the public of unregistered securities, directly or indirectly, on behalf of an issuer 
It should be noted that there is nothing in Section 2(11) which places a time limit on a 
person's status as an underwriter. The public has the same need for protection afforded 
by registration whether the securities are distributed shortly after their purchase or 
after a considerable length of time. 
A third factor, which must be considered in determining what is deemed not to 
constitute a "distribution," is the impact of the particular transaction or transactions 
on the trading markets. Section 4(1) was intended to exempt only routine trading 
transactions between individual investors with respect to securities already issued and 
not to exempt distributions by issuers or acts of other individuals who engage in steps 
necessary to such distributions. Therefore, a person reselling securities under Section 
4(1) of the Act must sell the securities in such limited quantities and in such a manner 
as not to disrupt the trading markets. The larger the amount of securities involved, the 
more likely it is that such resales may involve methods of offering and amounts of 
compensation usually associated with a distribution rather than routine trading trans-
actions. Thus, solicitation of buy orders or the payment of extra compensation are not 
permitted by the rule. 
In summary, if the sale in question is made in accordance with all of the provisions 
of the rule, as set forth below, any person who sells restricted securities shall be deemed 
not to be engaged in a distribution of such securities and therefore not an underwriter 
thereof. The rule also provides that any person who sells restricted or other securities on 
behalf of a person in a control relationship with the issuer shall be deemed not to be 
engaged in a distribution of such securities and therefore not to be an underwriter 
thereof, if the sale is made in accordance with all the conditions of the rule. 
Reg. §230.144. (a) Definitions. The following definitions shall apply for the 
purposes of this rule. 
(1) An "affiliate" of an issuer is a person that directly, or indirectly through one or 
more intermediaries, controls, or is controlled by, or is under common control with, such 
issuer. 
(2) The term "person" when used with reference to a person for whose account 
securities are to be sold in reliance upon this rule includes, in addition to such person, 
all of the following persons: 
(i) Any relative or spouse of such person, or any relative of such spouse, any 
one of whom has the same home as such person; 
(ii) Any trust or estate in which such person or any of the persons specified in 
paragraph (a)(2)(i) of this section collectively own ten percent or more of the total 
beneficial interest or of which any of such persons serve as trustee, executor or in 
any similar capacity; and 
(iii) Any corporation or other organization (other than the issuer) in which 
such person or any of the persons specified in paragraph (a)(2)(i) of this section 
are the beneficial owners collectively of ten percent or more of any class of equity 
securities or ten percent or more of the equity interest. 
Federal Securities Law Reports Reg. §230.144 H2705A 
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(3) The term "restricted securities" means: 
(i) securities that are acquired directly or indirectly from the issuer, or from 
an affiliate of the issuer, in a transaction or chain of transactions not involving 
any public offering; or 
(ii) securities acquired from the issuer that are subject to the resale limita-
tions of Regulation D (§ 230.501 through § 230.506 of this chapter) or Rule 701(c) 
(§ 230.701(c) of this chapter) under the Act; or 
(iii) securities that are subject to the resale limitations of Regulation D and 
acquired in a transaction or chain of transactions not involving any public 
offering; or 
(iv) securities that are acquired in a transaction or chain of transactions 
meeting the requirements of Rule 144A (§ 230.144A of this chapter). [Amended in 
Release No. 33-6862 (fl 84,523) effective April 30, 1990, 55 F.R. 17933.] 
.10 Annotations of rulings under paragraph 2706.3081; 2706.38; 2706.382; 2706.385; 
(a) of Rule 144—See fl 2706.222; 2706.223; 2706.412; 2706.4153; 2706.5012; 2706.5013; 
2706.2235; 2706.3039; 2706.307; 2706.308; 2706.5061; 2706.735 and 2706.83. 
(b) Conditions to be Met. Any affiliate or other person who sells restricted 
securities of an issuer for his own account, or any person who sells restricted or any 
other securities for the account of an affiliate of the issuer of such securities, shall be 
deemed not to be engaged in a distribution of such securities and therefore not to be an 
underwriter thereof within the meaning of Section 2(11) of the Act if all of the 
conditions of this rule are met. 
(c) Current Public Information. There shall be available adequate current public 
information with respect to the issuer of the securities. Such information shall be 
deemed to be available only if either of the following conditions is met: 
(1) Filing of Reports. The issuer has securities registered pursuant to Section 
12 of the Securities Exchange Act of 1934, has been subject to the reporting 
requirements of Section 13 of that Act for a period of at least 90 days immediately 
preceding the sale of the securities and has filed all the reports required to be filed 
thereunder during the 12 months preceding such sale (or for such shorter period 
that the issuer was required to file such reports); or has securities registered 
pursuant to the Securities Act of 1933, has been subject to the reporting require-
ments of Section 15(d) of the Securities Exchange Act of 1934 for a period of at 
least 90 days immediately preceding the sale of the securities and has filed all the 
reports required to be filed thereunder during the 12 months preceding such sale 
(or for such shorter period that the issuer was required to file such reports. The 
person for whose account the securities are to be sold shall be entitled to rely upon 
a statement in whichever is the most recent report, quarterly or annual, required 
to be filed and filed by the issuer that such issuer has filed all reports required to 
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the 
preceding 12 months (or for such shorter period that the issuer was required to file 
such reports) and has been subject to such filings requirements for the past 90 
days, unless he knows or has reason to believe that the issuer has not complied 
with such requirements. Such person shall also be entitled to rely upon a written 
statement from the issuer that it has complied with such reporting requirements 
unless he knows or has reason to believe that the issuer has not complied with such 
requirements. [As amended in Release No. 34-5452 (If 9928) effective March 15, 
1974.] 
(2) Other Public Information. If the issuer is not subject to Section 13 or 
15(d) of the Securities Exchange Act of 1934, there is publicly available the 
information concerning the issuer specified in paragraph (a)(5)(i) to (xiv), inclu-
sive, and paragraph (a)(5Xxvi) of Rule 15c2-ll (§240.15c2-ll of this chapter) 
under that Act or, if the issuer is an insurance company, the information specified 
1f 2705A.10 Reg. § 230.144 ©1990, Commerce Clearing House, Inc. 
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in Section 12(g)(2)(G)(i) of that Act [Amended in Release No 33-6862 (If 84,523), 
effective April 30, 1990, 55 F R 17933 ] 
.30 Annotations of rulings under paragraph 2706 4912, 2706 4915, 2706 4916, 2706 4917, 
(c) of Rule 144.—See 1(2706 141, 2706 2237, 2706 492, 2706 4921, 2706 494, 2706 495, 
2706 2241, 2706 328, 2706 49, 2706 4901, 2706 496, 2706 497, 2706 5151, 2706 58, 
2706 4902, 2706 4903, 2706 491, 2706 4911, 2706 581, 2706 70, 2706 86, 2706 88 and 2706 92 
(d) Holding Period for Restricted Securities. If the securities sold are restricted 
securities, the following provisions apply. 
(1) General rule. A minimum of two years must elapse between the later of 
the date of the acquisition of the securities from the issuer or from an affiliate of 
the issuer, and any resale of such securities in reliance on this section for the 
account of either the acquiror or any subsequent holder of those securities, and if 
the acquiror takes the securities by purchase, the two-year period shall not begin 
until the full purchase price or other consideration is paid or given by the person 
acquiring the securities from the issuer or from an affiliate of the issuer. 
(2) Promissory Notes, Other Obligations or Installment Contracts. Giving the 
issuer or affiliate of the issuer from whom the securities were purchased a 
promissory note or other obligation to pay the purchase price, or entering into an 
installment purchase contract with such seller, shall not be deemed full payment 
of the purchase price unless the promissory note, obligation or contract: 
(i) provides for full recourse against the purchaser of the securities; 
(ii) is secured by collateral, other than the securities purchased, having a fair 
market value at least equal to the purchase price of the securities purchased, and 
(ii) shall have been discharged by payment in full prior to the sale of the 
securities. 
(3) Determination of Holding Period. The following provisions shall apply for 
the purpose of determining the period securities have been held: 
(i) Stock Dividends, Splits and Recapitalizations. Securities acquired 
from the issuer as a dividend or pursuant to a stock split, reverse split or 
recapitalization shall be deemed to have been acquired at the same time as 
the securities on which the dividend or, if more than one, the initial dividend 
was paid, the securities involved in the split or reverse split, or the securities 
surrendered in connection with the recapitalization; 
(ii) Conversions. If the securities sold were acquired from the issuer for a 
consideration consisting solely of other securities of the same issuer surren-
dered for conversion, the securities so acquired shall be deemed to have been 
acquired at the same time as the securities surrendered for conversion; 
(iii) Contingent Issuance of Securities. Securities acquired as a contin-
gent payment of the purchase price of an equity interest in a business, or the 
assets of a business, sold to the issuer or an affiliate of the issuer shall be 
deemed to have been acquired at the time of such sale if the issuer or affiliate 
was tht committed to issue the securities subject only to conditions other 
than the payment of further consideration for such securities. An agreement 
entered into in connection with any such purchase to remain in the employ-
ment of, or not to compete with, the issuer or affiliate or the rendering of 
services pursuant to such agreement shall not be deemed to be the payment 
of further consideration for such securities. 
(iv) Pledged Securities. Securities which are bona fide pledged by an 
affiliate of the issuer when sold by the pledgee, or by a purchaser, after a 
default in the obligation secured by the pledge, shall be deemed to have been 
acquired when they were acquired by the pledgor, except that if the securities 
were pledged without recourse they shall be deemed to have been acquired by 
Federal Securities Law Reports Reg. §230.144 H2705A.30 
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the pledgee at the time of the pledge or by the purchaser at the time o 
purchase. 
(v) Gifts of Securities. Securities acquired from an affiliate of the issue) 
by gift shall be deemed to have been acquired by the donee when they wen 
acquired by the donor. 
(vi) Trusts. Where a trust settlor is an affiliate of the issuer, securities 
acquired from the settlor by the trust, or acquired from the trust by the 
beneficiaries thereof, shall be deemed to have been acquired when such 
securities were acquired by the settlor 
(vii) Estates. Where a deceased person was an affiliate of the issuer 
securities held by the estate of such person or acquired from such estate b> 
the beneficiaries thereof shall be deemed to have been acquired when the) 
were acquired by the deceased person, except that no holding period is 
required if the estate is not an affiliate of the issuer or if the securities are 
sold by a beneficiary of the estate who is not such an affiliate. 
NOTE: While there is no holding period or amount limitation for estates anc 
beneficiaries thereof which are not affiliates of the issuer, paragraphs (c), (h) and (1) oi 
the rule apply to securities sold by such persons in reliance upon the rule. 
(viii) Rule 145(a) transactions. The holding period for securities 
acquired in a transaction specified in Rule 145(a) shall be deemed tc 
commence on the date the securities were acquired by the purchaser in such 
transaction. This provision shall not apply, however, to a transaction effectec 
solely for the purpose of forming a holding company. 
[Amended in Release No. 33-6862 (f 84,523), effective April 30, 1990, 55 
F.R. 17933.] 
.40 Annotations of Rulings under para- 2706 41 thru 2706 421, 2706.429, 2706 4410 
graph (d) of Rule 144.—See fl 2706 153, 2706 625, 2706 641, 2706 642, 2706 732, 
2706.185; 2706.2236; 2706.3001; 2706.3042; 2706810,2706 93 
2706.3051; 2706.308; 2706.3510, 2706 391, 
(e) Limitation on amount of securities sold. Except as hereinafter provided, the 
amount of securities which may be sold in reliance upon this rule shall be determined as 
follows: 
(1) Sales by affiliates. If restricted or other securities are sold for the account of an 
affiliate of the issuer, the amount of securities sold, together with all sales of restricted 
and other securities of the same class for the account of such person within the 
preceding three months, shall not exceed the greater of (i) one percent of the shares or 
other units of the class outstanding as shown by the most recent report or statement 
published by the issuer, or (ii) the average weekly reported volume of trading in such 
securities on all national securities exchanges and/or reported through the automated 
quotation system of a registered securities association during the four calendar weeks 
preceding the filing of notice required by paragraph (h), or if no such notice is required 
the date of receipt of the order to execute the transaction by the broker or the date of 
execution of the transaction directly with a market maker, or (iii) the average weekly 
volume of trading in such securities reported through the consolidated transaction 
reporting system contemplated by Rule HAa3-l under the Securities Exchange Act of 
1934 (§ 240.1 lAa3-l) during the four-week period specified in subdivision (ii) of this 
paragraph. 
[Amended in Release No. 33-5717 (If 80,601), June 8, 1976, 41 F. R. 24702; 
Release No. 33-5979 (If 81,731), effective September 25, 1978, 43 F. R. 43711; Release 
No. 33-5995 (1f8l,759), effective November 15, 1978, 43 F. R. 54230; Release No 
34-16589 (If 82,455), effective April 5,1980, 45 F. R. 12377.] 
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(2) Sales by persons other than affiliates. The amount of restricted securities sold 
for the account of any person other than an affiliate of the issuer, together with all 
other sales of restricted securities of the same class for the account of such person 
within the preceding three months, shall not exceed the amount specified in paragraphs 
(e)(l)(i), (l)(ii) or (l)(iii) of this section, whichever is applicable, unless the conditions 
in paragraph (k) of this rule are satisfied. [Amended in Release No. 33-5979 (If 81,731), 
effective September 25, 1978, 43 F. R. 43711; Release No. 33-5995 (f 81,759), effective 
November 15, 1978, 43 F. R. 54230; Release No. 33-6032 (If 81,992), effective March 
12, 1979, 44 F. R. 15612; Release No. 33-6286 flf 82,821), February 6, 1981, effective 
March 16, 1981, 46 F. R. 12195.] 
(3) Determination of Amount. For the purpose of determining the amount of 
securities specified in paragraphs (e)(1) and (2) of this rule, the following provi-
sions shall apply: 
(i) Where both convertible securities and securities of the class into 
which they are convertible are sold, the amount of convertible securities sold 
shall be deemed to be the amount of securities of the class into which they are 
convertible for the purpose of determining the aggreagte amount of securities 
of both classes sold; 
(ii) The amount of securities sold for the account of a pledgee thereof, or 
for the account of a purchaser of the pledged securities, during any period of 
three months within two years after a default in the obligation secured by the 
pledge, and the amount of securities sold during the same three-month period 
for the account of the pledgor shall not exceed, in the aggregate, the amount 
specified in subparagraph (1) or (2) of this paragraph, whichever is applica-
ble. [Amended in Release No. 33-5995 (If 81,759), effective November 15, 
1978, 43 F. R. 54230.] 
(iii) The amount of securities sold for the account of a donee thereof 
during any period of three months within two years after the donation, and 
the amount of securities sold during the same three-month period for the 
account of the donor, shall not exceed, in the aggregate, the amount specified 
in subparagraph (1) or (2) of this paragraph, whichever is applicable; 
[Amended in Release No. 33-5995 (f 81,759), effective November 15, 1978, 
43 F. R. 54230.] 
(iv) Where securities were acquired by a trust from the settlor of the 
trust, the amount of such securities sold for the account of the trust during 
any period of three months within two years after the acquisition of the 
securities by the trust, and the amount of securities sold during the same 
three-month period for the account of the settlor, shall not exceed, in the 
aggregate, the amount specified in subparagraph (1) or (2) of this paragraph, 
whichever is applicable; [Amended in Release No. 33-5995 (fl 81,759), effec-
tive November 15,1978, 43 F. R. 54230.] 
(v) The amount of securities sold for the account of the estate of a 
deceased person, or for the account of a beneficiary of such estate, during any 
period of three months and the amount of securities sold during the same 
period for the account of the deceased person prior to his death shall not 
exceed, in the aggregate, the amount specified in subparagraph (1) or (2) of 
this paragraph, whichever is applicable; Provided, That no limitation on 
amount shall apply if the estate or beneficiary thereof is not an affiliate of 
the issuer; [Amended in Release No. 33-5995 (jf 81,759), effective November 
15,1978,43 F.R. 54230.] 
(vi) When two or more affiliates or other persons agree to act in concert 
for the purpose of selling securities of an issuer, all securities of the same class 
sold for the account of all such persons during any period of three months 
shall be aggregated for the purpose of determining the limitation on the 
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amount of securities sold; [Amended in Release No 33-5995 (1f8l,759), 
effective November 15,1978,43 F. R. 54230 ] 
(vii) Securities sold pursuant to an effective registration statement 
under the Act or pursuant to an exemption provided by Regulation A under 
the Act or in a transaction exempt pursuant to Section 4 of the Act and not 
involving any public offering need not be included in determining the amount 
of securities sold in reliance upon this rule [As amended in Release No. 
33-5432 (f 79,633), effective March 15,1974, 39 F R. 6069 ] 
.50 Annotations of rulings under paragraph 2706 306, 2706 328, 2706 3853, 2706 412, 
(e) of Rule 144.—See f 2706 2201, 2706 2231, 2706 481, 2706 50, 2706 501, 2706 5011, 
2706 2241, 2706 3025, 2706 303, 2706 3031, 2706 5012, 2706 5014, 2706 502, 2706 503, 
2706 3033, 2706 3034, 2706 3035, 2706 3036, 2706 504, 2706 505, 2706 506, 2706 5060, 
2706 3037, 2706 304, 2706 3042, 2706 3043, 2706 5061, 2706 64, 2706 642, 2706 652, 
2706 3047, 2706 305, 2706 3051, 2706 3052, 2706 723, 2706 732, 2706 86, 2706 88, 2706 92, 
2706 3053, 2706 3054, 2706 3055, 2706 3056, 270693 
(f) Manner of sale The securities shall be sold in "brokers' transactions" within 
the meaning of section 4(4) of the Act or in transactions directly with a "market 
maker," as that term is defined in section 3(a)(38) of the Securities Exchange Act of 
1934, and the person selling the securities shall not (1) solicit or arrange for the 
solicitation of orders to buy the securities in anticipation of or in connection with such 
transaction, or (2) make any payment in connection with the offer or sale of the 
securities to any person other than the broker who executes the order to sell the 
securities. The requirements of this paragraph, however, shall not apply to securities 
sold for the account of the estate of a deceased person or for the account of a 
beneficiary of such estate provided the estate or beneficiary thereof is not an affiliate of 
the issuer; nor shall they apply to securities sold for the account of any person other 
than an affiliate of the issuer, provided the conditions of paragraph (k) of this rule are 
satisfied. [Amended in Release No. 33-5979 (f 82,731), effective September 25, 1978, 
43 F. R. 43711; Release No. 33-6286 (1(82,821), February 6, 1981, effective March 16, 
1981,46 F.R. 12195.] 
.60 Annotations of rulings under paragraph 2706 2237, 2706 328, 2706 4231, 2706 656, 
(0 of Rule 144.—See f 2706 2241, 2706.2262, 2706 6561, 2706 86,2706 90, and 2706 92 
(g) Brokers' Transactions. The term "brokers' transactions" in Section 4(4) of the 
Act shall for the purposes of this rule be deemed to include transactions by a broker in 
which such broker— 
(1) does no more than execute the order or orders to sell the securities as 
agent for the person for whose account the securities are sold, and receives no more 
than the usual and customary broker's commission, 
(2) neither solicits nor arranges for the solicitation of customers' orders to buy 
the securities in anticipation of or in connection with the transaction; provided, 
that the foregoing shall not preclude (i) inquiries by the broker of other brokers or 
dealers who have indicated an interest in the securities within the preceding 60 
days, (if) inquiries by the broker of his customers who have indicated an unsolic-
ited bona fide interest in the securities within the preceding 10 business days; or 
(iif) the publication by the broker of bid and ask quotations for the security in an 
inter-dealer quotation system provided that such quotations are incident to the 
maintenance of a bona fide inter-dealer market for the security for the broker's 
own account and that the broker has published bona fide bid and ask quotations 
for the security in an inter-dealer quotation system on each of at least twelve days 
within the preceding thirty calendar days with no more than four business days in 
succession without such two-way quotations, 
Note to Subparagraph g(2)(ii). The broker should obtain and retain in his 
files written evidence of indications of bona fide unsolicited interest by his 
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customers in the securities at the time such indications are received. [As amended 
in Release No. 33-5452 (If 79,633), effective March 15, 1974.] 
.70 Annotations of rulings under paragraph 2706 4172, 2706 444, 2706 6561, 2706 6563, 
(g) of Rule 144.—See 1(2706.215, 2706 2237, 2706 6565, 2706 6567, 270686, and 2706 92 
2706.285, 2706.328, 2706.387, 2706 388, 
(3) after reasonable inquiry is not aware of circumstar s indicating that the 
person for whose account the securities are sold is an undei >riter with respect to 
the securities or that the transaction is a part of a distribution of securities of the 
issuer. Without limiting the foregoing, the broker shall be deemed to be aware of 
any facts or statements contained in the notice required by paragraph (h) below 
Notes, (i) The broker, for his own protection, should obtain and retain in his 
files a copy of the notice required by paragraph (h). 
(ii) The reasonable inquiry required by paragraph (g)(3) of this section should 
include, but not necessarily be limited to, inquiry as to the following matters: 
a. The length of time the securities have been held by the person for 
whose account they are to be sold. If practicable, the inquiry should include 
physical inspection of the securities; 
b. The nature of the transaction in which the securities were acquired by 
such person; 
c. The amount of securities of the same class sold during the past three 
months by all persons whose sales are required to be taken into consideration 
pursuant to paragraph (e) of this section; 
d. Whether such person intends to sell additional securities of the same 
class through any other means; 
e. Whether such person has solicited or made any arrangement for the 
solicitation of buy orders in connection with the proposed sale of securities; 
f. Whether such person has made any payment to any other person in 
connection with the proposed sale of the securities; and 
g. The number of shares or other units of the class outstanding, or the 
relevant trading volume. 
(h) Notice of proposed sale. If the amount of securities to be sold in reliance upon 
the rule during any period of three months exceeds 500 shares or other units or has an 
aggregate sale price in excess of $10,000, three copies of a notice on Form 144 shall be 
filed with the Commission at its principal office in Washington, D. C; and if such 
securities are admitted to trading on any national securities exchange, one copy of such 
notice shall also be transmitted to the principal exchange on which such securities are 
so admitted. The Form 144 shall be signed by the person for whose account the 
securities are to be sold and shall be transmitted for filing concurrently with either the 
placing with a broker of an order to execute a sale of securities in reliance upon this 
rule or the execution directly with a market maker of such a sale. Neither the filing of 
such notice nor the failure of the Commission to comment thereon shall be deemed to 
preclude the Commission from taking any action it deems necessary or appropriate 
wua respect to the sale of the securities referred to in such notice. The requirements of 
this paragraph, however, shall not apply to securities sold for the account of any person 
other than an affiliate of the issuer, provided the conditions of paragraph (k) of this 
rule are satisfied. [Amended in Release No. 33-5307 (f 79,001), effective November 1, 
1972, 37 F. R. 20577; Release No. 33-5452 fl[ 79,633), effective March 15, 1974, 39 F. 
R. 6069; Release No. 33-5452A, effective March 15, 1974, 39 F. R. 8914; Release No. 
33-5560 (f 80,066), effective March 15, 1975, 40 F. R. 6487; Release No. 33-5995 
(f81,759), effective November 15, 1978, 43 F. R. 54230; Release No. 33-6286 
(If 82,821), February 6, 1981, effective March 16, 1981, 46 F. R. 12195.] 
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.80 Annotations of rulings under paragraph 2706.419; 2706.500; 2706.59; 2706.611; 2706.635; 
(h) of Rule 144.—See f 2706.2237; 2706.301; and 2706.636. 
2706.3011; 2706.3012; 2706.3015; 2706.417; 
(i) Bona Fide Intention to Sell. The person filing the notice required by paragraph 
(h) shall have a bona fide intention to sell the securities referred to therein within a 
reasonable time after the filing of such notice. 
(j) Non-exclusive rule. Although this rule provides a means for reselling restricted 
securities and securities held by affiliates without registration, it is not the exclusive 
means for reselling such securities in that manner. Therefore, it does not eliminate or 
otherwise affect the availability of any exemption for resales under the Securities Act 
that a person or entity may be able to rely upon. [Added in Release No. 33-6032 
(f81,992), effective March 12,1979, 44 F. R. 15612] 
(k) Termination of certain restrictions on sales of restricted securities by persons 
other than affiliates. The requirements of paragraphs (c), (e), (f) and (h) of this rule 
shall not apply to restricted securities sold for the account of a person who is not an 
affiliate of the issuer at the time of the sale and has not been an affiliate during the 
preceding three months, provided a period of at least three years has elapsed since the 
later of the date the securities were acquired from the issuer or from an affiliate of the 
issuer. In computing the three-year period for purposes of this provision, reference 
should be made to paragraph (d) of this section. [Amended in Release No. 33-6286 
(H82,821), effective March 16, 1981, 46 F.R. 12195; Release No. 33-6488 (If 83,429), 
effective October 31, 1983, 48 F.R. 44770; and Release No. 33-6862 (f 84,523), 
effective April 30,1990, 55 F.R. 17933.] 
.90 Annotations of rulings under Rule 144 2706.2235; 2706.228; 2706.3012; 2706.39; 
generally.—See f 2706.221; 2706.223; 2706.4171; 2706.611; 2706.795. 
[Adopted in Release No. 33-5223 (1f 78,487), effective April 15, 1972, 37 F. R. 596; 
Release No. 33-5307 (f 79,001) effective November 1, 1972, 37 F. R. 20577; Release 
No. 33-5452 (1f79,633), effective March 15, 1974, 39 F. R. 6069; Release No. 
33-5452A, effective March 15, 1974, 39 F. R. 8914; Release No. 33-5560 (If 80,066), 
effective March 15, 1975, 40 F. R. 6487; Release No. 33-5613 (If 80,293), effective 
September 11, 1975, 40 F. R. 44541; Release No. 33-5517 (1f 80,601), June 8, 1976, 41 
F. R. 24701; Release No. 33-5979 (If 81,731), effective September 25, 1978, 43 F. R. 
54230; Release No. 33-6032 (1f 81,992), effective March 12, 1979, 44 F. R. 15612; 
Release No. 33-6180 (1f 82,426), effective February 25, 1980, 45 F. R. 6362; Release 
No. 34-16589 (H 82,455), effective April 5, 1980, 45 F. R. 12377; Release No. 33-6286 
(If 82,821), February 6, 1981, effective March 16, 1981, 46 F. R. 12195; Release No. 
33-6389 (If 83,106), effective April 15, 1982, 47 F. R. 11251; Release No. 33-6488 
(If 83,429), effective October 31, 1983, 48 F. R. 44770; Release No. 33-6768 (1f 84,231), 
effective May 20, 1988, 53 F. R. 12918; and Release No. 33-6862 flf 84,523), effective 
April 30, 1990, 55 F.R. 17933.] 
[H 2705AA] Private Resales of Securities to Institutions 
Preliminary Notes to Rule 144A 
1. This section relates solely to the application of Section 5 of the Act and not to 
antifraud or other provisions of the federal securities laws. 
2. Attempted compliance with this section does not act as an exclusive election; 
any seller hereunder may also claim the availability of any other applicable exemption 
from the registration requirements of the Act. 
3. In view of the objective of this section and the policies underlying the Act, this 
section is not available with respect to any transaction or series of transactions that, 
although in technical compliance with this section, is part of a plan or scheme to evade 
the registration provisions of the Act. In such cases, registration under the Act is 
required. 
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[ f 77,158] In the Matter of the Application of Nassau Securities Service. 
Securities Exchange Act Release No. 7464. November 19, 1964. Findings and opinion 
of the Commission in full text. 
NASD—Disciplinary Action on Member Upheld—Refusal to Pay Balance Arising 
Out of Buy-in Not Justified.—The failure of a N A S D member who made a short sale to 
pay a balance arising out of a buy-in executed by the purchaser was a violation of the 
N A S D rules requiring members to observe "high s tandards of commercial honor and 
just and equitable principles of trade." Consequently, the censure, fine and assessed costs 
imposed by the N A S D was upheld. The claim by the applicant that its refusal was based 
on suspected fraud was not justified since the applicant along with some other 16 dealers, 
participated in making a market in the stock, was aware of the factors which it claims 
suggest a manipulation, and when notified of the buy-in, at tempted to get another ex-
tension for delivery. 
See ^[25,681, "Exchange Act—Securities Associations" division, Volume 2. 
Irving Garber, for Nassau Securities Service. 
Marc A. Whi te and Lloyd J. Derrickson, for the National Association of Securities 
Dealers, Inc. 
Nassau Securities Service ("applicant") , 
a member of the National Association of 
Securities Dealers, Inc. ( " N A S D " ) , a reg-
istered securities association, has applied 
pursuant to Section 15A(g) of the Securi-
ties Exchange Act of 1934 for review of 
disciplinary action taken against it by the 
N A S D . 1 
On the basis of a complaint filed by 
another member, James Anthony & Co., 
Inc. ("complainant"), charging applicant 
with failure to settle a $325 balance arising 
out of a "buy-in" executed by complainant 
under Section 59 of the N A S D Uniform 
Practice Code,8 the N A S D found that ap-
plicant violated Section 1, Article I I I of 
the N A S D Rules of Fair Practice, which 
requires a member in the conduct of liis 
business to "observe high standards of 
commercial honor and just and equitable 
principles of trade." Applicant was cen-
sured, fined $1,000 and assessed costs of 
$256.67. Applicant and the N A S D filed 
briefs with us and we heard oral argument . 
Our findings are based upon an independent 
review of the record. 
[Buy-in Procedure] 
On October 24, 1962, applicant made a 
short sale of 100 shares of stock of Cryplex 
Industries, Inc. ("Cryplex") to complainant 
at $6.75 a share, for settlement on October 
30. Complainant had other transactions in 
Cryplex, one of which was a sale by it on 
October 25, for settlement on October 31, 
of 100 shares to Hampstead Investing Corp. 
("Hampstead") at $7 per share. Under 
date of October 31, one day after the settle-
ment date for the sale by applicant, com-
plainant, in accordance with the N A S D 
buy-in procedure, notified applicant that if 
delivery was not made by November 1 
complainant would buy-in the shares on 
the market for applicant's account. Appli-
cant requested and received an extension 
of time from complainant, and on Novem-
ber 2 it purchased 100 Cryplex shares from 
another dealer at $8.25 per share. Subse-
i Under Section 15A(h) of the Act. which 
defines the nature of our review, we must 
dismiss these proceedings if we find that ap-
plicant engaged in the conduct found by the 
NASD and that such conduct violated the 
NASD rule and was inconsistent with just and 
equitable principles of trade, unless we further 
find that the penalties imposed by the NASD 
are excessive or oppressive having due regard 
to the public Interest, and should be cancelled 
or reduced. 
- Section 59 of the NASD Practice Code pro-
vides in substance that where a seller has not 
performed its part of a contract for the sale 
of securities by the d-Jte delivery is due. the 
buyer, after giving due notice, may purchase, 
i.e., "buy-in," in the open market and for the 
account and risk of the seller, the securities 
which were to have been delivered. 
1177,158 © 1964, Commerce Clearing House, Inc. 
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quently, under date of November 9, at 
which time delivery had not yet been made 
on any of these transactions, Hampstead 
wrote complainant notifying it that unless 
its shares were delivered to it by 2:15 
P. M. November 13, Hampstead would 
buy-in complainant. Complainant informed 
applicant on the morning of November 13 
that if applicant did not deliver its shares 
by that afternoon, and that if Hampstead 
executed its buy-in against complainant, 
complainant would deem that buy-in a 
close-out of its contract with applicant, 
thus, in effect, executing its buy-in against 
applicant. Applicant failed to deliver the 
shares by the afternoon of November 13, 
and on that day Hampstead executed its 
buy-in against complainant by purchasing 
the Cryplex shares at $10 per share and 
complainant sent a confirmation to appli-
cant notifying it of the execution of the 
buy-in against complainant and the con-
sequent close-out of applicant's transaction. 
On November 14, applicant received late 
delivery of the 100 Cryplex shares which 
it had purchased on November 2 and ten-
dered them to complainant.* The tender was 
refused as too late. Subsequently, Hamp-
stead was paid the balance owed it by com-
plainant, but applicant has not paid com-
plainant the $325 difference between its 
contract price and the buy-in price. 
Applicant claimed before the N A S D and 
here that the market for Cryplex stock 
was manipulated, and that the buy-in pro-
cedure was being used as a part of the 
manipulation scheme. In support of this 
contention it stated that the price of $10 
per share was an unreasonably high price 
in relation to the company's earnings,4 and 
that it had been told by another dealer 
that "they're going to box" applicant in 
on the ick. It further asserted that the 
circumst inces here are very similar to 
8
 The NASD noted that applicant did not 
require its seller to guarantee delivery on the 
settlement date even through complainant's 
notice of buy-in had been previously received 
and even 'hough applicant admitted that, on 
previous '^casions, he had been the subject 
of buy-ins. 
* Applicant recites that a report of the issuer 
showed earnings of one cent per share for the 
year ending September 20, 1962. The issuer had 
made a public offering of 80,000 shares at $3.75 
per share in April 1962. 
5
 Recent price quotations for Cryplex have 
been in the range of SI.50 to $2 per share. A 
number of the dealers quoting prices for 
Cryplex stock in 1962, including Hampstead, 
are not now in business. Hampstead, which 
those in two previous instances where it 
was bought-in on other securities at very 
high prices, after which the prices of such 
securities dropped substantially and some 
of the dealers involved went out of business 
and could not be located, and that it had 
reported those situations to the N A S D 
without any results.* It states that it re-
fused to pay complainant in order to force 
the N A SD to make an investigation of 
the Cryplex market. 
The N A S D asserts that applicant's obli-
gation to complainant is clear, and that 
applicant offered no evidence to support 
the claim of manipulation and in fact was 
itself making a market in Cryplex and 
appeared in tbe sheets with an offer of $10 
per share when the buy-in took place. 
In this case we are called upon to decide 
whether under all the circumstances appli-
cant's refusal to pay the $325 balance aris-
ing out of a buy-in effected in accordance 
with the N A S D rules was without equit-
able excuse or justification.* W e conclude 
that it was. Applicant, although claiming 
before us and the N A S D that it suspected 
fraud in the trading of Cryplex, was itself, 
along with some 16 other dealers, partici-
pating in the making of a market in Cryplex 
during the period involved and at that time 
it was aware of most of the factors which 
it claims suggest a manipulation.7 Further-
more, the record indicates that applicant, 
when bought-in by complainant, did not 
communicate its asserted suspicions of fraud 
to complainant. Rather, applicant sought 
to secure another extension of time in 
which to make delivery of the shares. 
Applicant's contention that complainant 
should have "accommodated" it by staying 
the buy-in a second time is unreasonable. 
To have granted applicant's request would 
have meant as indicated by the District 
had been one of the underwriters in the Cryplex 
public offering in 1962, withdrew its broker-
dealer registration in April 1964. 
6
 See ElUot Evans Compiny, Securities Ex-
change Act Release No. 7378 (July 29, 1964); 
Franklin & Company, 38 S. E. C. 113, 116 (1957). 
7
 In response to the admonition of the Chair-
man of the subcommittee of the Board of 
Governors that applicant had a duty to stop 
trading Cryplex if it suspected a manipulation, 
applicant stated that it was, at that time, 
attempting to trade its way out of a short 
position. However, we note that applicant was 
entering oiTers as well as bids and its bids 
were consistently among the lowest, facts that 
would not indicate a desire on its part to pur-
chase shares in order to cover a short position. 
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Committee that complainant, already bought-
in by its vendee, would be assuming ap-
plicant's obligation. 
Although applicant asserts that it is not 
attempting to avoid the obligation and in-
dicates that it has offered to put the $325 
in escrow pending an investigation of the 
Cryplex market, it admits that it never 
made such an offer to complainant and it 
did not attempt to communicate with com-
plainant in order to seek a satisfactory 
solution. Although applicant claims that 
it suspected fraud it was not justified in 
resorting to non-payment of an obligation 
owed to a fellow member of the NASD as 
a lever to secure an investigation. 
We conclude that applicant had no equitable 
justification for its refusal to honor its 
obligation to complainant, and that ap-
plicant's conduct was inconsistent with just 
and equitable principles of trade and con-
trary to the requirements of Section 1, 
Article I I I of the NASD Rules. Under 
all the circumstances we cannot find that 
the penalty of censure and a $1,000 fine 
imposed by the NASD is excessive or 
oppressive having due regard to the public 
interest. 
Accordingly, IT IS ORDERED that the 
application for review of the disciplinary 
action taken by the National Association 
of Securities Dealers, Inc. against Nassau 
Securities Service be, and it hereby is, dis-
missed. 
By the Commission (Chairman COHEN 
and Commissioners WOODSIDE, OWENS and 
BUDGE), Commissioner WHEAT not partici-
pating. 
ihibition.—A 
and purchase 
erger involving 
Company Act. 
from the pro-
ss and fairness, 
Directors" di-
and Surety Company; Farmington Valley Insurance Company. 
Investment Company Act Release No. 4082, November 19, 1964. 
opinion of the Commission in full text. 
Transactions Between Affiliated Persons—Exchange of Securities^ 
sale by an affiliate of an affiliated person of a registered investment cona^P 
of other securities from the investment company incident to a plai^^^n! 
the affiliated persons are prohibited by Section 17(a) of the In^^Bnent 
However, the transfer effecting the exchange of securities wa^^Bmpted 
hibition where requirements of Section 17(b) of the Act, as toj^^ronablene 
were met. ^^y 
See If 48,134, 48,137, "Investment Companies—Affil^^^ Functions, 
vision of Volume 3. ^^W 
Transactions Between Affiliated Persons—Exej^Kn from Prohibition.—A sale to 
and purchase of securities from a registered inve^^Kit company by an affiliated person 
of an affiliated person of the investment c o m a f through an exchange of securities 
incident to a plan of merger involving the^^Bnated persons were held exempted by 
Section 17(b) of the Investment Companyj/Hr from the prohibition of transactions be-
tween affiliates under Section 17(a) of th^Hct. The terms of the proposed transactions, 
including the consideration to be paid j^Pfceived, were reasonable and fair and did not 
involve overreaching by any person^Brcerned and the proposed transaction was con-
sistent with the policy of the r e &«Bca investment company and the general purposes 
of the Act. jSr 
See ^48,162—48,164, "Irry^Pnent Companies—Affiliates; Functions; Directors" di-
vision, Volume 3. mtm 
Affiliated Person—Mnmion.—An insurance company was determined to be an 
affiliated person of a a^^Rered investment under Section 2 (a) (3) of the Investment 
Company Act, sinceJjHnnvestment company held 5.09% of its outstanding voting securi-
ties. A company j f imed by the insurance company as part of a plan of merger and 
exchange of sto^H^uso was held to be an affiliated person of the insurance company 
under the A c t j H r 
See ^jmBBE* "Investment Companies—Definitions" division of Volume 3. 
Diversified Company—Limitations.—A registered diversified investment company 
would meet the 10% limitations of Section 5 (b) (1) of the Investment Company Act 
1177,159 © 1964, Commerce Clearing House, Inc. 
EXHIBIT "QQ" 
JOHN MICHAEL COOMBS, ESQ., No. 3639 
72 East 400 South. Ste. 220 
Salt Lake City. UT 84111 
Telephone: (801)359-0833 
Attorney for Respondents 
~M ;ar Us 
NOV 0 2 RECTJ 
ARTMENT OF 
COMMERCE 
BEFORE THE SECURITIES DIVISION 
OF THE DEPARTMENT OF COMMERCE 
OF THE STATE OF UTAH 
IN THE MATTER OF THE REGISTRATION 
OF: 
JOHNSON-BOWLES COMPANY. INC. 
CRD NO. 07678 
IN THE MATTER OF THE REGISTRATION 
OF: 
MARLEN VERNON JOHNSON 
CRD NO. 2598888 
NOTICE OF NEWLY DISCOVERED 
FACTS AND EVIDENCE 
Case No. SD-89-46BD 
Case No. SD-89-47AG 
Respondents, by and through their counsel, hereby give notice that yesterday 
their counsel was apprised of pertinent material facts and evidence which directly bear on 
the Administrative Law Judge's Order of August 29. 1989. and Respondents' pending Rule 
12(b)(6) Motion. 
The newly discovered facts, events, and evidence, comprise the following: The 
NASD and Otra Clearing. Inc.. a California NASD member, have brought a disciplinary 
complaint against Respondents before the NASD Business District Conduct Committee. 
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District No. 3, alleging that Respondents' failure to honor trades with Otra in the securities 
of U.S.A. Medical constitute violations of the Rules of Fair Practice of the NASD and/or the 
Government Securities Rules of the NASD, the provisions of the federal securities laws, 
and/or the rules of the Municipal Securities Rule-making Board. The NASD Disciplinary 
Action is denominated by Complaint No. DEN-914 and entitled Otra Clearing, Inc. v. 
Johnson-Bowles Company, Inc., and Marlen Vernon Johnson. Such has been brought in 
reliance on Art. IV, §2 of the NASD Rules of Fair Practice, entitled "Complaints by public 
against members for violations of rules". NASD Manual, Rules of Fair Practice (CCH) H2202. 
The Division is requested to take judicial notice of the foregoing disciplinary proceedings in 
accordance with the Utah Rules of Evidence as contemplated in §63-46b-8(1)(b)(iv), Utah 
Code Ann. The foregoing is significant in that it evidences the undeniable conflict between 
federal securities laws and the instant state administrative adjudicative proceedings as 
Respondents have continuously and consistently alleged throughout these entire 
proceedings to no avail. In other words, the foregoing evidences that Respondents could 
not comply with their federal Exchange Act obligations and at the same time not violate 
state law as contemplated in the instant state administrative proceedings. [Emphasis 
added.] The foregoing further evidences the undeniable conflict the instant proceedings 
pose between state and federal law. Further, it is significant that the NASD/Otra 
disciplinary action, which seeks to revoke or suspend the NASD registration of Respondents, 
is not brought as an ordinary NASD arbitration matter. On the contrary, such is brought to 
discipline Respondents for alleged violations of federal law — federal violations which 
allegedly justify putting Respondents out of business for reasons diametrically opposite to 
those alleged in the instant administrative proceedings. The foregoing further evidences 
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that the Division's representations at the hearing on Respondents' Rule 12(b)(1) Motion on 
July 14, 1989, that the NASD would not discipline Respondents for not honoring Exchange 
trades is patently erroneous and false as Respondents have further contended all along. 
A true and correct copy of the NASD Notice of Complaint is attached hereto and 
incorporated by reference as Exhibit "A". 
DATED thlsy/, day of November. 
The undersigned hereby certifies that on t h e / , day of November. 1989, (s)he 
mailed a true and correct copy of the foregoing NOTICE OF NEWLY DISCOVERED EVIDENCE 
by regular mail, postage prepaid to John C. Baldwin, Director and Kathleen C. McQinley, 
Director of Broker-Dealer Section, Securities Division. Utah Department of Commerce, 160 
East 300 South, P.O. Box 45802. Salt Lake City. Utah 84145-0802; Administrative Law Judge 
J. Stephen Eklund. Esq., Department of Commerce, 160 East 300 South, P.O. Box 45802. 
Salt Lake City, Utah 84145-0802; Craig F. McCullough, Esq., Callister, Duncan. & Nebeker. 
Co-Counsel to Respondents, 8th Floor, Kennecott Bldg., 10 East South Temple Street, Salt 
Lake City, Utah 84133; and Mark J. Griffin. Esq.. Assistant Attorney General, 115 State 
Capitol Building, Salt Lake City, Utah 84114. ~ * ^ 
J:N0TICE.l 
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CP-2 (4/89) 
National Association of Securities Dealers, Inc. 
NOTICE OF COMPLAINT 
Complaint No.: DEN-914 
Date Filed: October 25, 1989 
Origin: 
To: Name and Address of Respondent(s): 
Johnson-Bowies Company, Inc., 430 East 400 South, Salt Lake City, UT 84111 
and Marlen Vernon Johnson, 430 East 400 South, Salt Lake City, UT 84111 
From: OTRA CLEARING, INC 
116 North Maryland, Suite 120 
Glendale, California 91206 
You are hereby notified that a complaint has been filed by Otra Clearing, Inc., a true copy of which 
is attached hereto, alleging that you have violated the Rules of Fair Practice of the NASD, and/or the 
Government Securities Rules of the NASD, the provisions of the federal securities laws, and/or the rules 
of the Municipal Securities Rulemaking Board 
All individual respondents named in this proceeding are reminded of the requirement to immediately 
update their application for registration (Form U-4) upon receipt of this notice ot complaint to reflect that 
they have been named a respondent in this complaint 
ANSWER: Pursuant to Article II Section 3(a) of die Code of Procedure applicable to disciplinary actions 
involving members and associated persons, you are required to submit to the District Business Conduct 
Committee^  three (3) copies of a written answer to said complaint within twenty (20) calendar days of the 
date of this notice on the forms enclosed herewith. The answer should be complete and responsive to 
each allegation contained in the complaint. If applicable, attenuating or mitigating circumstances should 
be discussed in the answer in order to give the Committee, benefit of this information. In complaints 
involving multiple respondents, copies of the answers submitted by each respondent will be mailed to all 
other respondents, 
HEARING: If you desire and indicate such in year answer, a hearing on this matter will be held at least 
ten (10) calendar days after notice of its time and place has been sent to you. 
EVIDENCE AT HEARING: Upon respondent's request, the NASD staffs witness list and proposed 
exhibits for the hearing shall be made available to the respondent no later than five business days before 
the hearing. Similarly a respondent shall submit to the NASD staff its proposed exhibits and witness list 
no later than five business days prior to the hearing. 
OFFER OF SETTLEMENT: Pursuant to Artide II Section 11 of the Code of Procedure you may 
propose an offer of settlement to Otra Clearing, Inc. Such offer must be in writing and contain a detailed 
restatement of the complaint, a consent to findings of fact and violations, a proposed sanction to be 
imposed, and a waiver of all rights of appeal 
Questions regarding the above should be directed to: 
, Cynthia King Sadick, Senior Regional Attorney, (303) 298-7234 
(Name, Title, Telephone No.) 
// 1 y, _ > C l t ) >-6^5 
-A i • V:>( • ;/, //.? 
District Director // L , ' < 
for District No. 3 I ~ ' 
cc NATIONAL ASSOCIATION OF SECURITIES DEALERS, INC. 
1735 K STREET, N.W., WASHINGTON, D.C. 20006 | | A * 
EXHIBIT "RR" 
Arbitration 
January 14, 1991 
National Association of 
Securities Dealers, Inc. 
425 California St., Rm. 1400 
San Francisco, CA 94104 
(415) 781-3343 
FAX: (415) 362-9946 
John Michael Coanbs, Esq. 
72 East 400 South, Ste. 220 
Salt Lake City, UT 84111 
Subject: NASD Arbitration Number 90-00757 
OTRA Clearing, Inc. vs. Johnson Bowles Company, Inc. and Marlen 
Vernon Johnson 
Dear Mr. Cocmbs: 
In accordance with the NASD Code of Arbitration Procedure, a decision in the 
above-captioned matter has been reached by the arbitrators and is enclosed. 
Any questions regarding this decision should be directed to me. The parties. 
«MSt not Contact the arbitrators directly, 
Very truly yours, 
Virginia Hall 
Arbitration Administrator 
415-781-3343 
VH:REH:LC09A 
Enclosure 
NATIONAL ASSOCIATION OF SECURITIES DEALERS, INC. 
In the Matter of the Arbitration Between 
Otra Clearing, Inc. 
Claimant 
vs. 
Johnson-Bowles Company, Inc. 
Marlen Vernon Johnson 
Respondents 
SUMMARY OF ISSUES 
Claimant alleged Respondents failed to fulfill a contract 
for the purchase and sale 01 150,000 shares of U.S.A. Medical 
common stock. Claimant alleged that Johnson-Bowles was a market 
maker for this stock and, as such, was obligated to complete the 
transaction. Claimant further alleged that it was compelled to 
buy-in the shares on behalf of Respondent Johnson-Bowles, and 
that it suffered a monetary loss from Respondents' failure to pay 
for the buy-in. Claimants alleged violations of federal 
securities laws and the NASD rules of Fair Practice. 
Respondents denied all allegations of wrong-doing, and 
asserted that a scheme to perpetrate a stock fraud was undertaken 
by third parties which victimized Respondents and left them 
unable to complete the transaction. Respondents further asserted 
that rulings of the State of Utah Division of Securities and of 
the U.S. District Court for the Central Division of Utah rendered 
the further trading of USA Medical illegal in the State of Utah, 
thus relieving them of the obligation to complete the 
transactions at the time. Respondents alleged that a later 
attempted delivery of the shares to Claimant was refused. 
DAMAGES AND RELIEF REQUESTED 
Claimant requested actual damages of $89,600.00, punitive 
damages of $100,000.00, plus interest, attorneys' fees and costs 
of arbitration. 
Respondents requested dismissal of all claims and an award 
of attorneys' fees. 
DAMAGES AND RELIEF AWARDED 
This claim was filed with the NASD on M?rch 14, 1990. A 
pre-hearing telephone conference was held October 31, 199 0, and 
lasted one (1) session. On December 13 and 14, 1990, the 
AWARD 
NASD # 90-00757 
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undersigned arbitrators heard the controversy between the 
parties as set forth in submissions to arbitration signed by 
Claimant on March 13, 1990, by Johnson-Bowles Company on May 7, 
1990, and by Marlen Johnson on December 13, 1990. The hearing 
was conducted in Salt Lake City, Utah and lasted four (4) 
sessions. The arbitration panel, having considered the 
pleadings, the testimony, and the evidence presented at the 
hearing, has determined in full and final resolution of the 
issues submitted as follows: 
1. Respondents Johnson-Bowles and Marlen Johnson are 
jointly and severally liable for and shall pay to 
Claimant the sum of $89,600.00 plus interest at the 
rate of 10% from February 23, 1989 to date of payment. 
2. The claim for punitive damages is dismissed. 
3. The parties shall each bear their respective costs 
including attorneys' fees. 
4. In accordance with Section 44 of the NASD Code of 
Arbitration Procedure, the NASD shall retain the 
$1,000.00 filing fee previously deposited by the 
Claimant as an assessment of forum fees. Respondents 
are jointly and severally assessed forum fees of 
$4,000.00, payable to the NASD. 
OTHER ISSUES 
This claim was ordered to arbitration by Order dated March 
1, 1989, in Case No. 89-C-157-G in the United States District 
Court for the District of Utah, Central Division. 
ARBITRATORS CONCURRING 
DATE SERVED: 1/14/91 
Peggy Peterson 
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Arbitration 
A r e i i A V I T OF a a f l f j g E N a t i o n a l Association of 
Securities Dealers, Inc. 
425 California St., Rm. 1400 
S t a t e o f C a l i f o r n i a ) San Francisco, CA 94104 
) SS. (415) 781-3343 
County of San Francisco ) FAX: <415) 362-9946 
I, Rhenee M. Ong, hereby declare, depose and state under penalty of 
perjury that: 
1. I am over eighteen years of age, am not a party to the arbitration 
proceedings, and am employed by the National Association of Securities 
Dealers, Inc. in San Francisco, California. 
2. On January 14
 r 1991 . I enclosed a true, accurate and complete copy 
of: 
AWARD SERVED: 
NASD Arbitration Number 90-00757 
OTRA Clearing, Inc. vs. Johnson Bowles Company, Inc. and Marlen Vernon 
Johnson 
in a properly addressed wrapper, with postage prepaid, and deposited it in a 
post office or official depository under the exclusive care and custody of 
the United States Postal Service within this state. The addressee(s) and the 
address(es) to which the above document(s) was/were sent is/are: 
John Michael Coombs, Esq. 
72 East 400 South, Ste. 220 
Salt Late City, IJT 84111 
Christopher Condie, Esq. 
Van Wagoner & Stevens 
215 South State Street 
Suite 500 
Salt Lake City, UT 84111 
3. The address (es) set forth in paragraph 2 is/are the address (es) 
designated for that purpose by a party/parties to the arbitration or 
its/their counsel or is/are the last known address (es) thereof. 
4. I declare under penalty of perjury, pursuant to 28 U.S.C. 1746, 
that the foregoing is true. 
M. Ong/ 
%D6CJ! 
EXHIBIT "SS 
JOHN MICHAEL COOMBS. ESQ.. No. 3639 
72 East 400 South. Ste. 220 
Salt Lake City. UT 84111 
Telephone: (801)359-0833 
Attorney for Respondents 
BEFORE THE SECURITIES DIVISION 
OF THE DEPARTMENT OF COMMERCE 
OF THE STATE OF UTAH 
IN THE MATTER OF THE REGISTRATION 
OF: 
JOHNSON-BOWLES COMPANY. INC. 
CRD NO. 07678 
IN THE MATTER OF THE REGISTRATION 
OF: 
MARLEN VERNON JOHNSON 
CRD NO. 2598888 
REQUEST FOR AGENCY REVIEW 
OF ENTIRE RECORD AND 
SUPPORTING BRIEF 
Case No. SD-89-46BD 
Case No. SD-89-47AG 
REQUEST 
PLEASE TAKE NOTICE that in accordance with Utah Code Ann. §63-46b-12 
and/or R151-46b-12 of the Rules of Procedure for Adjudicative Proceedings Before the 
Department of Commerce, Respondents hereby request agency or superior agency review 
of the entire record before the Administrative Law Judge Including, but not limited to the 
August 13,1990, Findings of Fact, Conclusions of Law, and Order. This request for agency 
review is not intended by Respondents to be a waiver of any right to judicial review under 
_ 1 _ 
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Utah Code Ann, §61-1-23. §63-46b-14. and/or §63-46b-16. Respondents interpret the 
UAPA and the corollary Department of Commerce Rules as requiring this request for agency 
review before judicial review is either permissible or available. By filing this Request. 
Respondents further do not intend to waive a ruling by the ALJ (or anyone else) on their 
pleadings filed August 20. 1990 relative to the August 13. Order. This is because under 
applicable rules. Respondents have no choice but to file this Request on or before today. 
August 23,1990. Respondents have also not furnished a copy of this Request to the ALJ in 
that they understand that the matter is out of his hands and he will not be participating in 
any decision on this Request. Respondents also incorporate herein by reference as Exhibit 
"A", a true and correct copy of the official transcript of the July 16,1990, proceedings 
before the Securities Advisory Board and the ALJ. 
BRIEF 
The following will serve as Respondents' Brief in support of this Request for 
Agency Review. Respondents make reference to the various memorandums in support of 
and in reply to the motions and subsequent orders issued by the ALJ in the record. The 
orders from which agency review is sought are numbered hereinbelow and the pleadings to 
which the reviewing or presiding officer is acted to refer to in each regard are further 
referenced below. The pleadings referenced below are in no way intended to be exhaustive 
of what is otherwise in the record and which should be considered in ruling on this Request. 
The reviewing officer is also directed to hear the tapes of any oral argument that occurred, 
as applicable to otherwise ensure that the ALJ did not err. Based on the foregoing, and, for 
the sake of convenience, the reviewing officer is directed to the following in the record. 
1. Order Granting The Division's Motion to 
Convert 07/14/89 
Reference is made to: Respondents' Objection 
to Motion to Convert. 05/30/89 
Reference is also made to tape of oral argument. 
With respect to this ruling, a ruling which determined the rights of Respondents throughout 
the remainder of the proceedings (and which prejudiced them accordingly). Respondents 
further submit that the Division promulgated its own set of rules whereby actions such as 
those brought against Respondents would strictly be designated as informal proceedings. 
Even in light of its own rules which the Division is obligated to follow, the Division still 
elected to bring the proceedings as informal at the outset and. while it never had or stated 
any legitimate grounds to convert. Respondents submit that it otherwise waived any right or 
other ability to convert the proceedings to formal. Further, the ALJ's order granting the 
motion to convert is erroneous in that its only effect Is to deprive Respondents of a trial de 
novo in the district court without any other basis in law or fact. For instance, so-called 
"cost-effectiveness" cannot be a basis for such order in that, after 1% years of costly and 
time consuming litigation, the Division has spent a fortune of the taxpayers' money in this 
litigation and a trial de novo in the district court would have been simpler, more efficient. 
cheaper, and swifter. Furthermore, if the ALJ is correct in his order granting the motion to 
convert, there would never be a circumstance when any informal proceeding could not be 
converted to formal simply because. Hke a spoiled child, that is what the Division, or any 
other agency, desires. The ALJ's Order is thus further contrary to what the legislature has 
provided by statute, namely, allowing those such as Respondents with the right to a trial de 
novo. 
PLEADINGS DATES 
2. Order Denying Respondents' Rule 12(b)(1) 
Motion. 08/29/89 
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Reference is made to: Respondents' Supporting 
Memorandum 07/03/89 
Reference is also made to: Affidavit in Support 
of 12(b)(1) Motion. 07/13/89 
Reference is further made to: Respondents' 
letter or Reply Memorandum to the ALJ. 07/13/89 
Reference is further made to Respondents' Brief in Support of Request for Agency Review 
of the ALJ's 8/29/89 order dated September 11.1989. and Respondents' Reply 
Memorandum in Support of Request for Agency Review dated October 6.1989. The 
reviewing officer is requested to address all issues presented in such memorandums and 
pleadings, item by item, more especially those that the ALJ neglected to address. 
3. Order Denying Respondent's 12(b)(6) Motion 12/18/89 
Reference is made to: Respondents' Supporting 
Memorandum. 09/27/89 
Reference is further made to Respondents 
Reply Memorandum. 10/25/89 
Respondents assign error on the basis of any one or all of the arguments presented In the 
foregoing pleadings and request that the reviewing officer address all arguments posed 
therein, item by item. There are also several Constitutional issues that the ALJ wholly 
neglected to address and which should be addressed for purposes of judicial appeal. 
4. Order Granting the Division's Motion to 
Dismiss Respondents' Counterclaim. 
(Separate from the order in #3 above.) 12/18/89 
Reference is made to the Respondents' Opposing 
Memorandum. 11/09/89 
5. Order Denying Respondents' Motion for Summary 
Judgment. 03/23/90 
Reference is made to: Respondents' Supporting 
Memorandum. 11 /28/89 
{ h ' l r \^,i) 
- 4 -
their Reply Memorandum. 12/21 /89 
their Objection and Motion to Strike. 12/21/89 
Respondents' counsel's Rule 56(f) Affidavit 
in Opposition to Petitioner's Motion for Partial 
Summary Judgment. 12/21/89 
Reference is further made to: Affidavits of the five (5) Utah residents from whom 
Respondents purchased the stock in issue, filed November 28,1989, with the ALJ, including 
the 11 /29/89 affidavit of Carl Smith. Reference is further made to the Affidavit of Bruce 
Eatchel dated December 20,1989 and Respondents' Supporting Affidavit dated November 
27.1989. 
The Order Denying Respondents' Motion for Summary Judgment was 
erroneous in that the ALJ was indeed competent to rule on the merits and his ruling should 
have been the subject of a Request for Agency Review and subsequent Judicial Review as 
opposed to proceeding unnecessarily with a trial on July 16,1990. Respondents believe 
that the August 13,1990, Order was pre-ordained and in the interest of expediting the 
process, the ALJ could have made the same ruling relative to Respondents' Motion for 
Summary Judgment. The fact of the matter is that there was no issue of fact for a trial and 
the ALJ was Just as competent as the Securities Advisory Board to make an ultimate ruling. 
The ALJ's 3/23/90, which concluded the contrary, was thus error and needlessly resulted In 
a trial on July 16.1990. 
However, most significantly, the ALJ erred In that Respondents should have 
been granted summary Judgment dismissing the proceedings on the basis of the arguments 
presented In the above-referenced pleadings. For instance. Respondents cannot be liable, 
as a matter of law, for aiding and abetting in that they neither created (nor participated in) 
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the problem which caused exemptions to be unavailable nor did they solicit their sellers as a 
matter of law —thereby nc* "substantially participating'' in any underlying wrong. In 
addition. Respondents are otherwise within the class of persons (i.e.. purchasers) that 
registration statutes were enacted to protect. Thus, the Division's aiding and abetting 
theory is fundamentally and logically flawed. See the law cited by Respondents in the above 
memorandums and the Schvaneveldt case quoted in Exhibit MAM attached hereto and 
incorporated by reference. Further see the transcript of Mr. David R. King's expert 
testimony in Exhibit "A" hereto. See also Kerbs v. Fall River Industries. Inc.. 602 F.2d 731 
(1974). the leading 10th Circuit case on aiding and abetting in the securities law context. 
6. Findings of Fact, Conclusions of Law and 
Order. 08/13/90 
See the entire transcript attached hereto as Exhibit "A". 
In support of Request for Agency Review of this particular order, reference is 
made to the transcript of the proceedings held on July 16.1990. which evidence that the 
August 13. Order Is not supported in the least by the evidence. A true and correct copy of 
the official transcript of the July 16.1990. hearing, with Respondents' counsel's 
corrections, is attached hereto and incorporated by reference into the record as Exhibit 
"A". Specifically, the Findings of Fact are superfluous and unsupported by the record; the 
Conclusions of Law do not follow from the Findings or the record of proceedings; and the 
Order, including the Sanction, is neither supported by the Findings of Fact nor the 
Conclusions of Law. 
In further support of review of this particular Order. Respondents incorporate 
by reference their August 20.1990. Objection to the form of content of such order, their 
counsel's supporting affidavit dated August 20, and their Demand for Disclosure of how and 
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by whom the August 13, Order was prepared, also dated August 20. Respondents are 
prejudiced on appeal by the August 13. Findings of Fact. Conclusions of Law, and Order 
("Order") in its present form. This is because the appellate court must defer to the finder of 
fact and may only overturn such Order in the event it concludes that no reasonable person 
could have made the findings set forth in such Order. Because the Order is grossly 
one-sided and "padded" with ridiculous material which is not reflective of what actually 
occurred on July 16. 1990. Respondents are infinitely prejudiced on appeal. In addition, 
considering that the Securities Advisory Board acted as a de facto Jury, there should be no 
findings of fact or conclusions of law. simply a verdict and corollary sanction analogous to a 
sentencing. It such event, it would be the transcript which would alone go up on appeal all 
by itself, not the prejudicial and biased Order in addition thereto (which will now get the 
most attention). 
CONCLUSION 
Based on the foregoing and Utah Code Ann. §63-46b-12(1)(b)(ii). Respondents 
pray for reversal of the Orders referred to above and for an order dismissing and vacating 
the proceedings, more especially the August 13.1990. Order, as a matter of law. 
In accordance with applicable Department of Commerce Rules, this document 
is intended to serve, on the basis of the portions of the record referred to. as a Brief in 
Support of Respondents' Request for Agency Review. Again, the citations to the record are 
not exclusive of what the reviewing officer should direct his attention to in ruling on this 
Request. 
The parties seeking review have further signed this Request as required under 
Utah Code Ann. §63-46b-12(b)(1). Respondents further waive oral argument in that they 
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believe their arguments are sufficiently presented in the record and in the ALJ's tape 
recordings of oral argument on each motion. The reviewing officer is also respectfully 
requested to listen to the tape recorded proceedings of formal hearings heard on each of 
the foregoing motions, as applicable. 
DATED this 23rd day of August. 1990/ 
Coombs 
ttorney for Respondents 
JOHNSON-BOWLES. COMPANY. INC.. 
Respondent 
By: MaNenV. 
Its: President 
Matylen\f\. Johnson, Respondent 
CERTIFICATE OF SERVICE 
The undersigned hereby certifies that on the 23rd day of August. 1990. (s)he 
hand-delivered a true and correct copy of the foregoing REQUEST FOR AGENCY REVIEW OF 
ENTIRE RECORD AND SUPPORTING BRIEF to John C. Baldwin. Director and Kathleen 
C. McGlnley. Director of Broker-Dealer Section. Securities Division. Utah Department of 
Commerce. 160 East 300 South. P.O. Box 45802. Salt Lake City. Utah 84145-0802; Mark J. 
Griffin. 115 State Capitol. Salt Lake City. Utah 84114; and Craig F. McCullough. Esq.. of 
Callister. Duncan & Nebeker. Co-Counsel to Respondents. 8th Floor, Kenqecott Bldg.. 10 
East South Temple Street. Salt Lake City. Utah 841: 
J:REQUEST.fl-ll 
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EXHIBIT "TT 
File Copy 
SECLT.riESD. 'fVON 
CERTIFICATE OF REGISTRATION 
(Not transferable) 
File Number 3334-14/A05794-21 
THIS CERTIFIES THAT USA MEDICAL CORPORATION ("USA") whose 
address is 2020 South 1900 West, Ogden, Utah 84401, has complied 
with the requirements of §61-1-10 of the Utah Uniform Securities 
Act, and is granted this registration FROM March 1, 1991 TO 
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1979. The Company has manufactured and markets medical products which 
include general aspirators. (See "Description of Business" and "Risk 
Factors.") 
Purchase of the shares of the Company's common stock (the "Shares") 
involve a high degree of risk to the public investors and shares should be 
purchased only by persons who can afford to lose their entire investment. 
(See "Risk Factors.") Although the Company is not a development stage 
corporation, it has had only limited operations since March 1989, there has 
been no public market for the shares of the Company, in Utah for over one 
year, and there can be no assurance that a public market will develop. This 
prospectus relates only to securities that are offered to residents of the 
state of Utah through the "secondary trading" market. 
THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION BECAUSE THEIR SECONDARY TRADING IS 
BELIEVED TO BE EXEMPT FROM REGISTRATION UNDER SECTION 4(1) OF THE SECURITIES 
ACT OF 1933 AND RULE 144 PROMULGATED THEREUNDER BY THE SECURITIES AND 
EXCHANGE COMMISSION. THE SECURITIES ARE REGISTERED UNDER THE SECURITIES LAWS 
OF THE STATE OF UTAH. 
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ACCURACY OR COMPLETENESS OF THIS PROSPECTUS. NO PERSON HAS BEEN AUTHORIZED 
TO MAKE ANY STATEMENTS NOT CONTAINED IN THIS PROSPECTUS. ANY REPRESENTATION 
'TO THE CONTRARY IS A CRIMINAL' OFFENSE. 
The Date of this Prospectus is March 1, 1991 (As amended to March 9, 1991) 
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NO BROKER, DEALER, SALESMAN, AGENT OR ANY OTHER PERSON HAS 
BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY 
REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS. 
PRACTICES TO THE CONTRARY ARE A CRIMINAL OFFENSE. IF GIVEN OR 
MADE, SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON 
AS HAVING" BEEN AUTHORIZED BY THE COMPANY. UTAH BROKERS WHO MAKE 
A MARKET IN THE COMPANY'S STOCK DURING THE ONE-YEAR REGISTRATION 
PERIOD MUST COMPLETE FORM 10.2-IB AND FILE IT WITH THE UTAH 
SECURITIES DIVISION. 
ANY AND ALL AMENDMENTS TO THIS PROSPECTUS WILL BE PROMPTLY 
FILED WITH THE UTAH SECURITIES DIVISION, DISTRIBUTED TO 
SHAREHOLDERS, AND MADE A PART OF ANY PROSPECTUS USED THEREAFTER. 
THE COMPANY WILL PROMPTLY NOTIFY THE UTAH SECURITIES DIVISION, 
MARKET MAKERS AND SECURITY HOLDERS IN WRITING OF ANY CHANGE IN THE 
MANAGEMENT, PURPOSE AND CONTROL OF THE ISSUER, OR ANY MATERIAL OR 
ADVERSE CONDITION AFFECTING THE COMPANY. 
THE ONGOING INVESTIGATION BY THE UTAH DIVISION OF THE 
COMPANY'S SECURITIES MAY RESULT IN THE ISSUANCE OF AN ORDER BY THE 
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SECURITIES OF THE COMPANY. 
REGISTRATION OF THIS PROSPECTUS WITH THE UTAH SECURITIES 
DIVISION IS NEITHER A RECOMMENDATION NOR AN ENDORSEMENT OF ANY 
SECURITY, INDIVIDUAL, FIRM, OR CORPORATION. 
Brokers effecting transactions in the Company's stock must
 r 
provide Form 10.2-1B within five days of the execution of the first 
trade in the Company's stock. 
(THIS SPACE INTENTIONALLY LEFT BLANK) 
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SUMMARY OP PROSPECTUS 
The following is intended merely to summarize certain material 
contained in this Prospectus and is qualified in its entirety by 
the information and the financial statements appearing elsewhere 
herein. 
Purpose of Prospectus 
On March 1, 1989, the Utah Securities Division issued Orders 
which suspended secondary trading of the Company's common stock 
within the state of Utah. On September 1, 1989, the Division 
publicly announced its decision to allow shares of the Company's 
stock to resume trading as soon as the Division declares effective 
the registration statement filed with the Division on behalf of the 
Company. The Division's decision to permit trading in U.S.A. 
Medical stock to resume does not reflect any approval or 
disapproval of these securities, nor does it reflect any opinion 
about whether these securities have any value. At the date of this 
prospectus, the Division's investigation into irregularities of 
trading of the Company's stock is continuing. Such investigation 
may result in the issuance of an order by the Division, at some 
future date, stopping further trading in the securities of the 
Company. 
Risk Factors 
The purchase of the Company's securities involves significant 
risks to an investor, including the fact that the Company has 
engaged in limited operations to date, stock certificates with 
forged signatures or certificates issued following transfer or 
cancellation of such certificates may exist, and other significant 
factors which make investment herein a highly speculative venture. 
(See "Risk Factors.'1) 
The Company 
Life Concepts, Inc., formerly U.S.A. Medical Corporation and 
S.M.I., Inc., (the "Company"), is a Wyoming corporation 
incorporated on January 12, 1979. The Company merged with a Utah 
company, in December 1987, which was engaged in development and 
manufacturing of medical products. Questions exist concerning the 
legality of this merger. The Company has had limited operations 
since its inception. (See "Description of Business.h) 
The offices of the Company are presently located at 202 0 South 
1900 West, Ogden, Utah 84401. 
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The Offering Through Secondary Trading 
The Company's shares are not being offered by the Company and 
the Company will receive no proceeds from the sale of shares 
contemplated herein. The shares are being registered with the 
state of Utah and may be offered for sale by existing shareholders 
through brokers and market makers. Questions exist concerning 
whether some presently existing shareholders acquired their shares 
through a transfer of stock certificates with forged signatures. 
Capitalization 
Date of Capitalization 
Shares of Common Stock: Insiders 
Shares of Common Stock: Publicly-Held 
Par Value Per Share 
Book Value Per Share 
Use of Proceeds 
No proceeds will be received by the Company pursuant to this 
registration and prospectus. 
Financial Summary 
The Company has had a limited operating history prior to this 
prospectus and has had only moderate revenue from operations 
during such period since inception. There is no assurance that the 
Company will ever have material revenues or that its operations 
will ever be profitable. (See the financial statements bound 
herein.) 
As of December 31, 1990: 
Total Assets $ 31,618 
Total Liabilities $238,293 
Shareholders' Equity ($206,675) 
RISK FACTORS 
1* Absence of Significant Operations, Income and Profit. 
Though the Company is not in the development stage, it is subject 
to all the risks inherent in the operation of a business which has 
limited capital resources, a limited history of operations and 
income, and no profitability. The Company's activities since 
organization have been limited to product development, national 
marketing and sales, organizational matters, and response to 
December 31, 1990 
16,000,000 
10,352,500 
$.001 
($.00784) 
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litigation and administrative investigations. Unforseen expenses, 
complications and delays are often associated with thinly 
capitalized companies and with the introduction of products. There 
is no assurance that products which are currently marketed, or may 
eventually be developed and marketed, by the Company will continue 
to be commercially accepted. (See "Description of Business.") 
2. Absence of Patent Protection; Product Obsolescence. 
Patents have been filed in the name of the Company's president, 
Luke Glenn, who has assigned the patents to the Company. Any 
competitor of the Company using equipment and processes which are 
generally available could manufacture and market similar products. 
Moreover, new surgical products and devices are constantly being 
developed and introduced to the marketplace, which may have the 
effect of rendering obsolescent the products which the Company 
proposes to develop and market. (See "Business—Patent.") 
3. Limited Experience and Potential Change of Management. 
The Company will be dependent upon the efforts and abilities of its 
officers. Luke Glenn and Ted Hillstead have had varying 
experience in the marketing of medical products which the Company 
markets, but have had limited experience in managing a publicly-
held company. (See "Management.") Mr. Glenn is the only person 
who has been previously involved in executive management positions 
of medical product companies or had experience in medical product 
development, and manufacturing. (See "Remuneration of Officers and 
Directors.") In the spring of 1990, Mr. Glenn .received an offer 
for a position with another company* Though he did not accept the 
position, failure of the Company to subsequently raise capital may 
result in his having to accept a permanent full-time position with 
another company. Unless the business of the Company changes 
through diversification of products or services, the loss or 
unavailability of the services of Mr. Glenn could have a materially 
adverse effect on the Company's business prospects and/or potential 
earning capacity because of his experience in product development 
and marketing and the services which he is expected to provide to 
the Company in those areas. The Company does not, at present, have 
any employment agreement with any of its officers, nor does the 
Company presently insure any of its officers against anticipated 
losses should their services be unavailable. Because of previous 
health complications, the Company cannot purchase key-man insurance 
on the life of Mr. Glenn. 
If the Company acquires other products, assets or entities, 
the transaction will most likely be consummated through an issuance 
of additional stock. Such transaction may result in a change in 
control and or management of the Company. 
4. Competition. The Company is engaged in a competitive 
business and is attempting to compete with major U.S. and foreign 
corporations who presently develop, manufacture and market medical 
and surgical devices and products of all types, including products 
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directly competitive with those currently marketed and proposed to 
be marketed by the Company. These firms are larger and have far 
greater resources, assets, technical staffs, and experience than 
those which are available to the Company. The Company is not at 
present, and will not in the foreseeable future, be a significant 
factor in the field in which it is engaged. Small firms such as 
the Company with limited resources are at a very serious 
disadvantage against established competitors. (See "Business— 
Competition.If) 
5. Government Regulation. In the manufacture and sale of 
its products, marketing and manufacturing by the Company will be 
subject to regulation by the Food and Drug Administration ("FDA11), 
'including registration of its manufacturing establishment (which 
has been completed), listing of the products which it proposes to 
market and sell (completed), and the necessity of submitting a 
premarket notification with respect to each of its medical or 
surgical products (completed). The FDA could require that 
premarket approvals be obtained with respect to some of the 
Company's products, which would be costly, time consuming, and 
adversely affect the Company's ability to operate profitably. In 
1987, the FDA made an inspection of Company's previous facilities. 
Certain information provided to prospectus shareholders may have 
been materially incomplete as to FDA rules and regulations. (See 
"Business—Government Regulation.") 
6. No Feasibility Studies. The Company has relied and 
intends to continue to rely upon the judgment and conclusions of 
its management based solely upon their experience, which is, in 
essence, the limited experience of Luke Glenn, relative to the 
needs of the Company. No formal feasibility studies or reports 
have been obtained, nor are any such studies planned by the 
Company. 
7. Limited Staff, The Company currently has no formally 
hired employees. Assuming the Company is successful in raising 
additional capital, the Company intends to employ each of its 
officers on a full-time basis with the exception of Mr. Hillstead 
(See "Management" and "Remuneration of Officers and Directors11) , 
and to hire one full-time employee for secretarial and 
administrative work. (See "Transactions With Management.") 
8. Additional Financing. Additional financing will be 
required. There can be no assurance that such financing will be 
available, or, if available, that it can be obtained on terms 
satisfactory to the Company. (See Paragraph 12 and "Business— 
Financial Status.") 
9. Noncumulative Voting; Control by Management Stockholders. 
The present management claims to own approximately 59 percent of 
the issued and outstanding common stock of the Company. Disputes 
may arise about ownership of this and all other stock in the 
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Company. Inasmuch as there are no cumulative voting rights under 
the Company's Articles of Incorporation, the present management of 
the Company will remain in control of the Company since they will 
be able to elect all of the directors of the Company, and the 
purchasers of the publicly-traded shares will not be able to elect 
any of the directors of the Company. (See "Capitalization and 
Securities.M) 
10. Transactions with Officers, Directors and Principal 
Shareholders. Management and a shareholder have made loans to the 
Company. The Company's operations are located in a building owned 
by one of the directors. Management intends to temporarily employ 
Judy Glenn, wife of the President, as secretary and office manager. 
#(See "Transactions With Management.") 
11. No Dividends and None Anticipated. The Company has not 
paid any dividends upon its common stock since its inception, and 
by reason of its present financial condition and its contemplated 
financial requirements, does not contemplate or anticipate paying 
any dividends upon its common stock in the foreseeable future. 
(See "Dividends.") 
12. Uncertainty of Funds from Possible Private Offering. The 
Company is considering a future private offering. The Company may 
attempt to obtain the services of an underwriter (stockbroker) to 
privately sell such shares on a "best efforts" basis, which means 
that there will be no binding or "firm" obligation on the part of 
the underwriter or any other person to buy any of the shares 
proposed to be sold. There is no assurance that such an 
underwriter can be engaged. Alternatively, the Company may attempt 
to sell such shares through the efforts of its officers and 
directors. In addition, the sale of such shares may be formulated 
so that none of the shares will be sold unless a specified minimum 
portion thereof are, in fact, sold. The Company may also consider 
merging with an existing private company. There can be no 
assurance that such private offering or merger will be completed 
and if it is not, the Company will have suffered the loss of the 
funds expended in pursuing such offering or merger. (See 
"Business—Financial Status.") 
13. Possible Rule 144 Sale bv Affiliates. The common shares 
presently owned by certain shareholders may be deemed to be 
"control securities" as such term is used in relation to Rule 144 
under the Securities Act of 1933, as amended. Rule 144 provides 
that a person who is an affiliate of the Company may, within a 
three-month period, sell in "brokers transactions" (as defined by 
the Rule) , an amount equal to the greater of 1 percent of the 
Issuer's outstanding securities of such class or the average weekly 
reported volume of trading in such securities during the four 
calendar weeks preceding the sale, if the conditions specified by 
the Rule are satisfied. If such person is not an "affiliate" of 
the issuer, as such term is defined by Rule 144, he may, after a 
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holding period of three years, in the case of restricted 
securities, sell the shares without a volume limitation. Because 
management currently owns 15 Million shares, future sales by such 
affiliates may have a depressing affect on the market price of the 
common shares, should a market for such shares exist, 
14. "Qualified Opinion" From Independent Certified Public 
Accountant. As shown in the financial statements attached hereto, 
the current liabilities exceed current assets by $226,021, and its 
total liabilities exceed total assets by $206,675. These factors 
indicate that the Company may not be able to continue in existence 
unless it is able to receive adequate funding. For this reason, 
the independent certified public accountant for the Company has 
issued a "qualified opinion" as to the financi?l condition of the 
Company. (See "Financial Statements.") 
15. Market Price of Shares Unreliable. The secondary trading 
of the Company's shares outside of Utah has experienced significant 
price fluctuations over the past two years. Since the order by the 
Utah Securities Division suspending secondary trading, there has 
been no public trading in the Companyfs stock in the state of Utah. 
Management believes that current price quotes, if any, may bear 
little or no relationship to the assets, earnings per share of the 
stock, or any other criteria of value applicable to the Company. 
Some shareholders have purchased stock based on speculation about 
market "short positions." "Short selling" or "short positions" 
occur when an investor sells shares of stock he does not own. 
Following the sale, the investor must deliver shares to the 
purchaser. The short seller hopes to purchase share from the 
market at a lower price than he sold it, thereby making a profit 
on the difference in price. Such short positions in the market have 
not been specifically identified and investment in these shares on 
that basis would be extremely speculative. Continuing price 
instability is probable. (See "Market Price of Shares") 
16. Uncertainty of Litigation and Regulatory Action. The 
Company has been engaged in litigation which may result in large 
expenses to defend or pursue legal rights. Additionally, state and 
federal securities authorities have been investigating and continue 
to investigate alleged market manipulation of the Company's stock 
and the existence of stock certificates with forged signatures and 
certificates issued following the transfer or cancellation of such 
certificates. Such regulatory review may adversely affect the 
ability of the Company to raise needed capital, affect the stock 
price, or drain the Company's capital resources to maintain legal 
representation. Additionally, the ongoing investigation by the 
Utah Securities Division may result, at a future date, in the 
issuance of an order suspending trading in the Company's 
securities. (See "Business—Litigation and Administrative 
Actions.") 
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17. No Manual Exemption. Subsequent to the effectiveness of 
the registration statement, any transaction in the Company's 
securities by or through a Utah broker-dealer will not be exempt 
through a "manual exemption" and, instead, may only be exempt if 
there is compliance with the "secondary trading" exemption. 
(THIS SPACE INTENTIONALLY LEFT BLANK) 
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DILUTION 
The following graphs illustrate the comparative stock 
ownership of the Shares as of December 31, 1990. Acquisitions of 
entities or product rights through the issuance of additional stock 
would result in further ownership dilution to current shareholders. 
Insiders 
59% 
Public 
Shareholders 
41% 
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At December 31, 1990, the Company had an aggregate of 
26,352,500 shares of common stock outstanding with a net tangible 
book value as reflected on the Company's balance sheet of 
($206,675) or approximately ($.0078) per share. Net tangible book 
value per share represents the amount of the Company's tangible 
assets less its liabilities, divided by the number of shares of 
common stock outstanding. Upon purchase of shares, and assuming 
no changes in the net tangible book value of the Company after 
December 31, 1990, the purchaser will own shares with negative book 
value. Public investors will most likely experience an immediate 
dilution in the net tangible book value per share of the common 
stock from the price per Share being offered on the secondary 
market. Uncertainty related to the existence of the stock 
certificates with forged signatures or certificates issued 
following the transfer or cancellation of such stock certificates 
may affect the value of stock. 
Dilution in this case represents the difference between the 
public market trading price per share and the net tangible book 
value per share. 
The following graphs illustrate the per share dilution based 
on a price as of December, 1989. (See "Capitalization and 
Description of Securities.11) 
MARKET PRICE IN RELATION TO NET TANGIBLE BOOK VALUE 
Cents 
Per Share 
Dilution to 
10 Public Investors plilplppil;;!!! 
$ - i o fliiifiilllilliiiiiiiilii 
8 llllillllllllllllllllllll 
6 
4 
2 
Net Tangible Book 
($.0078) 
Most 
Recent Stock Price 
$.10 
(December 1989) 
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USE OF PROCEEDS 
This registration of shares will not result in any proceeds 
received by the Company, 
DESCRIPTION OF BUSINESS 
CORPORATE HISTORY 
In approximately July of 1986, Luke Glenn and Ted Hillstead 
formed a partnership called "U.S.A. Medical". The partnership was 
formed to develop a machine called the "Maxim Aspirator", which is 
a high powered deep vacuum suction aspirator. Additionally, the 
partnership developed the suction cannula that is used in the 
aspirator system and marketed tubing and surgical clothing. 
Between July of 1986 and June of 1987, the partnership attended 
various trade and medical shows and were successful in 
manufacturing and selling the Aspirator and related products. In 
June of 1987, the partnership formed U.S.A. Medical Corporation, 
a privately-held Utah corporation. On December 7, 1987, the 
privately held corporation entered into an Agreement of 
Reorganization with SMI, Inc., a purportedly publicly held 
corporation. SMI, the surviving entity, was incorporated in 
Wyoming on January 12, 1979• Subsequent to the reorganization, 
SMI changed its name to U.S.A. Medical Corporation (the "Company"). 
Though management of SMI represent* 1 that the Company was publicly-
held, current management believes chat the Company's shares may 
have originally been held by a few undisclosed "control" persons 
and nominees, and that some or all of the signatures on the stock 
certificates of SMI at the time of the merger were forged. 
Uncertainty exists about the validity of the shares the Company 
issued following the merger. In March of 1991 the shareholders 
authorized a name change to Life Concepts, Inc. 
INTEGRITY AND EXISTENCE OF CORPORATE DOCUMENTS 
The Reorganization Agreement with SMI included SMI financials 
purporting assets worth $162,092 which primarily consisted of stock 
in another corporation. Those shares have never been found and 
management believes that the existence of this asset was 
misrepresented. Additionally, following the reorganization, 
management never received bylaws, organizational minutes, board of 
director minutes, shareholder minutes, or bank records. The 
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Company has subsequently adopted new Bylaws and amended its 
Articles of Incorporation. 
PRODUCT DEVELOPMENT 
The Company was formed to design, manufacture and market high-
powered surgical aspirators, precision surgical suction cannula, 
and other medical products such as tubing, masks, and garments. 
Though the aspirator may be used for a wide variety of fluid 
vacuation, it has primarily been purchased by doctors engaged in 
lipoplasty procedures. Initially, the firm's marketing efforts 
were directed primarily at plastic and reconstructive surgeons 
through professional symposiums and live-surgery demonstrations 
conducted around the country. Advertisements have also been placed 
in major scientific journals. The following table consists of 
sales estimates since formation of the original partnership: 
Period Aspirator Cannula 
July 1986 -
December 31, 19 86 1 50 
Year 1987 50 1,500 
Year 1988 30 400 
1st Quarter 1989 6 50 
2nd Quarter 1989 2 25 
3rd Quarter 1989 2 10 
4th Quarter 1989 1 5 
The Company expected to sell 1,000 aspirators over a twelve 
(12) month period between 1988 and 1989, which, at a retail price 
of $2,295, would have produced gross revenues of $2.3 million 
before sales discounts. Sales of surgical suction hand-held 
cannula were expected to reach 3,500 units over the period 
resulting in additional revenue of $625,000 before sales discounts. 
The combined revenue from these expected sales would be 
approximately $2.9 million• After sales discounts, manufacturing 
cost, and corporate expenses the Company hoped to achieve a net 
profit of about $500,000. Due to non-performance and possible 
stock manipulation by a "stock relations" firm which represented 
it would raise $300,000 for the Company, and recent litigation, 
there has been a delay in the planned private placement. This 
private placement was to have provided capital necessary for the 
Company to expand its manufacturing and marketing plans and 
accomplish the above. 
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Because of the nature of the products and the interest in 
surgical procedures requiring aspirators, management believes that 
with the proper capital the above revenue projections could be 
obtained and increase each year, not including the addition of any 
new products that are hoped to be added to the Company's marketing 
mix: i.e., surgical compression garments, marking pens, cannula 
brushes and cleaners, re-injection systems, disposable canisters, 
electro-surgical knives, operating room safety equipment, etc. 
Revenue expectations have been based solely on the experience of 
management in the aspirator market and has not been supported by 
independent market research. 
Government Regulation 
To the best of the Company fs knowledge, the FDA has refused 
to approve marketing of any surgical aspirators manufactured by any 
manufacturer for lipoplasty procedures. Nonetheless, the medical 
profession uses high powered aspirators for liposuction. The 
aspirator manufactured by the Company is approved by the FDA as a 
general high powered aspirator (Class I) . Class I approval 
requires the Company to satisfy the "general control11 provisions 
of the Federal Food, Drug and Cosmetic Act. Management is not 
aware of any product that has received classification beyond Class 
I. The aspirator manufactured by the Company is not approved by 
the FDA to be marketed as a liposuction device. A copy of the FDA 
conditional approval letter (hereinafter "FDA letter") is attached 
as an exhibit to this prospectus. 
The Company provided oral and written information to brokers 
and prospective shareholders in 1988 and 1989 which may have 
violated the prohibition in the FDA letter against direct or 
indirect promotion of the aspirator as a liposuction device. If 
the Company has violated the prohibition, the FDA may sanction the 
Company and this may affect the marketability of the aspirator and 
the value of Company stock. The Company has not received any 
notice, letter, or other communication from the FDA threatening to 
take any action against the Company, nor has the FDA made any 
findings that the Company has violated the conditions contained in 
the FDA letter. The FDA is currently investigating possible 
violations. 
High Powered Surgical Aspirator and Surgical Cannula Market 
The market for high-powered aspirators and related products 
is primarily limited by the number of physicians who are and will 
become skilled in using the equipment. The growing number of 
medical specialists becoming involved with procedures using high-
powered aspirators includes plastic surgeons, obstetricians/ 
gynecologists, dermatologists, otolaryngologists, and general 
surgeons. Concurrently, an increasing number of other physicians 
with adequate training, facilities and necessary equipment are 
expected to begin to use high vacuum machines in the future. There 
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are close to 500,000 physicians in the United States alone, 200,000 
of whom may eventually use high power vacuum machines. Management 
believes that the market outside the United States is even larger. 
The Company is currently conducting preliminary discussion with 
companies in foreign countries for establishing distributor/dealer 
outlets for its equipment. 
Rationale For High Powered Aspiration 
Before high-powered aspirators and suction cannula came onto 
the market, subcutaneous tissue and fluids was removed primarily 
by major surgery requiring extensive tissue cutting and long 
recuperation time. Today, with new technology and new cannula 
^development, removal of tissue can be performed easily and safely 
with only a minor incision. 
1. Advantages of the Maxim Aspirator: 
a. One of the lowest cost high-powered aspirator on 
the market. 
b. Modern design - aesthetically pleasing. 
c. Portable - carry or pull. 
d. Self-contained tissue and fluid collection system 
to eliminate accidental exposure to HIV virus. 
e. Quiet operation. 
f. Remote foot-switch. 
g. Maintenance free - Oiless operation. 
2. Advantages of Coolite Suction Cannula: 
a. More comfortable handle - reduces wrist fatigue. 
b. Lightweight - easy to handle and 50% lighter than 
most of the competition. 
c. Quick-disconnect fitting - Easier and faster to 
change cannula, less risk of fluid and tissue 
emission. 
NEW MEDICAL PRODUCTS 
As aspirators become more widely used within the medical 
profession, new techniques and equipment applications are sure to 
result. Current experimentation in the transplantation of fatty 
tissue from one anatomical site to another (e.g. breast 
enlargement, facial reconstruction, buttock enhancement, etc.) are 
controversial and the subject of professional debate. As with many 
. other surgical procedures in the past, however, it is possible that 
acceptable applications of such procedures will eventually be 
developed. The Company is currently investigating the new 
instrumentation and equipment design which will be required by 
these new reconstruction techniques. 
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Moreover, aspiration procedures have also been proven 
effective in the removal of non-malignant lipomata from the neck, 
arm, leg and abdominal sites with minimal trauma and post-operative 
scarring. 
In early 1988, the Company began to offer a revolutionary new 
safety system for the collection and disposal of human blood and 
tissue for all of the aspiration machines it has and will 
manufacture. Because the HIV (AIDS) virus is known to be 
transferrable through human blood, sera and tissue, proposed and 
pending federal and state legislation will soon mandate that full 
protection from accidental exposure to these substances be assured 
for all health workers and for the public. 
ACQUISITION OF OTHER PRODUCTS 
The Company is currently negotiating for the acquisition of 
a business engage in marketing products which are unrelated to 
surgical procedures or medical services. While the Company 
believes that there is a fair probability of consummating the 
acquisition, the negotiations and due diligence by both parties are 
continuing. Any definitive agreements will be publicly announced 
and presented to the shareholders for ratification. 
LITIGATION AND ADMINISTRATIVE ACTIONS 
Shortly after the reorganization in December 1987, the Company 
changed its transfer agent from Efficient Transfer, Inc. to 
Standard Transfer and Registrar. On March 29, 1988, the Securities 
and Exchange Commission filed a complaint for permanent injunction 
in the United States District Court, District of Utah, Central 
Division, against Efficient Transfer, Inc. and Roger Coleman, d/b/a 
Efficient Transfer. Among other things, the Commission alleged 
that Efficient had falsified the shareholder list of the Company. 
On May 24, 1988, United Stated District Court Judge David K. Winder 
ruled that Roger Coleman had failed to make and keep current logs, 
tallies, journals, schedules, and other records relating to the 
stocks that his business was handling. During this period the 
Company, through its counsel, consulted other co-counsel to aid in 
worKing with 1 \e Securities and Exchange Commission to determine 
how the Compan would be affected by Roger Coleman and Efficient 
Transfer acting as transfer agent prior to December of 1987. The 
Company continued discussions with the Securities and Exchange 
Commission and there was no definitive action taken by the 
Commission with regards to the Company. The Company's counsel 
determined that the prior relationship with Roger Coleman and 
Efficient Transfer was not material upon the operations and 
business of the Company, His opinion has not been approved or 
adopted by either the Securities & Exchange Commission or the Utah 
Securities Division. 
14 
From December of 1987 through January of 1989, the Company's 
shares experienced erratic fluctuations in price, possibly as a 
result of stock manipulation and "short selling" by some brokerage 
firms. On February 16, 1989 Johnson-Bowles Company, Inc. 
("Johnson"), a Utah brokerage firm allegedly holding a major short 
position in the market, filed suit in the United States District 
Court (Utah) against the Company and a large number of Utah 
brokerage firms. Pursuant to the complaint, Johnson sought 
injunctive relief and monetary damages. 
Johnson sought 1) a minimum of $3 00,000 in monetary damages, 
2) a court order declaring that the Company is without registration 
exemptions for its stock trading interstate and that all trading 
contracts with plaintiff are void, 3) a Temporary Restraining 
Order, 4) an Injunction against any shareholder meetings, 5) an 
Order mandating that the Company file a registration statement with 
the Securities and Exchange Commission, and 6) that the Company1s 
stock be suspended from trading. 
On February 21, 1989 Judge J. Thomas Greene granted Johnson 
a Temporary Restraining Order restraining Midwest Clearing 
Corporation from adjusting Johnson's accounts as it related to the 
Company's stock. A hearing for a permanent injunction was set for 
February 27. 
After hearing Johnson's case in late February, the District 
Court denied any injunctive relief for Johnson. In denying the 
relief sought, the court stated the following as conclusions of 
fact and law: 
1. With respect to Midwest Clearing, the Court 
does find and rules that the temporary restraining order 
which dissolved by its terms and any further injunctive 
relief against Midwest clearing is denied. The Court 
finds that it likely would cause interference with the 
prompt and accurate clearance and settlement of 
securities transactions and would negatively affect the 
goals of Section 17(a) of the Act to continue injunctive 
relief and restrain from the clearing functions of 
Midwest Clearing. 
2. The Court finds that the stock of U.S.A. 
Medical was unlawfully issued, has never been registered 
with any proper regulatory authority, is not exempt from 
such requisite registration and has been and is 
continuing•to be traded illegally. 
3. The stock of U.S.A. Medical has been and 
continues to be traded as part of fraudulent scheme and 
device to manipulate and artificially inflate the price 
of that stock in violation of the securities laws. 
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4. The Court finds, however, that the plaintiff, 
Johnson-Bowles, knew or should have known about the 
alleged irregularities as to non-registration, non-exempt 
status and illegal trading of U.S.A. Medical stock, and 
that in fact Johnson-Bowles participated in trading in 
the stock after it became a market maker, and is charged 
with knowledge of these irregularities. 
5. The Court finds that relative burden between 
Johnson-Bowles and other parties as well as damage to the 
public interest has not been shown by a preponderance of 
the evidence and that there is a failure of burden of 
proof to establish those elements. 
On April 10, 1989 the Company filed an Answer to Johnson's 
complaint and counter-claimed against the brokerage firm- The 
counter claim sought minimum damages of $100,000 and was based on 
the District Court's findings that Johnson knew about the non-
registered status of the Company's stock and actually participated 
in the trading of the Company's stock in a manner which may have 
been illegal. On March 27, 1990, the suit was dismissed without 
prejudice. The Company is currently conducting research prior to 
proceeding with any claims against Johnson-Bowles, or parties 
believed to have participated in an illegal distribution of stock. 
On January 29, 1991, Otra Securities Group Inc., a Deleware 
Corporation, and Otra Clearing, Inc., a Colorado corporation, filed 
a third-party complaint against Nathan Drage (current counsel to 
the Company), Richard Leedy (counsel to Standard Registrar), 
Michael Strand (a shareholder of the Company), Standard Registrar 
and Transfer (former transfers agent for the Company), U.S.A. 
Medical Corporation, and John Does 1-10, in the case of Burns v. 
Richfield Securities, et al. The Complaint alleges the parties 
conspired to artificially manipulate the price of the Company's 
shares in violation of state, federal and common laws. The above 
defendants have stated that they believe there is no merit to 
Otra's third-party complaint. Though the Company believes there 
is no merit to the suit, the Company will incur an unknown amount 
of legal fees to defend the suit and assert any counter claims. 
On March 6, 1989 the Securities and Exchange Commission 
suspended trading of the Company's stock. The suspension was based 
upon questions regarding market activity by brokerage firms and 
individuals, control of the Company's shares, and the Company's 
financial information. The suspension expired on March 15, 1989. 
On March 1, 1989 the Securities Division of the Department of 
Business Regulation of the State of Utah issued a Summary Order 
Denying the Availability of Exemptions From Registration. The 
denial of exemptions was based upon the following conclusions: 1) 
the failure to register securities, 2) failure to qualify for 
exemptions from registration, and 3) a scheme to defraud by persons 
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unknown and unnamed. The Company is informed that the third 
conclusion was based in part upon additional research and 
investigation by the Division, The Company worked with the 
Securities Division between March and August of 1989 to determine 
if their summary conclusions of fact were correct. P.G. McManus, 
the original incorporator of SMI is believed to have a history of 
securities violations. In July of 1990 James Averett pleaded 
guilty to a one count complaint accusing him of manipulating and 
artificially raising the price of the Company's stock. At the date 
of this prospectus, the Securities Division is continuing its 
investigation. 
9 By public release on September 1, 1989, the Division announced 
a settlement Agreement with the Company which would allow the 
Company secondary trading if it registered its shares. Until the 
time of this registration, the Company's stock was denied 
transactional exemptions within the state of Utah. The business 
of the Company is affected by Utah's administrative actions mainly 
to the extent that the Company has been limited in raising 
operational capital through the sale of securities within the state 
of Utah. 
By letters dated March 9 and June 22, 1989, the Company placed 
stop transfer orders on stock certificates totaling 1,383,350 and 
850,000 shares respectively. These are certificates which the 
Company believes may be held by undisclosed control persons or 
persons who are not bona fide purchasers. With regard to such stop 
transfers, the Company is in a very difficult situation. The only 
way management can protect the Company from stock manipulation by 
undisclosed control persons is to place stop transfer orders on 
certificates management believes to be held by such persons. Stop 
transfers, however, expose the Company to possible lawsuit by 
shareholders whose shares have received transfer restrictions. 
Additionally, the Company may be prevented from placing any stop 
transfer orders should the transfer agent require the posting of 
bonds. Consequently, if stock manipulation has occurred in the 
past, or does occur in the future, the Company is significantly 
limited in avoiding such manipulation. 
In June 1990, the staff of the Securities & Exchange 
Commission notified the Company and its management that it is 
recommending that the SEC take enforcement action against the 
Company, Mr. Glenn, and Mr. Hillstead. No action has yet been 
taken and it is unclear whether any action will be taken, or what 
form the possible action may take, or what settlement may be 
reached. 
The Company currently intends to register its common stock, 
or the Company, with the Securities and Exchange Commission when 
it has sufficient capital to do so. 
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PATENTS 
The Company's president filed for patent protection on the 
aspirator and related features on January 19, 1988. A U.S. patent 
(No. 4,857,063) was issued on August 15, 1989. In November 1987, 
the president assigned the patents to the Company, which assignment 
appears on the patent, 
COMPETITION 
The high power aspirator market consists mainly of five 
manufacturers. These manufacturers may be better financed and 
better known in the market. 
FINANCIAL STATUS 
The Company experienced losses of $78,470, $46,617, and 
$34,692 during fiscal years 1988, 1989, and 1990 respectively. 
Additionally, the Company has no current assets available to meet 
its obligations. Consequently, the Company will have to seek 
additional capital through additional loans, a private placement, 
public offering, or merger. 
OFFICES 
The Company has an informal agreement with one of its 
directors to provide approximately 2,4 00 square feet of 
office/manufacturing space. Management intends to conduct assembly 
activities at such location and believes that such facilities will 
be adequate for the Company for the foreseeable future. The 
director has designated a particular portion of the building for 
the Company, and will provide such space and equipment as may be 
reasonably required by the Company. The Company currently pays no 
rent for use of its office space but hopes to pay reasonable rent 
when the Company's financial condition allows it. 
EMPLOYEES 
The Company has no full-time employees. The president devotes 
approximately ten percent of his time to the Company's operations 
and, when finances permit, will return to full-time employment by 
the Company and will be paid compensation which is deemed 
reasonable and is expected to be $3,000 per month. (See 
"Compensation" and "Transactions With Management.") 
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CAPITALIZATION AND DESCRIPTION OF SECURITIES 
The capitalization of the Company as of December 31, 1990 is 
as follows: 
Amount 
Title of Amount Outstanding 
Class Authorized as of 12/31/90 
Common Stock 50,000,000 26,352,500 
$•001 par value Shares Shares 
With some possible exceptions, all shares are believed to be 
fully paid and non-assessable. All common shares are equal to each 
other with respect to voting, liquidation and dividend rights. 
Special meetings of the Shareholders may be called by the officers, 
directors, or upon the request of holders of at least ten percent 
of the outstanding voting shares. Holders of common shares are 
entitled to one vote at any meeting of the Shareholders for each 
common share they own as of the record date fixed by the Board of 
Directors. At any meeting of Shareholders, a majority of the 
outstanding shares of the Company entitled to vote, represented in 
person or by proxy, constitutes a quorum. A vote of the majority 
of the shares represented at a meeting will govern even if this is 
substantially less than a majority of the common shares 
outstanding. Holders of shares are entitled to receive such 
dividends as may be declared by the Board of Directors out of funds 
legally available therefor, and upon liquidation are entitled to 
participate pro rata in a distribution of assets available for such 
a distribution to Shareholders. There are no conversion, 
preemptive or other subscription rights or privileges with respect 
to any share. Reference is made to the Articles of Incorporation 
and By-laws of the Company as well as to the applicable statutes 
of the state of Wyoming for a more complete description of the 
rights and liabilities of holders of shares. It should be noted 
that the By-laws may be amended by the Board of Directors without 
notice to the Shareholders. The shares of the Company do not have 
cumulative voting rights, which means that the holders of more than 
fifty percent of the shares voting for election of directors may 
elect all the directors if they choose to do so. In such event, 
the holders of the remaining shares aggregating less than fifty 
percent will not be able to elect directors. 
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MARKET PRICE OP SHARES 
In the four month period prior to suspension of trading on 
March 1, 1989 by the Utah Securities Division, the shares of the 
Company fluctuated in price between $.01 and $1.00 (as adjusted for 
the 10 for 1 forward split in the first quarter of 1989) . Possible 
explanations of the increase in price include legitimate 
speculation in the growth and earning capabilities of the Company, 
deceptive manipulation by undisclosed shareholders holding large 
positions in the stock, and/or legitimate speculation about "short 
positions" held by brokers which would be bullish for investors 
holding "long positions," A "long position" exists when an 
individual or firm holds stock in that individual's or firm's 
account. Estimates of the current market short ranges from 500,000 
shares to 3,000,000 shares. The Company does not currently have 
reliable information to either confirm or deny such estimates. 
MANAGEMENT 
OFFICERS AND DIRECTORS 
The term of office of each director is one year or until his 
successor is elected at the annual meeting of the Company, which 
will be held in February 1991. The term of office for each officer 
of the Company is at the pleasure of the Board of Directors. The 
Board of Directors has no nominating, auditing or compensation 
committee. 
The following table states the name, address and positions 
held for each of the executive officers and directors of the 
Company. 
Title or 
Name and Residential Address Position 
Luke H. Glenn President and Director 
4016 Porter 
Ogden, UT 84403 
Ted W. Hillstead Secretary/Treasurer and Director 
601 Ogden Canyon Road 
Ogden, UT 844 01 
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LUKE H. GLENN, President and Director, Ogden, Utah has been 
involved with the medical industry since 197 0 after graduating from 
Weber State College, Ogden, Utah with a degree in Business 
Management and Economics. He took a position with Cutter 
Laboratories (a major manufacturer of medical devices and products 
used by hospitals worldwide) in 1970 as the Plant Quality Control 
Manager and was responsible for all quality activities including: 
quality engineering, statistical sampling, vendor approval, FDA 
compliance, sterile product control and good manufacturing 
practices (GMP) as outlined in the Food, Drug, and Cosmetic Act. 
From 1977 to 1984 he co-founded the G & H Company to develop, 
manufacture, and market vacuum/pressure systems. From 1984 to 
present he has been involved with the development, design, and 
marketing of high-powered surgical aspirators and precision suction 
cannula. In 1986 he co-founded U.S.A. Medical. He has traveled 
extensively around the United States marketing aspirators and 
cannula to plastic and reconstructive surgeons, clinics, and 
hospitals. Age 48. 
TED W. HILLSTEAD, Secretary/Treasurer and Director, Ogden, 
Utah began his career in 1956 after graduating from the University 
of Wyoming with a degree in Mechanical Engineering. From 1956 to 
1964 he was with the Marquardt Corporation, Ogden, Utah, 
developing, designing, and analyzing new jet engine systems. From 
1964 to 1974 he was instrumental in the development of automated 
material handling systems for Kenway Engineering and in 1974 he 
founded Tareco Corporation, Ogden, Utah specializing in the design, 
fabrication, and installation of automated material handling 
equipment for such firms as Goodyear Tire and Rubber, Kennecott 
Copper Corporation, Steelcase Corporation, and Caterpillar Tractor 
Company. In July 1986 he co-founded U.S.A. Medical, Ogden, Utah. 
Age 53. 
At a meeting of the Board of Directors held November 28, 1990, 
directors and shareholders representing over 60% of the shares 
outstanding, voted to terminate, with cause, David Ballard as an 
officer and director of the Company. The shareholders ratified 
this action at the Annual Shareholders meeting to be held in 
February of 1991. 
COMPENSATION 
When finances permit, Luke Glenn will devote his full-time 
efforts to the operations of the Company, for wnich Mr. Glenn will 
receive a monthly salary of approximately $3,000. 
21 
The following persons have received compensation since January 
1, 1989: 
Name Position Amount 
Luke Glenn President, Director $10,914.98 
Ted Hillstead Secretary/Treasurer, Director none 
Judy Glenn Former Director $ 500.00 
David Ballard* Former V.P, Director stock 
*The Company and major shareholders are in the process of 
filing suit to cancel the certificates representing 1,000,000 
shares. 
The Company has no written employment agreement with any of 
its officers or directors and has no retirement, profit sharing, 
pension or insurance plans covering them. (See "Transactions With 
Management.") 
INDEMNIFICATION OF OFFICERS AND DIRECTORS 
Wyoming law expressly authorizes a Wyoming corporation to 
indemnify its officers and directors against claims or liabilities 
arising out of such persons' conduct as officers or directors if 
they acted in good faith and in a manner they reasonably believed 
to be in or not opposed to the best interests of the Company. The 
Company intends to indemnify its officers and directors to the full 
extent permitted by Wyoming law. INSOFAR AS SUCH INDEMNIFICATION 
MAY BE DEEMED TO INCLUDE ANY CLAIM OR LOSS ARISING OUT OF ANY 
VIOLATION OF FEDERAL SECURITIES LAWS OR REGULATIONS, THE COMPANY 
HAS BEEN INFORMED, THAT, IN THE OPINION OF THE SECURITIES AND 
EXCHANGE COMMISSION, SUCH INDEMNIFICATION IS AGAINST PUBLIC POLICY 
AS EXPRESSED IN THE SECURITIES ACT OF 1933, AND IS, THEREFORE, 
UNENFORCEABLE. 
FIDUCIARY RESPONSIBILITY 
The officers and directors are required to exercise good faith 
and integrity in handling the Company's affairs. Management of 
the Company has agreed to abide by this fiduciary duty. Each 
Shareholder of the Company or his duly authorized representative 
may inspect the books and records of the Company at any time during 
normal business hours. A Shareholder may be able to institute 
legal action on behalf of himself and all other similarly situated 
Shareholders to recover damages where the Company has failed or 
refused to observe the law. Shareholders may, subject to 
applicable rules of civil procedure, be able to bring a class 
action or derivative suit to enforce their rights, including rights 
under certain federal and state securities laws and regulations. 
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Shareholders who have suffered losses in connection with the 
purchase or sale of their interest in the Company due to a breach 
of fiduciary duty by an officer or director of the Company in 
connection with such sale or purchase, including the misapplication 
by any such officer or director of the proceeds from the sale of 
these securities, may be able to recover such losses from the 
Company- It should be noted that this is a rapidly developing and 
changing area of the law. Investors are urged to consult their own 
legal counsel. 
TRANSACTIONS WITH MANAGEMENT 
In November 1987, the president assigned the product patents 
to the Company, 
The Company's secretary/treasurer currently leases office and 
warehouse space to the Company rent free. 
Ted Hillstead, secretary/treasurer and a director of the 
Company, has made loans to the Company, or retired bank loans made 
to the Company, exceeding $ 100,000. 
When finances permit, the Company intends to hire Luke Glenn. 
Also, the Company intends to hire Judy Glenn, wife of the 
Company's president, as a secretary and office manager. 
PRINCIPAL SHAREHOLDERS 
As of the date of this prospectus, the following persons were 
shareholders who owned of record, or who was known by the Company 
to own beneficially, ten percent or more of the Company's common 
stock. As of the date of this prospectus, these shareholders 
express no intent on selling their shares; though they may choose 
to do so at a later time. Questions concerning the existence of 
stock certificates with forged signatures or certificates issued 
following the transfer or cancellation of such certificates create 
uncertainty about the accuracy of the information known to the 
Company. The following table presents such information in tabular 
form as of the date of this prospectus: 
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Amount and Nature 
Name of of Beneficial Percent 
Title of Class Beneficial Owner Ownership of Class 
Common Stock Luke Glenn 7,500,000c1) 29.62% 
($.001 Par 
Value) Ted Hillstead 7,500,000c1) 29.62% 
(1) These shares were acquired on December 7, 1987 in 
exchange for shares in U.S.A. Medical corporation, a privately-held 
Utah company. James Averett, former counsel to the Company, has 
olaimed an ownership interest in 1,666,666 of the 15,000,000 shares 
held by Mr, Glenn and Mr. Hillstead. Due to the actions of Mr. 
Averett and their affect on the Company and management, Glenn and 
Hillstead intend to contest any ownership claims by Averett. 
The following table sets forth the security ownership of 
management of the Company as of the date of this prospectus. 
Amount and Nature 
Name of of Beneficial Percent 
Title of Class Beneficial Owner Ownership of Class 
Common Stock Luke Glenn 7,500,000 29.62% 
($.001 (Beneficially and 
Par Value) of record) 
Ted Hillstead(1) 7,500,000 29.62% 
Directors and 15f 000,000 59.24% 
Officers as a Group 
In addition to the above persons, management believes that 
ownership by the next two largest shareholders should be disclosed: 
Brian D. Burns(2) 1,859,500 7.00% 
c }
 Mr. Hillstead is the beneficial owner of these shares that 
are held in the name of Tareco. 
<2>
 Shares held in the name of Brian D. Burns and Brian D. 
Burns DC PC Retirement are treated here as being owned by Dr. 
Burns. Dr. Burns loaned the Company $25,000 in December of 1989. 
The loan was due in the first quarter of 1990. Mr. Glenn and Mr. 
Hillstead have agreed to each transfer 250,000 shares of their 
stock to Dr.. Burns in exchange for Dr. Burns suspending any legal 
action to collect on the note until May 1991. Those additional 
shares would bring total ownership to 2,359,500 or 8.95%. An 
additional 1.5 million shares have been pledged to Dr. Burns (see 
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Mike Strand' 1,496,200 5.67% 
footnote 3) , which brings the total number of shares under 
beneficial ownership or control to approximately 3.8 million or 
approximately 14.64%. Because of the large number of shares owned 
or controlled by Dr. Burns, the Company has requested, and Dr. 
Burns has given, consent to having his shares stamped with a legend 
which restricts the public sale of his shares to the volume 
guidelines of rule 144. This action by the Company should not be 
construed as any indication that the Company considers Dr. Burns 
to be a "control person." 
Shares held in the name of Michael Strand Family 
Partnership and John Dawson, are understood to be owned or 
controlled by Michael Strand. Of these shares, 986,200 shares are 
pledged to Brian D. Burns pursuant to an escrow agreement. An 
additional 500,000 shares have also been pledged to Dr. Burns. Mr. 
Strand is not an officer or director of the Company, but because 
of allegations of his previous involvement with the Company 
contained in a lawsuit filed in the United States District Court 
(which was subsequently dismissed), information regarding Mr. 
Strand is included herewith. Mr. Strand has been convicted of tax 
and securities fraud. The tax liability which served as the basis 
for the original charge has now been compromised civilly by the 
Internal Revenue Service to a sum less than $2,000. By letter, Mr. 
Strand's attorney has provided the following statement for 
disclosure purposes: 
Mr. Strand has been involved in the purchase and sale of 
over-the-counter stocks in the Salt Lake area for many years 
and has been associated with a variety, of over-the-counter 
stock companies based in Salt Lake City. 
In 1979, Mr. Strand was convicted in the United States 
District Court for the District of Utah for tax violations 
which involved failure to report certain income derived from 
a finders fee on his tax returns and fraud in the sale of 
securities. This conviction was appealed to higher Courts 
over a number of years, but the appeals were unsuccessful. 
Mr. Strand completed a satisfactory period of probation and 
has no further legal obligation in connection with that 
charge. 
In May of 1987, Mr. Strand was convicted in the United 
States District Court for the District of Wyoming on Three 
Counts. One (1) of Conspiracy, one (1) of Mail Fraud, and one 
(1) of Aiding and Abetting, in connection with a project known 
as the Overland Dome Oil Field. This conviction has been 
appealed to the United States Court of Appeals for the Tenth 
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Management has not entered into any arrangements the operation 
of which may at a subsequent date result in a change in control of 
the Company. Management is currently exploring acquiring other 
products or entities. Such acquisitions would be accompanied 
through the issuance of additional stock which may result in a 
change of control. Except as set forth below, none of the Shares 
held by management is subject to transferability restriction, 
contractual or otherwise. 
All shares held by present management are "restricted 
securities" within the meaning of Rule 144. Rule 144 allows the 
public resale without registration of restricted securities if 
certain conditions are satisfied. These conditions include the 
public availability of current information with respect to the 
Company, limitations on the volume of sales, and sales transacted 
through brokers. Information concerning the Company shall be 
deemed to be available only if the issuer is current in filing its 
reports with the Securities and Exchange Commission pursuant to 
the Securities Exchange Act of 1934, or, if the issuer is not 
subject to such reporting requirement, it has made publicly 
available the information concerning the issuer specified in 
clauses (1) to (14) , inclusive, and clause (16) of Paragraph (a) 
(4) of Rule 15c2-ll under that Act. As of, the date of this 
prospectus, the Company is not subject to the reporting 
requirements of the 1934 Act. Information is publicly available 
by contacting broker/dealers making a market in the Company's stock 
or by contacting the Company. Sales of securities of an affiliate, 
or a non-affiliate who has owned the stock for less than three 
years, are limited to one percent (1%) of the total outstanding 
shares of the issuer during the three months preceding the sale. 
Further, the securities must be sold in broker's transactions 
within the meaning of Rule 144. Pursuant to Paragraph (k) of Rule 
Circuit, who have remanded the case to the Trial Court for 
rulings on Mr. Strand's Motion for a directed verdict of 
acquittal. The Trial court has not yet ruled on these Motions 
and so the matter is still pending in both Courts. There has 
been no final adjudication in the case. 
Because of the degree of communication between the Company 
and Mr. Strand since October 1990, the Company has requested, and 
Mr. Strand has consented to, having his shares stamped with a "soft 
144" legend, thereby limiting his public sales of the Company's 
shares to 1% of the total shares outstanding during any given 90 
day period. This action by the Company should not be construed as 
any indication that the Company considers Mr. Strand to be a 
"control person." 
26 
144, non-affiliates who have beneficially owned their shares for 
more than three years are not subject to the limitations described 
above regarding public availability of information, quantity of 
sales, and broker transactions. As of the date of this prospectus, 
Luke Glenn and Ted Hillstead is believed to have satisfied the two-
year holding requirement of Rule 144 and are being registered 
pursuant to this document. The sale of such Shares may have a 
depressing effect upon the market price, if any. 
DIVIDENDS 
The Company is currently an undercapitalized business and no 
assurance can be given that it will generate earnings from which 
cash dividends can be paid. If earnings are generated, management 
may follow a policy of retaining all such earnings to finance the 
expansion of its business. Such a policy could be maintained so 
long as necessary to provide funds for the operations of the 
Company. Any dividends that may be paid in the future will be 
dependent upon the earnings and financial requirements of the 
Company and all other relevant factors. 
PLAN OF DISTRIBUTION 
This prospectus registers shares with the Utah Securities 
Division. The shares are not offered for sale by the Company, but 
by individuals, entities, brokers, etc. through secondary trading 
in the over-the-counter market of "Pink Sheet" companies. 
The Division has ordered that Utah brokers who make 
transactions in the Company's stock must provide this prospectus 
to the purchasers and obtain from the purchaser a "Purchaser 
Representation" form. This disclosure and purchaser representation 
procedure must continue for one year after the date of this 
prospectus. Any broker-dealer making a market in, or effecting a 
trade in, the Company's stock must list such quote or transaction 
on the OTC Stock Bulletin Board. 
Any broker-dealers effecting a trade in the Company's stock 
are prohibited from relying on the manual exemption provided at 
Sec. 61-1-14(2)(b) of the Utah Uniform Securities Act. Instead, 
the broker-dealer must rely on the transactional exemption from 
registration as provided in Sec. 61-1-14(2)(m) of the Act. 
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LEGAL MATTERS 
To the best knowledge of the Company, its officers and 
directors, other than disclosed herein, there are no material legal 
actions pending or judgments entered against the Company or its 
present officers and directors and no material legal actions are 
contemplated or threatened against such persons. Legal action 
against former officers, directors, transfer agents, promoters, 
agents, employees, or shareholders of the Company which may affect 
the value or transfer of shares of common stock are possible. 
This prospectus has been prepared pursuant to a Settlement 
Agreement with the Utah Securities Division. The Division has 
required this registration of securities prior to allowing the 
Company's shares secondary trading. Negotiations with the Division 
and preparation of the prospectus was performed by Nathan W. Drage, 
P.C., 2445 West North Temple, Salt Lake City, Utah 84116. Mr. 
Drage was retained by the Company after the decision by the federal 
district court was rendered and after trading was suspended by the 
Utah Securities Division. In the opinion of Mr. Drage, shares that 
are owned by bona fide purchasers are deemed legally issued, fully-
paid and non-assessable. 
EXPERTS 
The financial statements of the Company for the period ended 
December 31, 1990 appearing in this prospectus have been examined 
by Tanner & Company, Certified Public Accountants, as indicated in 
the report contained herein. Such financial statements are 
included herein in reliance upon the said report, given upon 
authority of such person as an expert in accounting and auditing. 
Tanner & Company was retained as the Company's auditors in the 
spring of 1989. 
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OTHER MATTERS 
The Company's transfer agent and registrar of its shares is 
Atlas Stock Transfer Corporation, 5899 South State, Murray, Utah. 
The Company has filed a Registration Statement with the Utah 
Securities Division, Salt Lake City, Utah, The complete 
Registration Statement may be inspected at such office and copies 
may be obtained by the public at the Securities Division, 160 East 
3 00 South, upon payment of the usual fees for reproduction. 
The Company's fiscal year end is December 31. 
EXHIBITS 
The following exhibits are attached hereto and incorporated 
into this Prospectus: 
Audited financial statements of the Company dated 
December 31, 1990, December 31, 1989 and December 31, 
1988. 
Financial statements of the Company dated December 31, 
1987 have been excluded because management now believes 
that the information necessary to create such statements 
is either unavailable or unreliable. 
Purchaser Representation Form 
FDA Letter 
Shareholder Letter - March 11, 1991 
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U.S.A. MEDICAL CORPORATION 
Financial Statements -
December 31, 1990 and 1989 
(With Auditors' Report Thereon) 
* 
INDEPENDENT AUDITORS' REPORT 
TANNER-Co. 
675 East 500 South, Suite 640 
Salt Lake City, Utah 84102 
Telephone i801) 532-7444 
Fax (801) 532-491 1 
v -r->OFES£ ^ N A i C 7 R 3 0 ' * A T ' O N 
To the Board of Directors and Stockholders 
of U.S.A. Medical Corporation 
We have audited the accompanying balance sheet of U.S.A. Medical Corporation as of 
December 31, 1990 and 1989, and the related statements of operations, stockholders' (deficit), and 
cash flows for the years then ended. These financial statements are the responsibility of the 
Company's management. Our responsibility is to express an opinion on these financial statements 
based on our audits. 
We conducted our audits in accordance with generally accepted auditing standards. Those 
standards require that we plan and perform the audit to obtain reasonable assurance about whether 
the financial statements are free of material misstatement. An audit includes examining, on a test 
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also 
includes assessing the accounting principles used and significant estimates made by management, 
as well as evaluating the overall financial statement presentation. We believe that our audits 
provide a reasonable basis for our opinion. 
In our opinion, the financial statements referred to above present fairly, in all material 
respects, the financial position of U.S.A. Medical Corporation as of December 31, 1990 and 1989, 
and the results of its operations and its cash flows for the years then ended in conformity with 
generally accepted accounting principles. 
As described in note 4 to the financial statements, the Company is party to various legal 
and regulatory actions. Those actions have resulted in a suspension of trading of the Company's 
stock and allege that the Company is in violation of the securities laws. The ultimate outcome of 
these uncertainties cannot presently be determined. Accordingly, the accompanying financial 
statements do not include any adjustments, if any, that might result from the outcome of these 
uncertainties. 
The accompanying financial statements have been prepared assuming that the Company 
will continue as a going concern. Because of significant operating losses and the excess of current 
liabilities over current assets, the Company's ability to continue as a going concern is dependent 
on attaining future profitable operations, restructuring its financing arrangements, and obtaining 
additional outside financing and/or capital. It is not possible to predict the outcome of future 
operations or whether the necessary alternative financing or additional capital may be arranged. 
The financial statements do not include any adjustments that might result from the outcome of this 
uncertainty. 
Salt Lake City, Utah 
January 23, 1991 
U.S.A. MEDICAL CORPORATION 
Balance Sheet 
December 31, 1990 and 1989 
Assets 1990 1989 
Current assets: 
Cash 
Accounts receivable 
Marketable securities 
Inventories 
Prepaid expenses 
Total current assets 
Property and equipment, at cost: 
Machinery and equipment 
Furniture and fixtures 
Less accumulated depreciation 
Property and equipment, net 
$ -
-
-
12,272 
-
12,272 
13,266 
10.225 
23,491 
9.600 
13.891 
7,370 
4,334 
590 
17,914 
5.151 
35.359 
13,266 
10.225 
23,491 
6.854 
16.637 
Patent costs, net of accumulated amortization 
of $347 and $101, respectively 5,455 5,802 
Liabilities and Stockholders' (Deficit) 1990 1989 
Current liabilities: 
Notes payable 
Accounts payable 
Accrued liabilities 
Advances from shareholders 
Total current liabilities 
35,583 
55,467 
51,438 
95,805 
44,873 
46,444 
39,659 
98,805 
238,293 229,781 
Stockholders' (deficit): 
Common stock, $.001 par value. 50,000,000 
shares authorized; 26,352,500 shares and 
25,352,500 shares issued and outstanding 
at December 31, 1990 and 1989, respectively 
Additional paid-in capital 
Accumulated (deficit) 
Total stockholders' (deficit) 
26,353 
138,108 
(371.136) 
(206.675) 
$ 31.618 
25,353 
138,108 
(335.444) 
(171.983) 
57.798 
See accompanying notes to financial statements. 
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U.S.A. MEDICAL CORPORATION 
Statement of Operations 
Years Ended December 31, 1990 and 1989 
1990 1989 
Revenue 
Cost of goods sold 
Gross margin 
Selling, general and administrative expenses 
Net operating (loss) 
Other income (expense) 
Loss on marketable securities 
Gain on forgiveness of debt 
Net (loss) 
$ 18,266 
7,973 
10.293 
57,685 
(47.392) 
(590) 
12.290 
11.700 
$ (35,692) 
11,491 
21,346 
(9.855) 
36,762 
(46.617) 
-
_ 
(46,617) 
(Loss) per share 
Weighted average number of shares outstanding 
$ (.001) 
26,102.500 
(.002) 
25,313.596 
See accompanying notes to financial statements. 
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U.S.A. MEDICAL CORPORATION 
Statement of Stockholders' (Deficit) 
Years Ended December 31, 1990 and 1989 
Common Stock Additional Accumulated 
Shares Amount Paid-in Capital (Deficit) 
Balance, January 1, 1989 25,312,500 $25,313 128,148 (288,827) 
Stock issued for cash on 
December 21, 1989 at $.25 
per share 40,000 40 9,960 
Net (loss) (46,617) 
Balance, December 31, 1989 25,352,500 25,353 138,108 (335,444) 
Stock issued for services 
at $.001 per share 1,000,000 1,000 
Net (loss) (35,692) 
Balance, December 31, 1990, 26,352,500 $26,353 138,108 (371,136) 
See accompanying notes to financial statements. 
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U.S.A. MEDICAL CORPORATION 
Statement of Cash Flows 
Years Ended December 31, 1990 and 1989 
1990 1989 
Cash flows from operating activities: 
Net (loss) $(35,692) (46,617) 
Adjustments to reconcile net (loss) to 
net cash (used in) operating activities: 
(Increase) decrease in: 
Depreciation and amortization 
Gain on forgiveness debt 
Loss on marketable securities 
Accounts receivable 
Inventories 
Prepaid expenses 
Deposits 
Increase (decrease) in: 
Accounts payable 
Accrued liabilities 
Common stock issued for services 
Net cash (used in) operating activities 
Cash flows from investing activities: 
Purchase of property and equipment 
Increase in patent costs 
Net cash provided by (used in) investing 
activities 
Cash flows from financing activities: 
Issuance of common stock 
Net borrowings - short-term notes payable 
Net cash provided by financing activities 
Net increase (decrease) in cash 
Cash, beginning of period 
Cash, end of period 
Noncash investing and financing activities: 
Marketable securities issued for debt $ 9,290 
Interest paid $ 3,410 
See accompanying notes to financial statements. 
3,093 
(12,290) 
590 
4,334 
5,642 
5,151 
9,023 
11,779 
1,000 
(7.370) 
-
-
-
(7,370) 
7.370 
£ -
2,847 
4,897 
(1,303) 
775 
7,497 
3,041 
(28.863) 
(4,791) 
(1.000) 
(5,791) 
10,000 
31.809 
41.809 
7,155 
215 
7,370 
U.S.A. MEDICAL CORPORATION 
Notes to Financial Statements 
December 3 1 , 1990 and 1989 
(1) Summary of Significant Accounting Policies 
Organization 
The Company was incorporated January 12, 1979 in the State of Wyoming under the 
name SMI, Inc. On December 7, 1987, the Company acquired all of the outstanding stock of 
U.S.A. Medical Corporation in a tax free exchange and changed its name to U.S.A. Medical 
Corporation. The Company is engaged in the manufacture, research and development of and 
sale of medical equipment. 
Inventories 
Inventories are comprised of completed products held for sale, parts and supplies and 
are valued at the lower of cost, determined using the first-in, first-out (FIFO) basis, or market. 
Depreciation 
Depreciation is calculated using the straight-line method based on estimated useful lives 
of 7 to 15 years. 
Patent Costs 
The Company incurred costs of $5,903 in applying for patent rights. The Company 
amortizes these costs over the life of the patent. 
Income Taxes 
There have been no earnings through December 31, 1990 and, accordingly, no provision 
for income taxes is reflected in the accompanying financial statements. The Company at 
December 31, 1990 has a net operating loss carryforward of approximately $370,000. 
(Loss) Per Common Share 
(Loss) per share of common stock is calculated based upon the weighted average number 
of common shares outstanding. 
Cash Flow Statement 
For purposes of reporting cash flows, cash and cash equivalents include cash on hand, 
amounts due from banks, and federal funds sold. Generally, federal funds are purchased and 
sold for one-day periods. 
Reclassifications 
Certain of the 1989 amount have been reclassified to conform with the 1990 presentation. 
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U.S.A. MEDICAL CORPORATION 
Notes to Financial Statements - Continued 
$ -
12,272 
$12.272 
8,585 
8,529 
800 
17,914 
12) Inventories 
Inventories at December 31, 1990 and 1989 consist of the following: 
1990 1989 
Finished goods 
Parts 
Supplies 
(3) Notes Payable 
Notes payable at December 31, 1990 and 1989 consists of the following: 
1990 1989 
Note payable to an individual with interest 
12.5% due in January 1990, unsecured. The 
Company is in default on the note. $25,000 25,000 
Note payable to two shareholders due March 1, 
1989 with interest at prime + 3%, unsecured. 
The Company is in default on these notes. 10,583 10,583 
Note payable to individuals payable upon 
demand without interest
 1_ 9,290 
$35,583 44,873 
(4) Contingencies 
Going Concern 
As shown in the accompanying financial statements, the Company incurred a net loss 
of $35,692 during the year ended December 31, 1990 and as of that date, the Company's 
current liabilities exceeded its current assets by $226,021 and its total liabilities exceeded its 
total assets by $206,675. These factors create an uncertainty about the Company's ability to 
continue as a going concern. 
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U.S.A. MEDICAL CORPORATION 
Notes to Financial Statements - Continued 
(4) Contingencies 
Litigation 
The Company is a party in legal actions regarding the trading of Company stock. 
Currently, trading of the stock in the state of Utah has been suspended. The outcome of these 
actions is uncertain. Management is unable to determine an adjustment, if any, that the 
Company may incur relating to these uncertainties. Therefore, no adjustment to the financial 
statement has been made based on their possible outcome. 
Insurance Coverage 
The Company at December 31, 1990 does not have any insurance coverage. 
(5) Related Party Transactions 
The accounts receivable at December 31, 1989, include amounts due from the Company's 
president and his wife in the amount of $2,417 for personal use of company credit cards. 
The company purchases medical equipment from a company owned by an employee of the 
company. The Company has purchases and accounts payable to the related company at December 
31, 1990 and 1989 of approximately $2,700 and $2,900, respectively. 
The Company has also received unsecured non-interest bearing advances from shareholders 
totaling $95,805 and $98,805 at December 31, 1990 and 1989, respectively. 
(6) Concentration of Credit 
The Company primarily has sales in the medical equipment industry to individuals and business 
in the United States. 
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U.S.A. MEDICAL CORPORATION 
Financial Statements - December 31, 1988 
(With Auditors' Report Thereon) 
r j - TANNER-Co. 
* 
INDEPENDENT AUDITORS' REPORT 
TANNER-Co. 
376 East 400 South Suite 2CC 
Salt Lake Cty Utah 84 111-2990 
To the Board of Directors and Stockholders Telephone son 532 7444 
of U.S.A. Medical Corporation *»«, , . < . - f w » A i i y i 
We have audited the accompanying balance sheet of U.S.A. Medical Corporation as of 
December 31, 1988, and the related statements of operations, stockholders' equity (deficit), and 
cash flows for the year then ended. These financial statements are the responsibility of the 
Company's management. Our responsibility is to express an opinion on these financial statements 
based on our audit. 
We conducted our audit in accordance with generally accepted auditing standards. Those 
standards require that we plan and perform the audit to obtain reasonable assurance about whether 
the financial statements are free of material misstatement. An audit includes examining, on a test 
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also 
includes assessing the accounting principles used and significant estimates made by management, 
as well as evaluating the overall financial statement presentation. We believe that our audit 
provides a reasonable basis for our opinion. 
In our opinion, the financial statements referred to above present fairly, in all material 
respects, the financial position of U.S.A. Medical Corporation as of December 31, 1988, and the 
results of its operations and its cash flows for the year then ended in conformity with generally 
accepted accounting principles. 
As described in note 4 to the financial statements, the Company is party to various legal 
and regulatory actions. Those actions have resulted in a temporary suspension of trading of the 
Company's stock and allege that the Company is in violation of the securities laws. The ultimate 
outcome of these uncertainties cannot presently be determined. Accordingly, the accompanying 
financial statements do not include any adjustments, if any, that might result from the outcome of 
these uncertainties. 
The accompanying financial statements have been prepared assuming that the Company 
will continue as a going concern. Because of significant operating losses and the excess of current 
liabilities over current assets, the Company's ability to continue as a going concern is dependent 
on attaining future profitable operations, to restructure its financing arrangements, and obtaining 
additional outside financing and/or capital. It is not possible to predict the outcome of future 
operations or whether the necessary alternative financing or additional capital may be arranged. 
The financial statements do not include any adjustments that might result from the outcome of this 
uncertainty. 
v / " 
Salt Lake City, Utah 
April 4, 1989, except for note 2 which is 
dated May 5, 1989 
*2- TANNER-Co. 
U.S.A. MEDICAL CORPORATION 
Balance Sheet 
December 3 1 , 1988 
Assets 
Current assets: 
Cash $ 215 
Accounts receivable (note 5) 9231 
Inventory (notes 1 and 2) 16,611 
Prepaid expenses __5J51 
Total current assets 
Property and equipment, at cost (note 1): 
Machinery and equipment 
Furniture and fixtures 
Less accumulated depreciation 
Property and equipment, net 
Deposits 
Patent costs (note 1) 
Liabilities and Stockholders' Equity (Deficit) 
Current liabilities: 
Accounts payable (note 5) $ 38,947 
Accrued liabilities 36,618 
Notes payable to related parties (note 3) 111,279 
Total current liabilities 186,844 
Contingencies (note 4) 
Stockholders' equity (deficit) (notes 4, 6 and 7): 
Common stock, $.001 par value. 50,000,000 
shares authorized; 2,531,250 shares 
issued and outstanding 2,531 
Additional paid-in capital 150,930 
Accumulated (deficit) (288,827) 
Total stockholders' equity (deficit) (135,366) 
See accompanying notes to financial statements. 
£ 
31,208 
13,266 
5,601 
18,867 
4,275 
14,592 
775 
4,903 
51,478 
$ 51,478 
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U.S.A. MEDICAL CORPORATION 
Statement of Operations 
Year Ended December 31, 1988 
Revenue - sales 
Cost of goods sold 
Gross margin 
Other expenses: 
General and administrative 
Selling and distribution 
Interest 
Depreciation 
Net (loss) 
(Loss) per share 
Weighted average number of shares outstanding 
See accompanying notes to financial statements. 
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*$* TANNER-Co. 
U.S.A. MEDICAL CORPORATION 
Statement of Stockholders' Equity (Deficit) 
Year Ended December 31, 1988 
Balance, December 31, 1987 as 
previously reported 
Prior period adjustment (note 6) 
Balance, December 31, 1988 
Common Stock Additional Accumulated 
Shares Amount Paid-in Capital (Deficit) 
2,531,250 
Restated balance, December 31, 1987 2,531,250 
Net (loss) 
2,531,250 
$2,531 150,930 (11,633) 
(198,724) 
2,531 150,930 (210,357) 
(78,470) 
150.930 (288,827) 
See accompanying notes to financial statements. 
-3-
"2- TANNER-Co. 
U.S.A. MEDICAL CORPORATION 
Statement of Cash Flows 
Year Ended December 31, 1988 
Cash flows from operating activities: 
Net (loss) 
Adjustments to reconcile net (loss) to net 
cash (used in) operating activities: 
Depreciation 
Decrease in accounts receivable 
Decrease m inventory 
Decrease in prepaid expenses 
Increase in deposits 
Increase in accounts payable 
Increase in accrued liabilities 
Net cash (used in) operating activities 
$(78,470) 
11,162 
4,235 
15,394 
344 
(775) 
4,909 
25,752 
(17,449) 
Cash flows from investing activities 
Cash flows from financing activities: 
Net borrowings - short term notes payable 
Net decrease in cash 
Cash, beginning of year 
Cash, end of year 
15,427 
(2,022) 
2.237 
$ 215 
See accompanying notes to financial statements. 
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U.S.A. MEDICAL CORPORATION 
Notes to Financial Statements 
December 3 1 , 1988 
(1) Summary of Significant Accounting Policies 
A. Organization 
The Company was incorporated January 12, 1979 in the State of Wyoming under 
the name SMI, Inc. On December 7, 1987, the Company acquired all of the outstanding 
stock of U.S.A. Medical Corporation in a tax free exchange and changed its name to 
U.S.A. Medical Corporation. The Company is engaged in the manufacture, research 
and development of and sale of medical equipment. 
B. Inventories 
Inventories are comprised of completed products held for sale, parts and supplies 
and are valued at the lower of cost or market on a first-in, first-out (FIFO) basis. 
C. Depreciation 
Depreciation is calculated using the straight-line method based on estimated 
useful lives of 7 to 15 years. 
D. Patent Costs 
The Company has incurred $4,903 in applying for patent rights. The Company 
will amortize these costs over the life of the patent once approval has been granted. 
E. Income Taxes 
There have been no earnings through December 31, 1988 and, accordingly, no 
provision for income taxes is reflected in the accompanying financial statements. The 
Company at December 31,1988 has a net operating loss carryforward of approximately 
$280,000. 
F. Income (Loss) Per Common Share 
Income (loss) per share of common stock is calculated based upon the weighted 
average number of common shares outstanding during the year ended December 31, 
1988. 
(2) Inventories 
Inventories at December 31, 1988 consist of the following: 
Finished goods $10,509 
Parts 5,722 
Supplies 380 
$16,611 
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r^ TANNER-Co. 
U.S.A. MEDICAL CORPORATION 
Notes to Financial Statements - Continued 
(3) Notes Payable 
Notes payable at December 31, 1988 consist of the following: 
Note payable to a stockholder payable on 
demand without interest, unsecured $ 95,805 
Note payable to two shareholders due March 1, 
1989 with interest at prime + 3%, unsecured 15,474 
$111,279 
(4) Contingencies 
A. Going Concern 
As shown in the accompanying financial statements, the Company incurred a net 
loss of $78,470 during the year ended December 31, 1988, and as of that date, the 
Company's current liabilities exceeded its current assets by $155,636 and its total 
liabilities exceeded its total assets by $127,779. In addition, the Company has a short 
term note payable to two stockholders in the amount of $15,474 which is past due. 
Those factors create an uncertainty about the Company's ability to continue as a going 
concern. 
B. Litigation 
The Company is a party in legal actions regarding the trading of Company stock. 
Currently, trading of the stock in the state of Utah has been suspended. The outcome 
of these actions is uncertain. Management is unable to determine an adjustment, rf any, 
that the Company may incur relating to these uncertainties. Therefore, no adjustment 
to the financial statement has been made based on their possible outcome. 
C. Insurance Coverage 
The Company at April 4, 1989 does not have any insurance coverage. 
(5) Related Party Transactions 
The accounts receivable include amounts due from the Company's president and his 
wife in the amount of $2,417 for personal use of company credit cards. 
The company purchases medical equipment from a company owned by a director of 
the company. The Company has accounts payable to the related company at December 31, 
1988 Of $2,448. 
The Company has two notes payable to stockholders totaling $111,279 (see note 3). 
"> TANNER-Co. 
U.S.A. MEDICAL CORPORATION 
Notes to Financial Statements - Continued 
(6) Prior Period Adjustment 
During the year ended December 31, 1988, it was determined that costs which had in 
prior years been capitalized as development costs were in fact normal operation expenses 
and research and development expenses. These previously capitalized costs total $198,724. 
The Company has charged the prior year's accumulated (deficit) for the $198,724 and 
removed the capitalized development costs. This charge will increase the loss in the prior 
year by $198,724 and increase the amount of loss per share by approximately $.078 per 
share. 
(7) Subsequent Events 
On December 31, 1988, the Board of Directors authorized a 10 for 1 forward stock split. 
This action is pending the authorization by three-fourths of the outstanding shares of company 
stock. 
Effective February 6, 1988, the Company acquired all of the outstanding stock of 
Impulse Corporation in exchange for 5,000,000 shares of Company stock in a tax free 
exchange. The following is summarized operating data for Impulse Corporation for the year 
ended December 31, 1988. 
Sales $47,731 
Cost of sales 3,349 
Gross margin 44,382 
Other income 653 
Total income 45,035 
Operating expenses 45.961 
Net (loss) $ (926) 
The following pro forma schedule shows the effect had the transaction taken place 
January 1, 1988: 
USA Impulse Pro Forma 
Medical Corporation Combined 
Sales $ 26,555 47,731 74,286 
Net (loss) $(70,883) (926) (71,809) 
(Loss) per share (.028) (.00) (.op 
On May 5, 1989, the Company entered into a loan agreement to meet its immediate 
operational needs whereby the Company will borrow $41,000 between May 5, 1989 and July 
15, 1989 to be repaid with interest at 12% per annum on December 1, 1989. The agreement 
also provides that the company pay a royalty of $200 for each Maxim Aspirator sold between 
May 5, 1989 and December 1, 1989 to the lender of the funds. 
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LIFE CONCEPTS, INC. 
Secondary Trading Purchaser Representation 
The Utah Securities Division requires ail brokers transacting 
the sale of Life Concepts, Inc. (the Company), formerly U.S.A. 
Medical Corporation, common stock within the state of Utah to have 
this form completed by the purchaser. The original shall be kept 
on file at the office of the broker/dealer. 
The undersigned purchaser of the Company's common stock hereby 
represents and affirms the following: 
1. I have purchased the securities with my own funds and not 
as a nominee for someone else, unless otherwise disclosed herein. 
2. A prospectus dated March 9, 1991 has been delivered to 
me prior to my purchase and I understand the risks associated with 
purchasing these securities. 
3. Name 
Address 
Phone Number 
Purchase Date Broker Firm 
Social Security Number 
4. Date 
5. signature 
6. The undersigned broker has reviewed the "Summary of 
Prospectus" section (pages 1 and 2) of the Prospectus 
with the Purchaser. 
Broker 
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 
Food and Drug Administration 
AUG - 4 iSdS 8757 Georgia Avenue 
Silver Spring MO 20910 
Mr. Ted Hillstead 
Official Correspondent 
USA Medical Corporation 
1569 W. 2650 S. Suite 7 
Ogden, Utah 84401 
Dear Mr, Hillstead: 
We have reviewed your Section 510(k) notification of intenc to market the 
above device and we have determined Che device to be substantially equivalent 
to devices marketed In interstate commerce prior to May 28, 1976, the 
anactment date of the Medical Device Amendments. You may, therefore, market 
7*our device subject to the general controls provisions of the Federal Food, 
Drug, and Cosmetic Act (Act) until such time as your device has been 
(Classified under Section 513. At that time, if your device is classified into 
either "class* II (Performance Standards) or class III (Premarket Approval), it 
irould be subject to additional controls. 
Dur substantially equivalent decision is based on the device not being 
Intended for use in. suction lipectomy. Devices Intended for this use are 
rurrently considered to be classified by statute in class III under the 
provisions of Section 513(f) of the Act. Any direct or indirect promotion of 
this device for suction lipectomy would first require that a premarket 
ipproval application (PMA) be approved or the device reclassified. 
General controls presently include regulations on annual registration, listing 
if devices, good manufacturing practice> labeling, and the misbranding and 
idulteration provisions of the Act. In the future, the scope of general 
lontrols may be broadened to include additional regulations. 
U.1 regulations and information on meetings of the device advisory committees, 
their recommendations, and the final decisions of the Food and Drug 
Administration (FDA) will be published in the FEDERAL REGISTER. We suggest 
rou subscribe to this publication so that you can convey your views to FDA if 
fou desire and be notified of any additional requirements imposed on your 
ievice. Subscriptions may be obtained from the Superintendent of Documents, 
J.S. Government Printing Office, Washington, D.C. 20402. Such information 
ilso may be reviewed in the Dockets Management Branch (HFA-305), Food and Drug 
Administration, Room 4-62, 5600 Fishers Lane, Rockville, Maryland 20857. 
Re: K862751 
USA Aspirator 
Dated: July 9, 1986 
Received: July 22, 1986 
Page 2 - Mr. Ted Hilistead 
This letter does not in any way denote official FDA approval of your device or 
its labeling. Any representation that creates an impression of official 
approval of this device because of compliance with the premarket notification 
regulations is misleading and constitutes misbranding. If you desire advice 
on the labeling for your device or other information on your responsibilities 
under the Act, please contact the Office of Compliance, Division of Compliance 
Operations (HJZ-320), 8757 Georgia Avenue, Silver Spring, Maryland 20910. 
Sincerely yours, 
Carl A. Larson, Ph.D. 
Director 
Division of Surgical 
and Rehabilitation Devices 
Office of Device Evaluation 
Center for Devices 
and Radiological Health 
LIFE CONCEPTS, INC. 
(Formerly U.S.A. Medical Corporation) 
2020 South 1900 West 
Ogden, Utah 84401 
Annual Shareholder Meeting Report 
March 11, 1991 
bear Shareholder: 
An annual meeting of the shareholders of Life Concepts, Inc. 
(formerly U.S.A. Medical Corporation and S.M.I., Inc.) was held at 
9:30 a.m. on March 9, 1991. 
At the meeting the shareholders voted in favor of the 
following: 
1) Election of Luke Glenn and Ted Hillstead to the Board of 
Directors; 
2) Changing the Company's name from U.S.A. Medical 
Corporation to Life Concepts, Inc.; 
3) Creation of a wholly-own Utah subsidiary and merger of 
that subsidiary for purposes of changing domicile; waiving the 
thirty day waiting period; 
4) Ratified actions of the Board since the last annual 
meeting, including amendments to the Bylaws and termination of a 
director, and change of transfer agent to Atlas Stock and Transfer. 
The Company also announced the signing of a preliminary 
agreement to merge or acquire Heiner Bottling Company in exchange 
for approximately 51% of the shares of the Company. Heiner bottles 
and markets mineral water from Northern Utah springs. Prior to 
consummation of that reorganization, Heiner is required to obtain 
audited financial information and the Company is to have another 
shareholder meeting to increase the number of shares authorized in 
order to complete the reorganization. 
Ted Hillstead 
Secretary 
HEINER BOTTLING COMPANY 
«Aa<wiiiinsira8» 
^/l<></{(/ . l/o(f/i/<tf/t _ l/utera/il a/e/ 
805 E. Como Springs Road 
P.O. Box 386 
Morgan, Utah 84050 
(801) 829-6779 
INTRODUCTION AND BRIEF HISTORY 
HEINER BOTTLING COMPANY was formed to engage in the business 
of bottling mineral water for distribution throughout the western 
United States, 
The springs that produce ANNIE HEINER PURE ROCKY MOUNTAIN 
MINERAL SPRING WATER are of volcanic origin. In the early 1870's 
Dr. Kohler of the Rush Medical College of Indiana came to the 
Morgan Valley. His attention was drawn to the Springs and he 
analyzed the water and found it to contain wonderful properties. 
As time passed, a Dr. T. S. Wadsworth and a Dr. C. F. Osgood made 
their homes in Morgan, and when they heard about the springs 
flowing freely under the rocks at COMO SPRINGS, they too analyzed 
the water and reached the same conclusion that Dr. Kohler had. 
The analysis done by Ford Chemical Laboratories confirmed that the 
water is a top quality MINERAL SPRING WATER. 
The natural mineral spring water flows from twenty-one springs 
located at Como Springs in Morgan, Utah. To confirm the fact that 
this is of the highest quality, we have included a comparison of 
our water and Perrier which is the largest selling bottled mineral 
water in the world. These tests clearly show our water to be one 
of the best in the world. 
Huish Chemical Company of Salt Lake has been distributing 
laundry and dish wash detergent throughout the western United 
States for over eight years. They have a network of over 160 
brokers, and a fleet of trucks for distribution. Dan Huish has 
been working with us on the bottling company, and his company will 
assist us with the distribution and sales to the major grocery 
chains. The relationships already established between Huish and 
these chains will allow our distributors immediate access to the 
marketplace. also, with Huish1s trucking network, we will be in 
places like California at less cost than the California bottlers. 
Initially, the company will produce two sizes and three 
flavors of ALL NATURAL MINERAL SPRING WATER. We will have a ten 
ounce and a one liter size, in glass containers. The all natural 
flavors will be 1) Natural - no flavors added, 2) lemon-lime, 3) 
Cherry. Our Market research indicates the mix of the two sizes to 
approximately 60-40. 
HEINER BOTTLING OCMPANY 
OOMD SPRINGS, UTAH 
KAY L. BOWEN & ASSOCIATES 
CERTIFIED PUBLIC ACCOUNTANT 
HEINER BOTTLING COMPANY 
«AHIQ3HIHNER» 
Lu/rc L/io<A// . l/ort/t/at/t . l/t/tera/ 'It a/er 
805 E. Como Springs Road 
P.O. Box 386 
Morgan, Utah 84050 
(801) 829-6779 
TO THE BOARD OF DIRECTORS 
AND STOCKHOLDERS 
HEINER BOTTLING COMPANY 
COMO SPRINGS, UTAH 
THE ACCOMPANYING BALANCE SHEET OF HEINER BOTTLING COMPANY ( A 
UTAH CORPORATION) AS OF DECEMBER 31, 1990, AND THE RELATED 
STATEMENTS OF INCOME, RETAINED EARNINGS, AND CASH FLOWS FOR THE 
THREE MONTHS THEN ENDED HAS BEEN PREPARED FROM THE BOOKS AND 
RECORDS OF THE COMPANY. 
TO THE BEST OF MY KNOWLEDGE, THE INFORMATION PRESENTED IN THESE 
FINANCIAL STATEMENTS IS COMPLETE AND ACCURATE. 
SINCERELY. 
<G> 
R. HEINER, PRESIDENT 
RUARY 26, 1990 
HEINER BOTTLING COMPANY 
COMO SPRINGS , UTAH 
UNAUDITED BALANCE SHEET 
DECEMBER 31, 1990 
ASSETS 
Current Assets: 
Cash 
Accounts receivable 
Subscriptions receivable 
Inventory - raw materials 
Inventory - finished goods 
Total Current Assets 
2,175 
3,559 
3,163 
15,974 
19,395 
$44,266 
Property, Plant & Equipment: 
Water rights - 500 acre feet 1,250,000 
Leasehold improvements 179,398 
Machinery and equipment 374,556 
Furniture and fixtures 13,924 
Total 1,817,878 
Less accumulated depreciation 10 , 825 
Total Property, Plant & Equipment $1,807,050 
Other Assets: 
Pre-production costs 
Less accumulated amortization 
61,553 
3,268 
Total Other Assets 58,285 
TOTAL ASSETS $1,909,601 
HEINER BOTTLING COMPANY 
COMO SPRINGS, UTAH 
UNAUDITED BALANCE SHEET 
DECEMBER 31, 1990 
LIABILITIES AND STOCKHOLDERS EQUITY 
Current Liabilities: 
Accounts payable 
Notes payable - current portion 
Accrued taxes and 
withholding payable 
Advertising reserve 
Accrued interest payable 
Total Liabilities 
2 
24 
, 057 
, 5 8 3 
465 
964 
300 
28,369 
Long-Term Liabilities: 
Notes and mortgages payable 
Notes payable - stockholders 
Total Long-Term Liabilities 
133,591 
188,186 
321,777 
Stockholders Equity: 
Common stock $1.00 par value, 
5,000,000 shares authorized, 
1,030,000 shares issued and 
outstanding 
Paid in capital 
Retained earnings (deficit) 
1,030,000 
555,200 
<25,745> 
Total Stockholders Equity 1,559,455 
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY $1,909,601 
HEINER BOTTLING COMPANY 
COMO SPRINGS
 f UTAH 
UNAUDITED STATEMENT OF INCOME AND RETAINED EARNINGS 
FOR THE THREE MONTH PERIOD ENDED DECEMBER 31, 1990 
Sales $ 1,888 
Less cost of goods sold 1,071 
Gross Income 817 
Less Operating Expenses: 
Interest expense 
Rent expense 
Depreciation expense 
Amortization expense 
Telephone and utilities 
Office expense 
Janitorial and cleaning expense 
Vehicle expense 
Supplies expense 
Repairs and maintenance 
Taxes and licenses 
Total Operating Expenses 
Net Income (Loss) 
Add Interest Income 
Net Income (Loss) 
Retained Earnings - October 1, 1990 
Retained Earnings - December 31, 1990 
4,772 
5,250 
8,121 
2,451 
738 
358 
22 
194 
281 
72 
110 
22,369 
<21,552> 
389 
<21,163> 
<4,582> 
<25,745> 
Earnings (Loss) Per Share $<.02> 
HEINER BOTTLING COMPANY 
COMO SPRINGS, UTAH 
UNAUDITED STATEMENT OF CASH FLOWS 
FOR THE THREE MONTH PERIOD ENDED DECEMBER 31f 1990 
Cash Flows From Operating Activities: 
Operations: 
Net Income (Loss) <21,163> 
Add (Deduct) Items Not Affecting Cash: 
Depreciation and amortization expense $ 10,572 
(Increase) in accounts receivable 5,321 
(Decrease) in inventories <6/097> 
(Increase) in accounts payable 1,074 
(Decrease in accrued taxes and 
withholding payable <21> 
Increase in advertising reserve 176 
Increase in accrued interest payable 4_7 
Total 11,072 
Net Cash Provided (Used) From Operations <10,091> 
Cash Flows From Investing Activities: 
Purchase of fixed assets and 
preproduction costs <26,620> 
Cash Flows from Financing Activities: 
Increase in notes and mortgages payable 12,654 
Increase in notes payable - stockholders 14,750 
Cash Provided From Financing Activities 27,404 
Net Increase in Cash <9,307> 
Cash Balance - October 1, 1990 11,482 
Cash Balance - December 31, 1990 2,175 
HEINER BOTTLING COMPANY 
COMO SPRINGS, UTAH 
UNAUDITED NOTES TO THE FINANCIAL STATEMENT 
DECEMBER 31, 1990 
Note 1 - Summary of Significant Accounting Policies: 
Heiner Bottling Company was incorporated under the laws of the 
State of Utah on June 12, 1986. It was organized to engage in the 
business of bottling mineral water, from the mineral water sprints 
£t Como Springs in Morgan, Utah, 
Revenue Recognition: 
Sales are recorded when an order for the product has been 
received, and the product has been shipped from the plant, by 
common carrier or in the buyer's own trucks. Shipments made on the 
Company's own trucks are not recorded as sales, until the product 
is received by the purchasing Company. 
Inventories: 
Raw material inventories are recorded at cost, using the 
First-in, First-out Method of inventory valuation. Finished goods 
inventories are recorded using the Full Absorption Costing Method 
for manufacturing costs. 
Repair parts and supplies are expensed in the period they are 
purchased. 
Property, Plant & Equipment: 
Property, plant and equipment are recorded at cost. The water 
rights were transferred to the Company, at incorporation, for 
capital stock. They were valued at $2,500 per acre foot, as 
appraised by the Lester S. Froerer, on August 9, 1989. 
Depreciation is provided using the following estimated periods 
of useful life, using a straight line method of depreciation. 
Machinery and Equipment 5 - 1 5 years 
Leasehold Improvements 25 years 
Furniture and Fixtures 5 - 1 0 years 
Expenditures, which materially extend the useful life of an 
asset, are capitalized as incurred. Normal maintenance and minor 
repairs are expensed. 
Pre-production Costs: 
Pre-production costs are the costs that were incurred in 1987-
1990, before actual production began, that could not be assigned to 
a specific function, equipment installation or leasehold equipment 
expenditure. These costs can reasonably be expected to be 
recovered over the next five years, and thus, are being amortized 
over sixty months. 
Note 2 - Notes and Mortgages Payable: 
The Company obtained long-term financing from First Security 
Blink, with an SBA loan on April 25, 1990, The loan is at prime 
plus 2% and matures on April 25, 1997. The loan calls for monthly 
payments of principle and interest in the amount of $2,702.00 per 
month. Collateral for the loan is the equipment and the inventory 
of the Company. 
The Company also has a note payable on a van in the amount of 
$9,250 dated December 31, 1990. The note is payable in monthly 
installments of $255.71 with interest at 12.9%. 
Also on December 31, 1990, the Company borrowed $7,000.00 on 
its line of credit at Valley Bank and Trust Co. 
Note 3 - Lease on Plant: 
The Company leases its facility, a 14,000 square foot 
facility, and surrounding grounds for $1,750.00 per month. The 
lease began on October 1, 1988 and extends for a period of five 
years, with three (3) five-year extensions on the lease available 
in the lease agreement. 
Note 4 - Notes Payable - Stockholdings: 
The amounts due Stockholders are advances, to the Company by 
the Stockholders, which draw no interest and are payable to the 
Stockholders from future earnings of the Company. 
Also past due lease payments have been recorded as notes 
payable to Como Springs Corporation. 
EXHIBIT "UU" 
1392 5-7-90 Exempted Securities— § 3(b) 2635-3 
H 2367] Statement Required in all Offering Circulars 
Reg. § 230.259. There shall be set forth on the cover page of every offering 
:ircular the following statement in capital letters printed in boldface roman type at 
east as large as ten-point modern type and at least two points leaded, 
THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION DOES 
W T PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY 
SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT 
?>ASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING 
ZIRCULAR OR OTHER SELLING LITERATURE THESE SECURITIES ARE 
3FFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH 
rHE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN 
INDEPENDENT ^DETERMINATION THAT THE SECURITIES OFFERED 
HEREUNDER ARE EXEMPT FROM REGISTRATION." 
[Adopted in Release No. 33-3663, July 23, 1956, 21 F. R. 5739, amended in 
Release No. 33-6340 fl[ 83,015), effective September 17, 1981, 46 F R. 41766.] 
H 2368] Reports of Sales Hereunder 
Reg. § 230.260. Within 30 days after the end of each six-month period following 
he date of the original offering circular (offering statement—Part II) required by 
} 230.256, or of the statement required by §230 257, the issuer or other person for 
vhose account the securities are offered shall file with the Regional Office of the 
Commission with which the offering statement was filed four copies of a report on Form 
!-A containing the information called for by that form. A final report shall be made 
lpon completion or termination of the offering and may be made prior to the end of the 
ix-month period in which the last sale is made. 
[Adopted in Release No. 33-3663, July 23, 1956, 21 F. R. 5739, amended in 
Release No. 33-6340 (If 83,015), effective September 17, 1981,46 F. R 41766.] 
11 2369] Suspension of Exemption 
Reg. §230.261. (a) The Commission may, at any time after the filing of an 
iffering statement, enter an order temporarily suspending the exemption, if it has 
eason to believe that— [Amended in Release No. 33-6340 (If 83,015), effective Sep-
ember 17,1981,46 F. R. 41766.] 
(1) no exemption is available under §§230.251 to 230.262 for the securities 
mrported to be offered hereunder or any of the terms or conditions of § §230 251 to 
130.262 have not been complied with, including failure to file any report as required by 
(230.260; 
(2) the offering statement or any other sales literature contains any untrue 
tatement of ajnaterial fact or omits to state a material fact necessary in order to 
nake the statements made, in the light of the circumstances under which they are 
nade, not misleading; [Amended in Release No. 33-6340 (jf 83,015), effective Septem-
ber 17, 1981, 46 F. R. 41766.] 
(3) the offering is being made or would be made in violation of Section 17 of the 
kct; 
(4) any event has occurred after the filing of the offering statement which would 
lave rendered the exemption hereunder unavailable if it had occurred prior to such 
iling; [Amended in Release No. 33-6340 (jf 83,015), effective September 17, 1981, 46 
\ R. 41766.] 
(5) any person specified in paragraph (c) of § 230.252 has been indicted for any 
rime or offense of the character specified in subparagraph (3) thereof, or any 
iroceeding has been initiated for the purpose of enjoining any such person from 
'ederal Securities Law Reports Reg. §230.261 112369 
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engaging in or continuing any conduct or practice of the character specified in 
subparagraph (4) of such paragraph; 
(6) any person specified in paragraph (d) of § 230 252 has been indicted for any 
crime or offense of the character specified in subparagraph (1) thereof, or any 
proceeding has been initiated for the purpose of enjoining any such person from 
engaging in or continuing any conduct or practice of the character specified in 
subparagraph (2) of such paragraph; or 
(7) the issuer or any promoter, officer, director or underwriter has failed to 
cooperate, or has obstructed or refused to permit the making of an investigation by the 
Commission in connection with any offering made or proposed to be made hereunder. 
(b) Upon the entry of an order under paragraph (a) of this section the Commission 
will promptly give notice to the persons on whose behalf the offering statement was 
filed (1) that such order has been entered, together with a brief statement of the 
reasons for the entry of the order, and (2) that the Commission, upon receipt of a 
written request within 30 days after the entry of such order, will, within 20 days after 
the receipt of such request, set the matter down for hearing at a place to be designated 
by the Commission. If no hearing is requested and none is ordered by the Commission, 
the order shall become permanent on the thirtieth day after its entry and shall remain 
in effect unless or until it is modified or vacated by the Commission. Where a hearing is 
requested or is ordered by the Commission, the Commission will, after notice of an 
opportunity for such hearing, either vacate the order or enter an order permanently 
suspending the exemption. [Amended in Release No. 33-6340 (jf 83,015), effective 
September 17, 1981, 46 F. R. 41766.] 
(c) The Commission may, at any time after notice of and opportunity for hearing, 
enter an order permanently suspending the exemption for any reason upon which it 
could have entered a temporary suspension order under paragraph (a) of this rule. Any 
such order shall remain in effect until vacated by the Commission. 
(d) All notices required by this rule shall be given to the person or persons on 
whose behalf the offering statement was filed by personal service, registered or certified 
mail or confirmed telegraphic notice at the addresses of such persons given in the 
offering statement. [Amended in Release No. 33-6340 (f 83,015), effective September 
17,1981, 46 F.R. 41766.] 
[Adopted in Release No. 33-3663, July 23, 1956, 21 F. R. 5739; amended by 
Release No. 33-3935, July 11, 1958, 23 F. R. 4455; and Release No. 33-4744, effective 
December 11, 1964, 29 F. R. 16982; amended in Release No. 33-6340 fll 83,015), 
effective September 17, 1981, 46 F. R. 41766.] 
[H 2370] Consent to Service of Process 
Reg. § 230.262. (a) If the issuer, any of its directors or officers, any person for 
whose account any of the securities are to be offered, or any underwriter of the 
securities to be offered, is not a resident of the United States, each such non-resident 
person shall, at the time of filing the offering statement required by §230 255, furnish 
to the Commission in a form prescribed by or acceptable to it, a written irrevocable 
consent and power of attorney which—[Amended in Release No. 33-6340 (fl 83,015), 
effective September 17, 1981,46 F. R. 41766.] 
(1) designates the Securities and Exchange Commission as an agent upon whom 
may be served any process, pleadings, or other papers in any civil suit or action 
brought against the person executing the consent and power of attorney or to which he 
has been joined as defendant or respondent, in any appropriate court in any place 
subject to the jurisdiction of the United States, where the cause of action (i) accrues on 
or after the effective date of this rule, and (ii) arises out of any offering made or 
purported to be made under §§230.251 to 230.262 or any purchase or sale of any 
security in connection therewith; and 
H2370 Reg. §230.262 ©1990, Commerce Clearing House, Inc. 
